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Abstract 
Bovine mastitis is recognised worldwide as the most important and costly disease affecting dairy 
cattle. The reduction of herd mastitis rates is crucially needed to improve animal welfare and 
profitability, and lessen the reliance on antibiotics.  
Single nucleotide polymorphisms (SNPs) within genes that have a critical role in the innate 
immune response, such as Toll-like receptors (TLRs) and the chemokine receptors CXCR1 and 
CXCR2, could impact on establishment and progression of intramammary infection, and therefore 
influence an animal’s susceptibility to disease. The genetic selection of animals with favourable TLR 
and CXCR1/2 mutations, with no impact on production traits, could be incorporated into dairy 
breeding programmes.  
In order to investigate any associations with clinical mastitis (CM) incidence and milk quality 
and quantity, this study identified and analysed SNPs alongside actual CM and production data from a 
Holstein-Friesian herd. This revealed 46 SNPs, 9 of which are novel, within boTLR1/4/5, boCD14, 
boCXCR1 and boCXCR2; selected SNPs were then tested for association with CM. This is the first 
report of boTLR1 SNPs and a non-coding boCXCR1 SNP that associate significantly with 
susceptibility to CM. Favourable linkage of reduced CM with increased milk fat and protein was 
observed, indicating selection for these markers would not be detrimental to milk quality.  
Furthermore, this study provides evidence that some of these SNPs underpin functional 
variation in bovine TLR1 and CXCR1, and possibly underlie an immunological mechanism for 
disease susceptibility. SNPs in boTLR1 and boCXCR1 were significantly associated with impaired 
transcript levels in milk somatic cells. In addition boTLR1 SNPs associated with impaired cytokine 
responses from cell populations when exposed to ligand or heat-killed mastitis-causing bacteria. The 
potential impact of boTLR1 variation on the immune response to Staphylococcus aureus is 
demonstrated, and this has implications for boTLR1-mediated immune responses to other pathogens. 
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1.1 Bovine mastitis 
1.1.1 Bovine mastitis is an economically important disease 
Bovine mastitis is a disease in cattle resulting from inflammation of the mammary gland 
which can lead to swelling and hardening of the udder, changes in the composition and 
quality of the milk and permanent damage to the mammary tissue (Zhao and Lacasse 2008). 
Mastitis is generally the result of teat duct invasion and intramammary establishment of 
bacteria, whereupon host detection initiates inflammatory responses in an attempt to 
eliminate infection. The ubiquitous presence of mastitis-causing bacteria in or on the cow and 
around the farm environment means the most effective disease control measures often rely on 
farm management practices to limit the duration of bacterial infection and to restrict 
contagious spread of pathogens through the herd. Commonly this involves isolation of 
affected cows from the milking herd to either allow to self-cure or to treat with an appropriate 
antibiotic regimen. The severity of a seemingly untreatable long-term infection or the damage 
and permanent loss of productivity from repeated infection can result in premature culling of 
the cow. Losses due to reduction in milk yield, discarding of ‘unhealthy’ milk, increased 
mortality, culling and treatment costs make mastitis the most economically important disease 
of dairy cattle worldwide, with annual losses to industry in the United Kingdom (UK) alone 
estimated at £300 million (Viguier, Arora et al. 2009). The disease further raises major issues 
for animal welfare and food product safety (Oliver, Jayarao et al. 2005), as well as concerns 
over the widespread and sometimes inappropriate use of antibiotics that may promote the 
development of resistance in mastitis-causing bacteria (Goni, Vergara et al. 2004; 
Vanderhaeghen, Cerpentier et al. 2010). Bovine mastitis continues to be a significant problem 
and the development of additional long term and complementary control measures to further 
reduce incidence will be of great benefit to the industry, the welfare of the animal and the 
biosecurity of the consumer.  
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1.1.2 Nature and current trends of disease  
Bovine mastitis is a common but complex and multifactoral disease that varies considerably 
in its occurrence and severity, and can have an infectious or non-infectious aetiology. This 
can be attributed to a variety of factors best viewed as an interrelationship or imbalance 
between the cow, pathogen and the environment. Udder inflammation is predominantly a 
pathophysiological response to a diverse range of causative agents, with up to 137 different 
organisms identified as causes of mastitis (Watts 1988). Bacteria account for the vast 
majority of mastitis cases and in most countries, including the UK, leading bacterial causes 
are Escherichia coli, Staphylococcus aureus, Streptococcus uberis, Streptococcus 
dysgalactiae and Streptococcus agalactiae (Bradley, Leach et al. 2007). Pathogen nature and 
duration of infection determine, to some extent, the degree of mastitis severity. Contributory 
host factors include cow productivity, nutrition, age, lactation stage, immune function and 
status, while environmental or management factors including season, region, housing, 
hygiene and herd size can all further influence both the presence of pathogen and the 
pathogen/host response (Sordillo, Shafer-Weaver et al. 1997; Waage, Sviland et al. 1998; 
Barkema, Schukken et al. 1999; Ericsson Unnerstad, Lindberg et al. 2009; Tenhagen, Hansen 
et al. 2009).  
Mastitis can be subdivided into categories based on parameters of disease 
presentation; clinical or subclinical mastitis, and the type or origin of the causative pathogen; 
environmental or contagious. Defining cases by these broad criteria can aid interpretation and 
management of disease. Clinical mastitis (CM) typically manifests with an acute onset of 
mild to severe inflammation, visible as swelling, pain and redness of the affected udder 
quarter/s with adverse changes to the milk such as clotting. As severity increases, milk 
production continues to decrease, tissue damage due to bacterial toxins can ensue and the 
cow can become systemically ill with potential for progression to septicaemia and death. 
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Subclinical mastitis shows no outward signs of disease, however infection can become 
chronic and progress with clinical episodes that can cause permanent hardening and damage 
to the udder. Subclinical cases are confirmed by bacteriology and culture of a mastitic 
pathogen, along with an indirect approach via the detection of a raised milk somatic cell 
count (SCC), from the affected quarter/s.   
Mastitis can also be classed as contagious or environmental, depending on the origin 
of infection. Environmental mastitis is caused by opportunistic pathogens not adapted to 
survival within the host, which spread from the environment to the cow and include E. coli, 
Klebsiella spp., and S. uberis. Opportunistic pathogens typically invade and multiply to elicit 
a host immune response resulting in successful elimination. Contagious mastitis is caused by 
pathogens that survive on or in the udder, with infection spread by direct quarter to quarter or 
cow to cow contact, or via fomites in the milking parlour. Subclinical mastitis is often 
associated with contagious pathogens, including S. agalactiae and S. aureus. Whilst defining 
mastitis in this way can be convenient at a management level, at a pathogen level this 
distinction is less practical. In theory all ‘environmental’ pathogens could exhibit contagious 
spread within and between cows. Infection with the opportunist S. uberis, for example, can be 
difficult to manage and control if subclinical infection remains undetected for a prolonged 
period, allowing a greater opportunity for contagious spread. In herds where contagious 
transmission is being controlled, infection by S. uberis is likely to result from environmental 
sources, including faecal matter originating from the cows (Lopez-Benavides, Williamson et 
al. 2007). An overview of the general disease presentation for pathogens commonly isolated 
from bacterial mastitis is presented in Table 1.1. 
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Table 1.1 - Common causes of bacterial mastitis and associated patterns of disease 
 
Pathogen 
Gram 
Stain 
 
Origins 
 
Presentation and nature of disease  
Escherichia coli -ve Environmental Almost always clinical, infection can vary from mild and self-curing, to severe 
and acute toxic, requiring treatment and neutralisation of endotoxins. High SCC. 
Streptococcus uberis +ve Environmental* Cause of both clinical and subclinical infections that may become persistent. 
Moderate to high SCC rise.  
Staphylococcus aureus +ve Contagious Chronic subclinical infection with sporadic clinical episodes. Can become 
persistent and difficult to treat, causing long-term udder damage and culling of 
the animal. Variable SCC rises. 
Streptococcus dysgalactiae +ve Environmental* Often associated with teat damage, infection mostly clinical and easy to treat. 
Streptococcus agalactiae +ve Contagious Cause of both clinical and subclinical infections, can be mildly chronic. High 
SCC rise. Easy to treat and control.  
Coagulase-negative 
Staphylococci (CNS)
 ┼
 
+ve Contagious Considered a commensal, rarely causes clinical infection, commonly subclinical. 
Moderate increase in SCC. Often isolated from well managed herds. 
Klebsiella spp. -ve Environmental* Commonly associated with dirty conditions. Coliform mastitis. 
Enterobacter spp. -ve Environmental Can be difficult to treat, coliform mastitis. 
Pseudomonas spp. -ve Environmental Can cause severe and chronic mastitis. Sourced from contaminated water. 
Corynebacterium bovis
┼
 +ve Contagious Considered a common commensal, rarely causes clinical infection. Slight SCC 
elevation. Presence may be protective to infection from other pathogens 
Mycoplasma bovis N/A Contagious Usually introduced into a herd, can cause severe clinical infection. 
 
*Can display contagious spread. ┼Considered a minor pathogen and may not be actual cause of CM episodes.    
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Overt CM can be the result of a new infection or the progression of an existing 
subclinical one. It is recorded and analysed within a herd by prevalence, the proportion of a 
population having CM at a given time or by incidence with the number of cases over a period 
of time (rate) often presented as CM cases /100 cows /year. Regular recording of incidence is 
essential when comparing national and historical CM data trends, which appear to be 
evolving due to the emerging importance of different pathogens (Bradley 2002). A ‘Five 
Point Plan’ control strategy initiated in the 1960s to improve animal hygiene and husbandry 
led to a thirty year progressive decline in UK dairy herd mastitis from around 150 cases /100 
cows /year, to 40 cases /year (Kingwill, Neave et al. 1970; Kossaibati, Hovi et al. 1998). A 
2007 survey of dairy herds across England and Wales suggested that the incidence has since 
increased to between 47-65 cases /100 cows /year (Bradley, Leach et al. 2007). The survey 
further highlights the limited success of the ‘Five Point Plan’ in controlling only contagious 
pathogen spread, since opportunistic pathogens such as E. coli and S. uberis predominate and 
are now the leading cause of CM in the UK (Figure 1.1) and common causes of mastitis 
worldwide (Bradley, Leach et al. 2007). Although S. aureus continues to be a major cause of 
subclinical mastitis, a larger proportion of cases resulted in the isolation of the opportunist S. 
uberis (Bradley, Leach et al. 2007), highlighting the shift in environmental pathogen 
importance. Vaccination programmes may be required to further control mastitis (Leigh 
1999), however an effective vaccine has yet to be established (Prenafeta, March et al. 2010). 
The use of teat sealants and improvement of bedding systems and herd energy balance are 
potential solutions to lowering disease (Huxley, Green et al. 2002; Ericsson Unnerstad, 
Lindberg et al. 2009; Moyes, Drackley et al. 2010). However an additional long term and 
complementary strategy to reduce CM incidence is the genetic selection of cattle that are less 
susceptible to mastitis. 
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Figure 1.1 - The changing trends for UK clinical mastitis and importance of key 
pathogens 
(A) Effectiveness of the ‘Five Point Plan’ at reducing UK herd averages for CM incidence 
since implementation in the 1960s. (B) The shift in pathogen importance in the past 40 years: 
comparison of common causes of CM (%) from UK dairy herds in 1967 and 2007 (Bradley 
2002; Bradley, Leach et al. 2007). 
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1.1.3 Current breeding strategies require accurate CM markers 
Dairy products are a major part of the food chain for the majority of the world’s population 
and growing demand and reduced profit margins continue to influence breeding for 
favourable production traits in dairy herds. High yields, good milk fat and protein content and 
a reduced SCC are financially rewarded qualities that have all been optimised largely because 
of genetic selection (Shook 2006). The heritability of these and other traits, including growth, 
fertility, calving ease and weight, are all correlated and indexed into estimated breeding 
values (EBVs). These are used to evaluate and market the performance of sires to yield 
progeny of commercial value. However selective breeding on the basis of optimal production 
traits could be detrimental to the health and well-being of the cow (Simianer, Solbu et al. 
1991). Holstein-Friesians are the favoured commercial dairy breed and herds in many 
countries are significantly inbred due to the lack of an expansive Holstein semen gene pool 
(Kantanen, Olsaker et al. 2000; Zenger, Khatkar et al. 2007). Any heritable genetic 
dysfunctions and associated traits passed on consecutively through a dairy herd could have a 
negative impact on disease such as mastitis. The ability to select cattle less susceptible to 
mastitis, with little or no impact on milk production, will considerably benefit both the 
industry and the animal. 
A lack of comprehensive phenotypic data on CM currently limits many breeding 
programmes which select on the basis of a lowered milk SCC, the number of somatic cells 
per millilitre (mL) of milk, as a surrogate of CM. As well as accounting for subclinical cases, 
SCC is more routinely recorded and is estimated to have low to moderate heritability as a 
breeding trait (Rupp and Boichard 1999). However there are limitations when relying on SCC 
data, as arguably the use of current recordings as a proxy for intramammary infection (IMI) 
status is not absolutely correlated with bacterial presence (Schepers, Lam et al. 1997; 
Heringstad, Gianola et al. 2006; Koeck, Miglior et al. 2012). Furthermore, selective breeding 
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for a reduced SCC is selecting against the immune cell which, as the first line of immune 
defence, can eliminate IMI in the absence of overt clinical signs. Dairy herds selected for a 
reduced SCC are consequently becoming more susceptible to opportunistic infections 
(Barkema, Schukken et al. 1998; Suriyasathaporn, Schukken et al. 2000).  
The ability to select animals that are likely to exhibit a reduced level of actual CM 
incidence, whilst maintaining production traits such as milk yield, would therefore be more 
beneficial than simply the selection of animals by SCC. The identification of single 
nucleotide polymorphisms (SNPs) in genes involved with the mammary innate immune 
response are receiving particular interest as DNA markers for CM susceptibility and 
associated production traits (Sharma, Leyva et al. 2006; Pant, Schenkel et al. 2008; 
Verschoor, Pant et al. 2009; Beecher, Daly et al. 2010; Chen, Yang et al. 2010; Skelding, 
Schenkel et al. 2010; He, Chu et al. 2011). SNPs are an abundant form of heritable DNA 
point base mutations (Brookes 1999) often linked with gene and protein dysfunction that may 
underlie disease. For example a coding non-synonymous (NS) SNP, that translates into an 
amino acid substitution, may impact the protein’s tertiary structure; whereas a non-coding 
SNP that lies within DNA regions containing promoter and regulatory sequences can affect 
gene splicing, transcription, and translation. Large-scale genome SNP analyses in cattle have 
demonstrated substantial genetic variance within and between breeds (Gibbs, Taylor et al. 
2009; Stothard, Choi et al. 2011), and extensive reviews highlighting the links between SNPs, 
both coding and non-coding, and livestock diseases have been published (Ibeagha-Awemu, 
Kgwatalala et al. 2008). Many SNPs may remain undetected with those already identified 
requiring verification, particularly in dairy breeds. Several CM association studies have 
analysed the association of SNPs within key genes with reduced SCC as a surrogate for CM 
in dairy cows (Sharma, Leyva et al. 2006; Pant, Schenkel et al. 2008; Verschoor, Pant et al. 
2009; Beecher, Daly et al. 2010; Chen, Yang et al. 2010; Skelding, Schenkel et al. 2010; He, 
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Chu et al. 2011). Using actual CM incidence, the identification of SNPs associated with 
reduced susceptibility may improve accuracy for genomic selection of these phenotypes. 
1.2 Innate immune responses of the mammary gland 
1.2.1 Overview of mammary defence 
The mammary gland possesses a variety of anatomical, cellular and humoral defence 
mechanisms to help prevent the invasion and establishment of pathogens (Sordillo, Shafer-
Weaver et al. 1997; Rainard and Riollet 2006). Pathogens usually gain entry to the quarter via 
the teat canal by breach of the teat orifice. This varies in penetrability before, during and after 
lactation periods, and is further influenced by teat morphology, lactation and mastitis history 
(Seykora and McDaniel 1985). A keratin waxy plug, formed from the stratified squamous 
epithelial lining within the duct, seals the teat canal during dry periods and between milkings 
(Craven and Williams 1985; Paulrud 2005). This forms an effective physical and 
microbicidal barrier to invasion. However, damage to the plug, often from excessive milk 
flux from multiple lactations, can temporarily or permanently increase the penetrability of the 
teat canal (Schultze and Bright 1983). Pathogens which colonise the canal can then invade 
and multiply in the mammary gland cistern, where they encounter the second line of 
mammary gland defence that enlists numerous soluble and cellular components. Although the 
added presence of non-specific soluble factors in milk, including lactoferrin, complement and 
lysozyme, can target pathogens and supplement mammary defence (Rainard and Riollet 
2006), it is the cells of the innate immune system that have a significant role in the detection 
of pathogens and initiation of early immune response mechanisms (Sordillo, Shafer-Weaver 
et al. 1997; Oviedo-Boyso, Valdez-Alarcon et al. 2007).  
Immune cells found in the milk of uninfected udders are predominantly macrophages 
(MØ), with polymorphonuclear neutrophils (PMNs) present in much smaller numbers (Lee, 
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Wooding et al. 1980). Together these leukocytes account for the majority of somatic cells in 
‘normal’ milk and collectively function to detect and phagocytise pathogens and 
subsequently initiate an appropriate immune response. Following establishment of IMI, 
continued interaction with pathogens induces resident leukocytes and mammary epithelial 
cells (MEC) to synthesise and release soluble factors including the pro-inflammatory 
cytokines tumour necrosis factor-α (TNF-α), interleukin (IL) -6 and the neutrophil 
chemoattractant, CXCL8 (formerly IL-8). Expression of cytokines and other immune markers 
function to recruit circulating leukocytes to the foci of infection and enhance their 
bactericidal activity. Production of CXCL8, for example, induces chemotaxis of neutrophils 
from surrounding blood vessels into the mammary gland. During mastitis the mass migration 
of neutrophils is vital to contain infection. Increasing neutrophil numbers makes them the 
dominant cell type in infected quarters, resulting in the observed increase in milk SCC. The 
migration and continued presence of MØ is also important to activate adaptive immunity, if 
needed, and limit tissue damage by ingesting apoptotic neutrophils that would otherwise 
release harmful reactive oxygen species. If the IMI is resolved efficiently, migration of 
neutrophils ceases with potentially only a mild inflammatory episode and minimal or no 
clinical signs. 
Persistence of an infection can occur if the neutrophil influx is ineffective, either 
because of a poor migratory response, or because a pathogen is highly resistant to PMN 
phagocytosis, for example strains of S. uberis (Field, Ward et al. 2003). Continued pathogen 
growth within the mammary gland can lead to sustained leukocyte migration and further 
complications such as the development of chronic inflammation or the potentially fatal build-
up of bacterial toxins. The ability of a pathogen to evade certain components of the innate 
response may therefore require opsonins, MØ or an influx of lymphocytes for specific cell-
mediated and/or humoral responses to control infection; activated T cells have been observed 
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during S. aureus and S. uberis mastitis (Soltys and Quinn 1999; Rivas, Schwager et al. 2007) 
although their exact immunological role is unknown. Early and effective pathogen detection 
however is likely to have an influential role in the development of an appropriate mammary 
immune response. 
1.2.2 Innate immune components of mammary immunity  
Our knowledge of the innate immunity of the bovine mammary gland has recently grown in 
complexity (Rainard and Riollet 2006). Resident leukocytes and MEC differentially express 
an array of effector molecules for the initiation and progression of an immune response 
following infection. Analysis of cytokine profiles in infected animals has highlighted that the 
pathogen specificity of the immune response and the location within the gland of that 
response potentially correlate to the outcome of infection. (Swanson, Stelwagen et al. 2009; 
Rinaldi, Li et al. 2010; Rinaldi, Li et al. 2010a). These immune responses, which appear to be 
conserved between cattle breeds challenged with the same pathogen (Bannerman et al. 2009), 
involve cell synthesis of cytokines and other immune effector molecules that are induced by, 
and targeted at, innate receptor proteins that reside on mammary, neutrophil, MØ and 
lymphocyte cell surfaces. GermLine-encoded pattern recognition receptors (PRR) are 
responsible for the innate recognition of pathogen-associated molecular patterns (PAMPs), 
and include proteins from the Toll-like receptor (TLR) family. The detection of PAMPs by 
TLRs, and the subsequent initiation of signalling pathways to induce cytokine production, 
can promote chemotactic migration of cells, including neutrophils and MØ, from surrounding 
blood vessels. This is facilitated by the chemokine receptor protein family, responsible for 
activating and directing cell movement into the mammary gland. Impairment in TLR and 
chemokine receptor function or expression will have a negative impact on the outcome of 
infection by mastitis-causing pathogens.  
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1.3 Toll-like Receptors 
1.3.1 Background, structure and function 
Mammalian Toll-like receptors are a key family of innate immune proteins and a major class 
of PRR, serving principal recognition and signalling functions critical to host defence 
mechanisms (Medzhitov 2001). The Toll protein originally demonstrated immune importance 
in Drosophila (Lemaitre, Kromer-Metzger et al. 1995; Rosetto, Engstrom et al. 1995) 
promoting the discovery and study of a human ‘Toll-like’ homologue (now designated as 
TLR4), establishing mammalian Toll as a crucial mediator of inflammatory and adaptive 
responses (Medzhitov, Preston-Hurlburt et al. 1997). Ten human (hu) TLRs have since been 
identified, each possessing their own ligand recognition repertoire, allowing the receptor to 
differentiate between an array of PAMPs from bacterial, viral, fungal and protozoan sources 
(Werling and Jungi 2003; Kawai and Akira 2005).  
TLRs are a structurally conserved family of type I transmembrane glycoproteins, 
characterised by an extracellular leucine-rich repeat (LRR) domain, a short transmembrane 
region and an intracellular Toll/interleukin-1 receptor (TIR) domain (Figure 1.2). The LRRs 
are short amino acid sequence motifs with hydrophobic intervals, and are responsible for 
determining the TLR’s extracellular horseshoe-shaped structure that is required for the 
interaction and binding of ligands (Kobe and Deisenhofer 1995; Kobe and Kajava 2001; 
Matsushima, Tanaka et al. 2007; Botos, Segal et al. 2011). Recognition of a TLR ligand 
elicits a conformational change, which leads the intracellular TIR domain to recruit and 
activate internal cytoplasmic adaptor proteins. This initiates downstream signalling events 
and gene transcription, directing production of cytokines, chemokines and other effector 
molecules for a regulated immune response (Werling and Jungi 2003; Pasare and Medzhitov 
2005).  
14 
 
 
Figure 1.2 - Overview of a typical TLR structure  
(A) LRR consensus sequence for TLR3 with highlighted residues forming the β strand. L 
denotes leucine residues, N and F an asparagine and phenylalanine residue respectively 
(Botos, Segal et al. 2011). (B) A LRR loop from human TLR3 with conserved residues 
forming a hydrophobic core. The boxed region forms the surface that interacts with the ligand 
(Botos, Segal et al. 2011). (C) Ribbon diagrams of the human TLR3 ectodomain, showing 23 
LRRs coloured blue to red (numbered within convex) capped by LRR N-terminal (LRRNT) 
and LRR C-terminal (LRRCT) motifs (grey) (Bell, Botos et al. 2005), and the TIR 
intracellular domain. 
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Ten functional bovine (bo) TLRs have been characterised (Coffey et al. unpublished) 
(McGuire, Jones et al. 2006), revealing close (83-90%) nucleotide identity to their human 
orthologues (Menzies and Ingham 2006). In general, the mammalian TLR family can be 
divided into two subgroups depending on their extracellular or intracellular localisation. 
TLRs 3, 7, 8 and 9 are primarily located on intracellular endosomal membranes, where they 
mostly detect internalised pathogen nucleic acids, such as single-stranded (TLRs 7 and 8) and 
double-stranded (TLR3) RNA, and unmethylated CpG DNA (TLR9). TLRs 1, 2, 4, 5, 6 and 
10 are sited on the cell membrane where they predominantly interact with microbial patterns, 
namely bacterial cell wall components, including lipoproteins (TLR2) and lipopolysaccharide 
(LPS) (TLR4), and proteins within the bacterial flagellum (TLR5). TLRs require dimerisation 
to themselves or other cell surface receptors/molecules to extend ligand recognition and/or 
enhance their signalling potential. Heterodimerization of TLR2 with TLR1 or TLR6 expands 
its spectrum of ligand recognition to include triacylated and diacylated lipoproteins 
respectively. A TLR2 and TLR10 heterodimer has also been postulated (Hasan, Chaffois et 
al. 2005), since TLR10 shows close identity and ancestry to TLR1 and TLR6, with all three 
encoding genes sharing a common locus in humans and cattle (Opsal, Vage et al. 2006). The 
absence of a functional TLR10 mouse equivalent (Hasan, Chaffois et al. 2005) has precluded 
the use of knockout methodologies to determine a ligand(s) for TLR10/TLR2. Evidence that 
TLR10 may share TLR1 ligands has been reported, however a signalling mechanism has yet 
to be determined (Guan, Ranoa et al. 2010). TLR2 further collaborates with the lectin family 
receptor Dectin-1 to enhance inflammatory responses towards β-glucan-containing particles 
(Gantner, Simmons et al. 2003). TLR4 is involved
 
in LPS signalling with the co-receptor 
CD14 (Chow, Young et al. 1999) and requires the accessory molecules LPS-binding protein 
(LBP) and MD-2 to enhance LPS interactions (Shimazu, Akashi et al. 1999). TLRs 1-10 and 
their principal ligands are summarised in Table 1.2. 
16 
 
Table 1.2 - Mammalian Toll-like receptors and their principal ligand targets 
TLRs LRRs
*
 Localisation Ligand/s Target Microbes  SNP Links to disease 
TLR1 (+TLR2) 19 CM Triacylated Lipopeptides Bacteria (Gram +ve and 
Gram–ve) 
Leprosy, TB 
TLR2 
 
 
19 CM Lipoprotein/Lipopeptides, 
Mycoplasma, Lipoteichoic acid, 
Peptidoglycan, Glycolipids, 
Porins 
Bacteria (+ve) Leprosy, TB, Sepsis, Rheumatic fever 
TLR2 (+Dectin-1) - CM Zymosan Fungi Fungal infections (Plantinga, van der Velden et 
al. 2009) 
TLR3 23 Endo dsRNA, ssRNA Viruses COPD, asthma (Ritter, Mennerich et al. 2005) 
TLR4 
(+CD14, MD-2) 
21 CM/Endo LPS, Lipid A, Fusion protein 
(RSV)   
Bacteria (-ve) and 
viruses 
RSV, Sepsis, 
Malaria (Mockenhaupt, Cramer et al. 2006) 
TLR5 20 CM Flagellin Bacteria (+ve and –ve) Legionnaire’s disease 
TLR6 (+TLR2) 19 CM Diacylated Lipopeptides, 
Lipoteichoic acid, Soluble 
Tuberculosis Factor (STF), 
Zymosan 
Bacteria (+ve) and 
Fungi 
Prostate cancer (Sun, Wiklund et al. 2005), 
TB 
TLR7 25 Endo ssRNA  Viruses HIV progression 
TLR8 25 Endo ssRNA Viruses HIV progression 
TLR9 25 Endo Unmethylated CpG motifs Bacteria and Viruses HIV progression 
TLR10 (+TLR2?) 19 CM/extracell
ular 
Unknown,  
(Triacylated Lipopeptides?) 
 Asthma (Lazarus, Raby et al. 2004) 
TLR ligand identification is expanding as new affinities continue to be discovered for the receptors. CM = cellular membrane, Endo = 
endosomal membrane, ssRNA = single-stranded RNA, dsRNA = double-stranded RNA, CpG = Cytosine phosphate-guanosine, TB = 
tuberculosis, COPD = chronic obstructive pulmonary disease, HIV = human immunodeficiency virus, RSV = respiratory syncytial virus. 
*Number of LRR from huTLR orthologues, boTLR LRRs yet to be fully characterised. LRR and ligand information (Manavalan, Basith et al. 
2011). Unless citation given, TLR disease information (Misch and Hawn 2008). 
1
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Five TLRs and their ligand/dimer complexes have been modelled; TLR1/TLR2, 
TLR2/TLR6, TLR4/MD-2, and TLR3 (Jin, Kim et al. 2007; Liu, Botos et al. 2008; Kang, 
Nan et al. 2009; Park, Song et al. 2009), and these serve as templates for the prediction of 
structures and complexes of other TLRs. In addition, they reveal the importance of agonist 
binding to induce TLR dimers or conformational changes in existing dimers, furthering our 
understanding of the TLR signalling mechanism. For example, binding of double-stranded 
RNA and LPS initiates the formation of TLR3 and TLR4 homodimers respectively, allowing 
the cytoplasmic TIR domains to dimerise and recruit specific adaptor proteins, initiating 
downstream signalling (Jin and Lee 2008; Botos, Segal et al. 2011). Specific adaptor proteins 
include Myeloid differentiation factor 88 (MyD88), MyD88 adaptor-like (MAL or TIRAP), 
TIR-domain-containing adaptor-inducing interferon-β (TRIF) and TRIF-related adaptor 
molecule (TRAM) (Carpenter and O'Neill 2009). Briefly, TLR TIR domains initiate one of 
two signal-transduction pathways according to their use of MyD88 or TRIF to mobilise 
nuclear factors such as NF-κB for pro-inflammatory cytokine production (Figure 1.3). The 
MyD88-dependent pathways are used by all TLRs (except TLR3), whereby TIR domains 
associate directly with MyD88 or indirectly via another adapter protein, TIRAP (MAL). The 
MyD88-independent pathways are utilised by TLR3 and endosome-bound TLR4, since their 
TIR domains associate with the TRIF adaptor protein, and activate additional nuclear factors, 
such as IRF3 for interferon production. Only TLR4 can utilise both pathways by associating 
with MyD88 at the cell surface, and then following LPS interaction, internalise on endosomes 
to permit indirect TIR association with TRIF via TRAM (Tanimura, Saitoh et al. 2008). The 
above outlines the general TLR signalling pathway. However, this pathway involves many 
more components as part of a highly regulated and complex network (Kawai and Akira 2007) 
with potential crosstalk to other innate receptors (Kawai and Akira 2011) and the 
complement system (Hajishengallis and Lambris 2010). 
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Figure 1.3 - Overview of mammalian TLR dimers and their signalling mechanisms 
TLR homodimers and heterodimers allow TIR domains to initiate one of two signal 
transduction pathways according to their direct or indirect association with MyD88 or TRIF 
adapter proteins. TLR4 utilises both MyD88-dependent and MyD88-independent signal 
pathways, which subsequently mobilise nuclear factors such as NF-κB or IRF3 for pro-
inflammatory cytokine or interferon (IFN) production.  
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1.3.2 SNPs in TLRs can predispose to disease 
The effects of SNPs within mammalian TLRs are dependent on their location. Within the 
extracellular ligand-binding or intracellular TIR domains they can cause weakening of the 
interaction of PAMP ligands and signalling leading to an unregulated or insufficient immune 
response and a higher risk of infection (Schroder and Schumann 2005). Extensive reviews 
have been published to highlight huTLR SNP markers that predispose severity and 
susceptibility to a spectrum of bacterial diseases (Misch and Hawn 2008), including leprosy, 
TB, and Legionnaire’s disease (Table 1.2).  
Bovine TLRs are highly polymorphic between cattle breeds (Cargill and Womack 
2007; Seabury, Cargill et al. 2007; Seabury and Womack 2008). In addition, boTLR SNPs are 
linked with cattle disease, including infectious bovine keratoconjunctivitis (Kataria, Tait et al. 
2011) and Mycobacterium avium paratuberculosis (MAP) infection. The single or 
cumulative presence of NS SNPs within and around ectodomain LRR motifs in boTLRs 1, 2 
and 4, and a TIR missense SNP in boTLR2, may impact PAMP recognition of, and increased 
susceptibility to, MAP infection (Mucha, Bhide et al. 2009; Ruiz-Larranaga, Manzano et al. 
2011). There is potential to expand these studies to identify non-coding SNPs that may 
interrupt gene promoter sites or microRNA sites, splice sites or other regulatory motifs, 
potentially interfering with messenger RNA (mRNA) regulation and protein expression. 
Polymorphic variants of boTLRs may impact on receptor expression, function and response 
and, therefore, the innate immune response to mastitis-causing pathogens and contribute 
towards differences in the pathology of disease. 
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1.4 Chemokines and Chemokine Receptors 
The chemokine system functions by selectively activating and directing cell migration, 
serving vital roles in both homeostasis and host inflammatory responses. This is 
accomplished by the chemokines, a subfamily of cytokines that can induce and direct 
chemotaxis in a cell(s)-specific manner, through the interaction and activation of the 
appropriate chemokine G-protein linked 7-transmembrane serpentine receptor/s (Allen, 
Crown et al. 2007). The chemokines are grouped into one of four families, CC, CXC, XC and 
CX3C, depending on the positioning of the first two highly conserved and structurally 
determining cysteine amino acid pairs, as illustrated in Figure 1.4. Based on the chemokine 
family they bind, receptors are subsequently classified CCR, CXCR, XCR or CX3CR. In 
humans 20 chemokine receptors, CCR1-10 (including two variants of CCR3), CXCR1-7, 
XCR1 and CX3CR1, have so far been identified, recognising the 50 chemokines (ligands) 
currently known (Table 1.3). The chemokine system is highly promiscuous, as multiple 
chemokines can bind the same/multiple receptors within their structure-based subfamily, to 
add robustness to the system (Mantovani 1999). In addition, evidence of receptor/ligand 
dimerisation (Allen, Crown et al. 2007) and non-signalling ‘decoy’ receptors (e.g. DARC and 
D6), now classified as atypical chemokine receptors (Graham, Locati et al. 2012), provide 
further complexity. This allows attenuation or fine-tuning of a specific chemokine gradient 
for cell-dependent activation and migration. All bovine homologues for the chemokine 
receptor repertoire have now been fully characterised, along with the identification of an 
additional bovine chemokine receptor closely related to human CCR1; named CCR like-1 or 
CCRL1 (Widdison, Siddiqui et al. 2010). The bovine chemokine system therefore, whilst 
retaining high similarity to that in human, exhibits species diversity with potential for novel 
functions (Widdison and Coffey 2011) (Table 1.3). 
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Figure 1.4 - Chemokine classes  
The four classes of chemokines are illustrated (A-D) with red lines representing a basic 
tertiary structure, and black lines representing the disulphide bonds that bridge adjacent 
cysteine (C) residues - X represents any non-cysteine amino acids, with the exception of 
proline.  
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Table 1.3 - Chemokine receptors and their known ligands 
Receptor Chemokine Ligand/s Total 
CCR1 CCL3, CCL3LI, CCL5, CCL7, CCL13, CCL14, CCL15, CCL16, CCL23 9 
CCRL1
†
 Unknown - 
CCR2 CCL2, CCL7, CCL8, CCL13 4 
CCR3 CCL5, CCL7, CCL11, CCL15, CCL16, CCL24, CCL26 7 
CCR4 CCL17, CCL22 2 
CCR5 CCL3, CCL3LI, CCL4, CCL5, CCL8 5 
CCR6 CCL20 1 
CCR7 CCL19, CCL21 2 
CCR8 CCL1 1 
CCR9 CCL25 1 
CCR10 CCL27, CCL28 2 
CXCR1 CXCL6, CXCL7, CXCL8 3 
CXCR2 CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, CXCL8 7 
CXCR3 CXCL4, CXCL9, CXCL10, CXCL11, CXCL12 5 
CXCR4 CXCL12 1 
CXCR5 CXCL13 1 
CXCR6 CXCL16 1 
CXCR7* CXCL11, CXCL12 1 
XCR1 XCL1, XCL2 2 
CX3CR1 CX3CL1 1 
DARC* CCL2, CCL7, CCL8, CCL11, CCL13, CCL14, CCL16, CCL17, CXCL1, 
CXCL5, CXCL6, CXCL7, CXCL8, CXCL9, CXCL11, CXCL13 
16 
D6* CCL2, CCL3LI, CCL4, CCL5, CCL7, CCL8, CCL11, CCL13, CCL14, 
CCL17, CCL22 
11 
CCX-CKR* CCL19, CCL21, CCL25 3 
 
†
Novel receptor identified in cattle (Widdison, Siddiqui et al. 2010). *Atypical chemokine 
receptors. Chemokines in bold are inflammatory chemokines, in italics are homeostatic 
chemokines, underlined are both inflammatory and homeostatic. Content sourced from Allen, 
Crown et al. (2007) and Mantovani, Savino et al. (2010). 
 
 
 
23 
 
Chemokines have homeostatic and/or inflammatory roles. Pro-inflammatory 
chemokines are up-regulated in response to antigen and direct the migration of leukocytes 
from the blood, across the endothelium and into the affected tissue. Homeostatic chemokines 
are constitutively expressed to coordinate the continuous basal level of cell migration 
required. Roles range from the development of B and T lymphocytes by trafficking their 
migration to secondary lymphoid organs, to the constant cell monitoring of at risk areas, such 
as skin and lungs, to maintain immune surveillance (Moser and Ebert 2003; Moser and 
Willimann 2004). Because of their key role in maintaining health and modulating disease, 
extensive reviews have been published to highlight the links between chemokine receptors in 
inflammatory disorders (e.g. atherosclerosis and allergy), infectious diseases (e.g. malaria and 
HIV), and progression of tumour malignancy (e.g. breast cancer) (Murdoch and Finn 2000; 
Mantovani, Savino et al. 2010; Bonecchi, Locati et al. 2011). Chemokine receptor genetic 
variability can also influence disease severity and susceptibility. The presence of SNPs within 
CCR5 has been associated with more severe bronchiolitis due to the receptor's influence on 
inflammation (Hull, Rowlands et al. 2003). SNPs in CCR2 have been linked to sarcoidosis 
(Spagnolo, Renzoni et al. 2003) and poor myocardial health, including heart attack risk 
(Petrkova, Cermakova et al. 2003).  
This project primarily focuses on the two chemokine receptors CXCR1 and CXCR2, 
which have affinity for the chemokine CXCL8. 
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1.5 Summary  
The early detection of mastitis-causing pathogens and the subsequent initiation of appropriate 
immune responses help prevent onset of disease, and require innate immune receptors which 
reside on immune cell surfaces to discriminate microbial patterns and facilitate cell 
migration. Functional expression of TLRs on resident mammary leukocytes and epithelia is 
important in the initiation and control of innate immune responses towards mastitis-causing 
bacteria (Goldammer, Zerbe et al. 2004; De Schepper, De Ketelaere et al. 2008; Ibeagha-
Awemu, Lee et al. 2008; Yang, Zerbe et al. 2008). TLR interaction with pathogens leads to 
the secretion of immune effector molecules, including NF-κB-mediated production of the 
pro-inflammatory chemokine CXCL8 (Farhat, Sauter et al. 2008). During mastitis, synthesis 
of CXCL8 increases rapidly (Lee, Bannerman et al. 2006), providing a potent chemotactic 
gradient to facilitate movement of neutrophils. Efficient recruitment of neutrophils into the 
mammary gland is vital if IMI is to be controlled, and therefore relies on the functioning of 
the CXCL8 chemokine receptors, CXCR1 and CXCR2, that are expressed on neutrophil cell 
surfaces (Figure 1.5). Variations in TLRs or these chemokine receptors in the form of SNP 
mutations may affect the immune response and contribute towards observed differences in 
disease pathogenesis. Investigation of potential variation may highlight a role in mastitis 
disease and therefore their identification may provide suitable genetic markers for selection. 
Our approach to the control of bovine mastitis, which has long been considered a 
management problem, has now evolved into the search for such genetic risk factors (Su, 
Guldbrandtsen et al. 2010). To complement current and novel control strategies, selecting 
animals with favourable TLR and CXCR mutations could further reduce herd mastitis rates, 
crucially needed for improving animal welfare, dairy herd sustainability and profitability, and 
for the decreased farm use of antibiotics.  
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Figure 1.5 - Schematic summarising the importance of mammary TLR and neutrophil 
CXCR during mastitis in an udder quarter 
Bacterial invasion via breach of the teat canal may enable establishment of infection in the 
gland cistern. Efficient recruitment of PMN is vital for containing infection; their chemotaxis 
relies on PAMP recognition by TLR residing on MEC and resident milk leukocytes to initiate 
production of CXCL8 which acts as the chemoattractant. This generates a potent chemotactic 
gradient to attract PMNs from surrounding blood vessels (extravasation) and direct them into 
the gland (chemotactic movement), and is facilitated by chemokine receptors CXCR1 and 
CXCR2 which bind CXCL8 to activate and direct cell migration.  
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1.5.1 Bos taurus genome assembly 
The most complete sequencing of the Bos taurus genome, annotation build Btau_4.0, was 
published in 2009 and is available in GenBank under accession number AAFC03. This 
assembly version, built from two Hereford cows using a mixture of hierarchical shotgun 
(bacterial artificial chromosome (BAC) clones) and whole-genome shotgun (WGS) 
sequencing methods, totals 2.98 Gb in length with >90% of the assembly placed on 30 cow 
chromosomes (Liu, Qin et al. 2009). Refinements of the Btau_4.0 version assembly, 
including Btau_4.5 assembly (NCBI) and the Ensembl prediction build 
Bos_taurus_UMD_3.1 (Partipilo, D'Addabbo et al. 2011), have been released incorporating 
further WGS reads to improve on chromosome scaffolding. Assembly UMD_3.1 has a 
slightly reduced genome length of 2.7 Gb largely due to removal of duplicate reads; however, 
unassigned sequences still amount to 4-6% of the assembly. Bovine post-genomic resources 
are available through NCBI and Ensembl, allowing accurate BLAST (Basic Local Alignment 
Search Tool) of DNA sequence reads to the latest cow genome assembly. 
1.5.2 Alternate approaches to mapping mastitis resistance in cattle 
Association of singular gene SNPs to a disease trait may lend greater accuracy when 
identifying specific genetic determinants; however, this can be a laborious and time-
consuming method. For multifactoral disease traits such as CM susceptibility, multiple genes 
spread across the genome may directly and/or indirectly have an influence and therefore 
associate with disease. An alternative and cost effective approach is to perform genome-wide 
association studies (GWAS) using suitable SNP array technologies. GWAS allows 
examination of many (>60k) SNP markers, including some of known disease importance, in 
different individuals (often case-control comparisons) to identify a SNP or group of SNPs 
that associates frequently with disease (Matukumalli, Lawley et al. 2009). Wide genome 
coverage from SNP arrays provides a robust platform for mapping disease genes and 
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quantitative trait loci (QTLs) - stretches of genomic DNA containing or linked to the genes 
underlying a phenotypic trait such as disease susceptibility. QTL mapping involves observing 
the inheritance of a large set of SNP markers with a trait; however, marker spacing and 
inheritance patterning (e.g. haplotypes) often result in QTLs that span large genomic regions 
containing multiple genes. Mastitis and milk QTLs, for example, are spread over most 
chromosomes due to the number of genetic and environmental factors that contribute to the 
animal’s phenotype (Ogorevc, Kunej et al. 2009). Genome-wide QTL studies have revealed 
the boTLR6-TLR1-TLR10 gene cluster to be situated within a dense QTL region for CM and a 
number of milk production traits (Klungland, Sabry et al. 2001; Ogorevc, Kunej et al. 2009), 
whilst boTLR4, boCD14, boCXCR1 and boCXCR2 have all similarly been highlighted as 
candidates for association with mastitis susceptibility (Ogorevc, Kunej et al. 2009). Despite 
QTLs narrowing genomic focus, analysis of individual genes within each QTL is still 
necessary. 
1.6 Objectives of this project  
The objectives of this study were to identify SNPs in bovine genes encoding the cellular 
membrane-localised PRRs, boTLRs 1, 2, 4, 5, and 6, and boCD14, all known to interact with 
bacterial PAMPs, and genes encoding boCXCR1 and boCXCR2 that are critical to the 
recruitment of neutrophils. These genes were investigated for SNPs within coding and non-
coding regions including introns, 5’UTR and 3’UTR, and adjacent genomic 
upstream/downstream regions. In order to investigate any associations with mastitis incidence 
and milk quality and quantity, identified SNPs were analysed alongside health and production 
data from a Holstein-Friesian herd. This study aims to challenge the following hypothesis:  
SNPs in receptors critical to the innate immune response of the mammary gland can 
influence an animal’s susceptibility to disease as well as milk production traits. 
28 
 
 
 
 
 
Chapter 2.0 - Materials and Methods  
 
 
 
29 
 
2.1 Sample population 
The herd of Holstein-Friesian cows used for this study (Mayfield Dairy, Institute for Animal 
Health, Compton, UK) contributes to the National Milk Records (NMR) (www.nmr.co.uk), 
which submits production records for each animal to a database accessed through the 
InterHerd software programme (University of Reading/PAN Livestock services team, UK). 
This, along with health data held locally, provided comprehensive information for each cow 
within the herd. All animal data were recorded within the years 2001-2010, during which the 
mean CM incidence for the milking herd was 64 cases/100 cows/year, above the historic 
national average for England and Wales, estimated at 47 cases (Bradley, Leach et al. 2007). 
The Mayfield herd trends for CM incidence and mean SCC between the years 2001 and 2010 
are illustrated in Figure 2.1. CM incidence had declined to a low of 30 cases /100 cows /year 
in 2005, before increasing to 100 cases /100 cows /year in 2009, following the establishment 
of a larger milking herd. Mean milk SCC per cow showed a steady rise during the years 2001 
– 2004 to peak above 200,000 cells /mL, and then declines, to remain at ~150,000 cells for 
five consecutive years before returning above 200,000 in 2010. This trend suggests a very 
weak positive correlation with CM incidence (Figure 2.1). The herd maintained a steady level 
in milk quality with mean milk fat and protein percentages showing little change during 
2001-2010 (Figure 2.2). Production has decreased however, with reduced 305d milk yield 
averages in 2009 and 2010 (Figure 2.2), years coinciding with raised CM incidence (Figure 
2.1).  
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Figure 2.1 – Trends for mean herd CM incidence and SCC for cows within and up to 
their third parity at the Mayfield dairy between the years 2001 and 2010  
Mean CM incidence (blue line) presented as cases per 100 cows/year (primary Y axis), and 
mean milk SCC (red dashed line) presented on the secondary Y axis (‘000s) are 
representative of all cows that were within and up to their third parity for that year. Milking 
herd size (grey bars using the secondary Y axis) is representative of cows of any parity. Weak 
positive correlations of 0.029 and 0.07 were detected between CM incidence and SCC, and 
CM and herd size respectively (Pearson correlation whereby +1.0 = strong positive 
correlation). 
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Figure 2.2 – Herd trends for milk production and quality at the Mayfield dairy between 
the years 2001 and 2010 
Milk quality presented as mean milk fat (blue line) and protein (red line) percentages 
(primary Y axis). Milk production (grey bars) presented as mean 305d yields (secondary Y 
axis). Positive correlations of 0.436 and 0.502 were detected between milk yield and fat 
percentage and milk yield and protein percentage respectively, however these were not 
significant. A significant negative correlation (P>0.05) of -0.73 was detected between milk 
yield and CM incidence data from Figure 2.1. 
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2.2 Isolation and extraction of genomic DNA from milk somatic cells 
Fresh milk samples (50 mL) were stored on ice prior to centrifugation (3000 g /5 min at 4°C). 
Supernatants were carefully removed along with any residual fat layer. Remaining casein 
micelles were removed using an adaptation of a procedure devised previously (Murphy, 
Shariflou et al. 2002). In brief, cell pellets were resuspended in 1.5 mL Phosphate Buffered 
Saline (PBS) GIBCO
TM 
(Life Technologies Ltd. Paisley, UK) / Ethylenediaminetetra-acetic 
acid (EDTA) (Sigma-Aldrich Chemical Co. Poole, Dorset, UK) solution (1 mL PBS, 300 μL 
0.5 M EDTA and 200 μL Tris-EDTA (TE) buffer – 10 mM-Tris-HCl-1 EDTA pH 7.6), 
mixed well and allowed to stand at room temperature (RT) for 10 min. Cells were re-pelleted 
by centrifugation (7000 g /1 min /RT), the supernatant discarded and cells resuspended in 1.5 
mL of TE buffer before a final centrifugation step (7000 g /1 min) and resuspension in 200 
μL PBS. 
Milk somatic cells were processed using the DNeasy Blood and Tissue Kit (Qiagen 
Ltd., Crawley, UK) for genomic DNA isolation. Briefly, 20 μL proteinase K solution 
(Qiagen) was added to the cells resuspended in PBS and mixed well before overnight 
incubation at 4°C. To ensure RNA-free genomic DNA, 4 μL RNase A (100 mg/mL, Qiagen) 
was added following overnight incubation and samples left for 2 min at RT. DNA was then 
extracted according to manufacturer’s instructions (Qiagen). The quantity and quality of 
DNA was analysed using a NanoDrop 8000 spectrophotometer (Thermo Scientific, USA).  
 
2.3 Sequencing and identification of SNPs  
Specific primers for polymerase chain reaction (PCR) amplification of coding and non-
coding genomic regions were designed based on either the Bos taurus genome annotation 
build Btau_4.0 (NC_007304.4), an assembly built from two Hereford cows (Liu, Qin et al. 
2009), or the Ensembl prediction build Bos_taurus_UMD_3.1, a refinement of the Btau_4.0 
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assembly (Partipilo, D'Addabbo et al. 2011). Sequencing of PCR amplicons from a DNA 
pool comprising animals with high (greater than six lifetime CM cases) or no mastitis case 
histories was initially chosen as a method of accelerating detection of disease-associated 
SNPs. Selected animals were unrelated and shared similar ages and lactation histories. 
Sequencing of purified PCR products (protocols detailed below) was carried out using the 
BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Warrington, UK) 
according to manufacturer's instructions. Samples were sequenced by capillary 
electrophoresis on an ABI PRISM 310 Genetic Analyser (Applied Biosystems), and analysed 
using the Sequencher
TM
 package version 4.1.4 (Gene Codes Corporation, Ann Arbor, MI, 
USA). All primers (Table 2.1) were designed using Primer3 software (Rozen and Skaletsky 
2000) (http://frodo.wi.mit.edu/) and synthesised by Sigma-Genosys Ltd. (Haverhill, UK). All 
SNP offsets are given relative to their position (bp) from the 'A' nucleotide of the ATG codon 
of each gene, as based on the Human Genome Variation Society guidelines 
(http://www.hgvs.org/mutnomen/recs.htmL). 
2.3.1 PCR 
PCR amplification of DNA was performed using DreamTaq™ DNA polymerase (Fermentas 
UK, York, UK) according to the manufacturer’s protocol. Typically, each 50 µL reaction 
contained 2 µL of each primer (10 pM), 5 µL of 10X DreamTaq™ Buffer (+ 20 mM 
MgCl
2+
), 1 µL 10 mM dNTPs (Fermentas), 34.75 µL Ambion® DEPC-treated water (Life 
Technologies), 5 µL 50-100 ng template DNA and 0.25 µL (1.25 units - U) DreamTaq™ 
DNA polymerase. An initial DNA denaturation step, at 95°C for 3 min, was followed by 30-
34 cycles of the following; denaturation at 95°C for 30 s, annealing at appropriate 
temperature (see below) for 30 s and extension at 72°C for 1 min/kilo base (kb) of expected 
product size. This was followed by a final extension at 72°C for 10 min. Oligonucleotide 
primer annealing temperatures were estimated by subtracting 2-3°C from their melting 
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temperature (Tm); calculated using the Wallace rule: Tm (°C) = 4°C  x  (number of G’s and 
C’s in the primer) + 2°C  x  (number of A’s and T’s in the primer). Annealing temperatures 
were optimised by performing PCRs over a range of temperatures. All PCRs were run with a 
negative template control (addition of H2O in place of DNA).  
2.3.2 DNA electrophoresis 
DNA was visualised by electrophoresis in agarose (electrophoresis grade, Sigma-Aldrich) 
gels of 0.75-2% (weight/volume) made with 1X Tris-borate-EDTA (TBE): 1 M Tris, 0.90 M 
Boric acid, 100 mM EDTA, and stained with GelRed
TM
 (Biotium Inc., Hayward, CA, USA) 
stock solution diluted at 1:10,000. DNA was loaded into lanes; diluted 5:1 with loading dye: 
Blue/Orange 6X loading dye – 0.4% orange G, 0.03% bromophenol blue, 0.03% xylene 
cyanol FF, 15% Ficoll
®
 44, 10 mM tris-HCl (pH 7.5, 50 mM EDTA (pH 8.0) (Promega UK, 
Southampton, UK). A 1 kb DNA Step ladder (Promega) was used for qualitative 
measurement of DNA product size. Gels were run in electrophoresis tanks containing 1X 
TBE and GelRed
TM 
at 1:10,000, and results visualised on a 300 nm transilluminator.   
2.3.3 PCR purification 
PCR products were purified using the QIAQuick PCR Purification Kit (Qiagen) according to 
the manufacturer's protocol. 
2.3.4 DNA gel extractions 
Gel extraction and purification of DNA was carried out using the QiaQuick Gel Extraction 
Kit (Qiagen) according to manufacturer’s protocol.  
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Table 2.1 - Primers used for PCR amplification of genomic regions and RFLP PCR digests 
Gene Application Genomic Region 
Annealing 
Temp (°C) Forward primer (5’- 3’) Reverse primer (5’- 3’) 
BoTLR1 Genotyping 5’ upstream region to 5’ UTR1 59 CCTCTGTCCTGTTGGCAGTC GCCTTGTTCCCTGTGGTAGA  
  Genotyping 5’UTR1 to 5’UTR intron 1 60 CAGACTGCCAACAGGACAGA CCTTCTCCAGGGGATCTTTC 
  Genotyping 5’ UTR3 to 5’UTR intron 3 60 AAGGAGGACCCCTGTCTAGG  CAATGTTGGCATGGAGTGAG 
  Genotyping  5’ UTR intron 3 to CDS +218bp 59 GCCTCCTTACTGTGCCTGAG TGGTTGTTTCCAGGGATAAGTT 
  Genotyping  5’ UTR intron 4 to CDS +820bp 59 GGACATGGTTAGGAGGTGGA GTACGCCAAACCAACTGGAG 
  Genotyping  CDS +650 to +1760bp 59 GCACCACAGTGAGTCTGGAA TTCTTCACCCAGGCAGAATC 
  Genotyping  CDS +1671to 3’ UTR region 60 AGGGCTGGCCTGAGTCTTAT CTGGGGCCTGAAAAGACATA 
  Genotyping  CDS +2160 to 3’ UTR region 58 ACTTTGCCCACCACAATCTC CTGGGGCCTGAAAAGACATA 
  RFLP SNP C+798T Mbo II digest 59 GCACCACAGTGAGTCTGGAA GTACGCCAAACCAACTGGAG 
  RFLP  SNP A+1762G Bcl I digest 60 AGGGCTGGCCTGAGTCTTAT TTCTTCACCCAGGCAGAATC 
BoTLR2 Genotyping 5’ UTR to 5’UTR intronic region 59 CCAGATTCCACCCTCTCAAG AAACCAACGCAGCAGAATTT 
  Genotyping  CDS +167 to + 1156bp 59 GCCTTGACCTGTCCAACAAT AGGCATCCTTACAGGCTGAG 
  Genotyping  CDS +2137 to 3’ UTR region 60 TTTGTGAAGAGCGAGTGGTG CAATTTGGTCGCAGTTTTGA 
BoTLR4 Genotyping 5’ UTR to intron 1 61 GCCACAGTTCCTGGGTAGTC TTTGATTCCTGCGGTTTCTT 
  Genotyping  Intron 1 to intron 2 61 TTGGATGGATGGATGTTTGA CAGCACCATGCTCAGGTTTA 
  Genotyping  Intron 2 to CDS +720bp 61 TTGCCGGACTTCTTTGTTTC AAGAAGGGCTTGTAGACTTCCT 
  Genotyping  CDS +2110bp to 3’ UTR region 61 AGCAGGAACACCTACCTGGA GAGGGGAATCTGAATCAGGAG 
BoTLR5 Genotyping 5’ upstream region to CDS +242bp 59 GCTCACATGGTCACCACAAG AAACTGAGTTCCCAGCTCCA 
  Genotyping  CDS +2302bp to 3’ downstream region 58 TTCCTTAGAGACGGGTGGTG GTCGATGCAATGGGAGAGAT 
BoTLR6 Genotyping 5’ upstream region to intron 1 59 GGCAGAGTGAACACAGGTGAA CATCAGCAGAGGCATTCTCA 
BoCD14 Genotyping 5’ UTR region to CDS+154bp 59 ATGGAAAGTACCCAGGCTGA GACGGCAACCATACACTGAA  
  Genotyping  CDS +986bp to 3’ UTR region 58 GACCTGACTCTGGACGGAAAT TCCTTCCAGGCATGTTTACC 
BoCXCR1 Genotyping 5’ intron to CDS +249 59 ATCTGAATGCCCAGACATGG AGTGACAGAGCGACCAATCC  
  Genotyping  CDS +553 to 3’ UTR 59 GAGGCCTATCAACCACCGTA TTCCTGGCTGACAAGGAAAG 
BoCXCR2 Genotyping 5’ upstream to intron1 60 AGGAGCATGGTCAGAGAGGA GAGGTGTGGGGATAGATGGA  
  Genotyping  CDS +935 to 3’ downstream 59 TCAACCCCCTCATCTACGTC AATGCCATCACCCTTGAAAC 
CDS = Coding sequence. 
3
5
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2.4 Restriction fragment length polymorphism (RFLP) - PCR analysis 
In addition to sequencing of PCR amplicons, the boTLR1 SNPs +798C>T and +1762A>G 
were genotyped using RFLP analysis of PCR products using restriction enzymes. Restriction 
enzyme MboII, which recognises 5’- GAAGA(N)8
▼
- 3’, digests DNA in the presence of the 
C allele for SNP +798C>T. Restriction enzyme BclI, which recognises 5’- T▼GATCA- 3’, 
digests DNA in the presence of the A allele (Isoleucine) for the NS SNP +1762A>G (Li, Shi 
et al. 2009). Restriction digests were performed with 2 µL 10X buffer, 10 µL PCR product, 2 
U of appropriate restriction enzyme (New England Biolabs UK, Hitchin, UK) and X amount 
of Ambion® DEPC-treated water (Life Technologies) to a final volume of 20 µL. Digests 
were incubated at the recommended temperature for 2 h, with subsequent heat inactivation of 
the enzyme at 65°C for 20 min. Homozygous and heterozygous samples, confirmed by 
sequencing, were included as controls. 
2.5 Identifying associations between SNPs and CM and milk quality 
Identified SNPs were correlated to health or milk productivity data available through the 
InterHerd software program and NMR data. These included CM case histories, milk SCC, 
mean 305d milk yields and mean milk protein/fat concentrations. All animal data were 
recorded within and up to the first three lactations only. This recording parameter represents 
the average number of parities per animal and further limits the influence of age and any 
farmer bias of culling on CM within each genotyped population. Mean SCC were 
transformed logarithmically as NEWSCC = LOG2 (SCC/100 000) +3. This model accounts 
for the skewness of data distribution (Rupp and Boichard 1999). Mastitis was investigated in 
three ways, percentage of population affected, mastitis rate and recurrence rate, parameters 
recommended for effective farm monitoring of mastitis (Edmondson and Blowey 1998). 
Percentage of population affected was calculated by the presence or absence of CM cases per 
animal for their first three lactations. Mastitis rate, or mean incidence of CM, is presented as 
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cases/cow/year ([total number of cases/total number of milking days]*365) during the first 
three lactations. CM was defined as an individual clinically apparent event, coupled with a 
rise in milk SCC and/or isolation of pathogen, recorded on a single day within any/all 
quarters during a lactation period. Repeated cases within the same quarter were noted 
(recurrence rate = number of repeat cases/total number of mastitis cases) but only regarded as 
a new case after seven CM-free days return to milking. In the event of an animal having CM 
history, the total number of milking days was adjusted to take into account the 14 day animal 
recovery period per CM case. Other factors, such as the number of cases within the first 14 
days of each new lactation (often the result of infection during dry-off period), were analysed 
for significant differences between genotypes.  
 
2.6 Selection of genotyped cows for functional assays  
Samples collected from genotyped cows selected for functional assays were from healthy, 
mid-lactating, age-matched cattle that had recorded no IMI in the two weeks prior to sample 
collection. Health of each cow two weeks post-sample collection was also recorded, and in 
the event of an animal having IMI within this time-frame, data was not used.  
 
2.7 TLR ligands  
All TLR ligands, Pam3CSK4 (PAM3), lipoteichoic acid from S. aureus (LTA) and 
lipopolysaccharide (LPS) EB Ultrapure (InvivoGen, San Diego, CA, USA), were 
reconstituted in sterile endotoxin-free water, according to the manufacturer’s instructions, to 
a concentration of 1 mg/mL, and stored at -20°C. PAM3 is a synthetic triacylated lipoprotein 
and potent stimulus of TLR1/2 complexes. LTA is a TLR2 stimulus and LPS stimulates 
TLR4. 
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2.8 Stimulation of whole blood with TLR ligands 
Whole blood (WB) was collected into heparin (final conc. 10 U/mL) and stimulated using an 
adaptation of a procedure devised previously (Kovach, Yee et al. 1990). Briefly, 400 µL of 
heparinised blood were pipetted into 1.5 mL tubes. 100 µL of TLR ligand, further diluted in 
filtered PBS to appropriate concentrations (PAM3 - 250 ng/mL, LPS - 100 ng/mL, LTA - 1 
µg/mL), were added to each blood aliquot and vortexed. The tubes were then incubated at 
37°C for 24 h with gentle agitation. Following incubation, a further 800 µL of filtered PBS 
was added to each tube. Cellular components were pelleted by centrifugation at 800 g for 15 
min, allowing removal of residual diluted plasma. 
 
2.9 Isolation of PMN leukocytes from bovine blood 
PMN leukocytes were isolated from 50 mL blood samples. Briefly, blood was collected into 
EDTA (final concentration of ~1.5% weight/volume), centrifuged at RT (1000 g /15 min) and 
the plasma and buffy coat phases carefully removed. For every 2.5 g of lower blood phase, 10 
mL of H2O were added. The mixture was agitated and left for 40 s before adding half the 
water volume of NaCl/PO4 reagent (2.7% NaCl/PO4 reagent: 2.7 g NaCl into 10 mL 0.132 M 
phosphate buffer (18.74 g Na2HPO4 and 17.96 g KH2PO4 into 1 L H2O, pH 6.8) and made up 
to 100 mL with H2O) to restore isotonic strength. PMNs were pelleted by centrifugation (125 
g /10 min /RT), the supernatant discarded and the cells resuspended in 1.5 mL of PBS. This 
was repeated twice to wash the cells. Typically 1 × 10
8
 PMN cells were obtained per 50 mL 
sample. 
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2.10 Stimulation of PMNs with TLR ligands 
Isolated PMNs were seeded to 1 × 10
6 
/1 mL into culture media: RPMI 1640 + GlutaMAX
TM
 
with 10% heat-inactivated foetal calf serum (FCS) (both Invitrogen, Life Technologies, UK) 
and 100 U mL
-1 
/100 μg mL-1 Penicillin/Streptomycin (Sigma, St Louis, MO, USA). Prior to 
stimulation, seeded cells were incubated at 37°C, in 5% CO2 for approximately 18 h in 24-
well tissue culture plates. PAM3 was added to the cells in 100 µL of culture media, at final 
concentrations of 100 ng/mL, 250 ng/mL and 500 ng/mL. Negative controls included a media 
control (no ligand) and LPS (100 ng/mL), as a non-TLR1 stimulant. Stimulated cells (4 h and 
8 h post-stimulation) were lysed and total RNA extracted as detailed in section 2.15.1. 
Supernatants were taken 24 h post-stimulation for detection of cytokine production by ELISA 
as detailed in section 2.17. 
 
2.11 Isolation of CD14+ leukocytes from bovine blood 
CD14+ leukocytes were isolated from 50 mL blood samples. Briefly, heparinised blood (final 
concentration 10 U/mL) was collected and separated over a density gradient (Histopaque 
1083; Sigma-Aldrich) by centrifugation (1000 g /30 min /RT) to enrich the peripheral blood 
mononuclear cell (PBMC) percentage. Following careful removal of the buffy coat phase 
(PBMCs) into sterile PBS (50 mL), cells were pelleted by centrifugation (125 g /10 min 
/4°C), the supernatant discarded and the cells resuspended in 50 mL of PBS. This was 
repeated twice to wash the cells. Cells were aliquoted 1×10
7
/mL in FCS containing 10% 
Dimethyl Sulphoxide (DMSO) (Sigma-Aldrich) and stored in liquid nitrogen (-80°C). 
Monocytes (CD14+ cells) were enriched from PBMCs following incubation with 
monoclonal anti-human (mouse IgG2a) CD14 Microbeads (Miltenyi-Biotech Ltd. Surrey, 
UK) and the labelled cells isolated using a MiniMACS® column (Miltenyi-Biotech) 
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according to the manufacturer's instructions. Typically 1×10
5
 CD14+ cells were obtained 
from 1×10
6
 PBMCs. 
  
2.12 Flow cytometric analysis of isolated CD14+ cells 
The purity of each isolated CD14+ cell population was evaluated by flow cytometric analysis 
following incubation with an anti-human (mouse IgG2a) CD14+ antibody, conjugated with 
the fluorochrome fluorescein isothiocyanate (FITC) (Miltenyi-Biotech). An appropriate 
FITC-conjugated mouse IgG2a isotype control antibody (Miltenyi-Biotech) was used to 
distinguish specific from non-specific fluorescence. In addition, cells from each CD14+ sort 
were incubated with propidium iodide (PI) solution (Sigma-Aldrich) for assessment of cell 
viability. Briefly, samples from each cell sort were incubated with the appropriate amount of 
primary antibody for 10 min at +4°C; or PI solution (25 µg/mL) for 5 min at +4°C. Stained 
cells were washed in refrigerated (2-8°C) cell sorting buffer solution: PBS/0.5% Bovine 
Serum Albumin (BSA) (Sigma-Aldrich)/ 2mM EDTA pH 7.2, and pelleted (300 g/10 min 
/RT) prior to the removal of supernatant. This step was repeated twice before final suspension 
of cells in an appropriate volume of FACSflow fluid (BD Biosciences, San Jose, CA, USA). 
Cytometric analysis was performed on a BD FACSCanto
TM
 II flow cytometer (BD 
Biosciences). Ten thousand events were collected for each sample, and the data analysed 
using BD FACSDiva
TM
 software (BD Biosciences). 
 
2.13 Bacterial strains and preparation of heat-killed bacterial reagents 
The four strains of bacteria used for this study represent three highly important pathogens and 
causative agents of bacterial mastitis: S. uberis, E. coli (strain P4) and S. aureus (strain M60). 
Two strains of S. uberis were used, strain 0140J (strain ATCC BAA-854/0140J, originally 
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isolated from a clinical case of bovine mastitis in the UK and known to be of high virulence), 
and strain EF20 (a strain isolated from a healthy udder and infrequently associated with 
pathogenesis). Both S. uberis isolates have been used in previous studies (Hill 1988; Egan, 
Kurian et al. 2010). E. coli and S. aureus strains were both virulent isolates from cases of 
bovine mastitis (BramLey 1976; Anderson 1977). 
Bacteria were grown overnight in Todd Hewitt broth (Oxoid Ltd., Cambridge, U.K.) 
at 37°C to an exponential phase of growth. All cultures were of similar optical densities of 
between 0.9-1.0 OD550nm. Bacterial numbers were calculated for each aliquot prior to heat 
treatment via plate spreading of serial dilutions and colony counting (typically 1×10
9
 colony 
forming units (CFU) /mL). Aliquots containing 1 mL of overnight culture were incubated in a 
water bath for 1 h at 60°C for E. coli P4, or 70°C for S. uberis 0140J, S. uberis EF20 and S. 
aureus M60, to heat-inactivate/kill the bacterium. Swabs from each heat-killed (HK) aliquot 
were plated and incubated overnight at 37°C to confirm zero growth of colonies and 
effectiveness of treatment. HK bacteria from each aliquot were pelleted (125 g /5 min) and 
washed twice in sterile PBS before final suspension in 1 mL of PBS. 
 
2.14 Stimulation of CD14+ cells with TLR ligands and pathogens 
Isolated CD14+ cells were seeded to 1×10
5
 /1 mL in culture media: RPMI 1640 + 
GlutaMAXTM with 10% FCS and 100 U mL-1 /100 μg mL-1 Gentamycin (Sigma). Prior to 
stimulation, seeded cells were incubated at 37°C, in 5% CO2 for approximately 2 h in 24-well 
tissue culture plates. PAM3 was added to the cells in 100 µL of culture media, at a final 
concentration of 250 ng/mL; shown to be effective in inducing a TLR1-mediated response 
(see section 2.9). Negative controls included a media control (no ligand) and LPS (100 
ng/mL), as a non-TLR1 stimulant. The equivalent of ~10
6
 of HK bacterium in 100 µL of 
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culture media was added to CD14+ cells, giving an equivalent of 10:1 multiplicity of 
infection (MOI). Supernatants were taken 24 h post-stimulation for detection of cytokine 
production by ELISA. 
    
2.15 RNA isolation and cDNA synthesis  
2.15.1 RNA isolation 
Pelleted cell samples were lysed in RLT buffer for total RNA extraction using the RNeasy 
Mini Kit (Qiagen) according to manufacturer’s instructions. Samples were DNase-treated 
(DNAfree, Ambion®, Life Technologies) and 1 µL of the sample was quantified on the 
NanoDrop 8000 spectrophotometer. Integrity of RNA (and mRNA) was additionally 
visualised on agarose gels by assessing the clarity of 28S and 18S rRNA bands. 
2.15.2 First strand complementary DNA (cDNA) synthesis 
 Total RNA was used for cDNA synthesis using SuperScript II Reverse Transcriptase 
(Invitrogen Ltd. UK) using the recommended protocol. Typically, each 20 µL reaction 
contained ~1 µg total RNA, 1 µL of oligo dT (500 µg/mL) (Promega UK), 1 µL 10 mM 
dNTPs (Fermentas), and X amount of Ambion® DEPC-treated water to an initial volume of 
12 µL. The mixture was incubated at 65°C for 5 min and stored on ice for 1 min, before the 
addition of 4 µL of 5X First-Strand buffer, 2 µL of 0.1 M dithiothreitol (DTT) and 1 µL (20 
U) Ribonuclease inhibitor (RNAsin) (Promega UK). Following incubation at 42°C for 2 min, 
1 µL (200 U) of SuperScript II was carefully added, followed by continued incubation at 
42°C for 50 min before inactivating the reaction by incubation at 70°C for 15 min. 
Complementary RNA was removed from cDNA by the addition of 2 U Rnase H (Invitrogen) 
and incubated at 37°C for 20 min. Quantification of cDNA was carried out using the 
NanoDrop 8000 spectrophotometer. 
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2.16 Q-PCR analysis  
Quantitative PCR (Q-PCR) was performed with the ABI Prism 7500 FAST Sequence 
Detection System (Applied Biosystems) using FAST Universal Mastermix (Applied 
Biosystems) according to the manufacturer’s protocol. Taqman® probe and primers for 
bovine GAPDH, CXCL8, CXCR1, CXCR2, IL-6, IL-10, TNF-α and Bcl2A1 have been 
described previously (Collins, Howard et al. 1999; Werling, Collins et al. 2002; Widdison, 
Watson et al. 2008; Widdison, Watson et al. 2009; Widdison, Watson et al. 2011). Taqman
®
 
probe and primers for bovine TLR1, TLR2, TLR4, TLR5, TLR6, TLR10 and RPLP2 were 
designed from sequenced templates, avoiding any SNPs, and wherever possible, spanning 
intron/exon boundaries, using the Primer3 software (Rozen and Skaletsky 2000). All primers 
and probes (Table 2.2) were synthesised by Sigma-Genosys Ltd. and Eurogentec Ltd. 
(Romsey, UK) respectively. Probes were labelled at the 5’ end with the reporter dye FAM (6-
carboxyfluorescein) and at the 3’ end with the quencher dye TAMRA (6-
carboxytetramethylrhodamine). 100 ng of cDNA template from each animal were tested in 
triplicate and quantified by comparison with a standard curve from plasmid DNA of known 
copy number. Relative target gene expression was then calculated by normalising to the 
combined mean expression levels of the housekeeping genes glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) and ribosomal protein, large, P2 (RPLP2). Both genes are 
commonly used as reference genes for Q-PCR, and GAPDH expression stability has been 
shown in bovine cells responding to inflammatory stimuli (Bougarn, Cunha et al. 2011). 
Expression stability of boRPLP2/boGAPDH ratios were observed for Q-PCR assays 
involving PAM3 stimulated PMNs in this study (Appendix I). Analysis was performed using 
Microsoft
®
 Excel 2008 (Microsoft Co., Redmond, WA, USA) and Prism® 5.04 software 
(Graph Pad Software, Inc, CA, USA).  
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Table 2.2 - Primers and probes used for quantitative PCR (QPCR) assays 
Gene Forward primer (5’- 3’) Reverse primer (5’- 3’) Probe (5’- 3’) 
BoTLR1  GCACCACAGTGAGTCTGGAA  GTACGCCAAACCAACTGGAG  TGTGTGCTTGATGATAATGGGTGTCCT 
BoTLR2 ACGACGCCTTCGTGTCCTAC GCTCCTGGACCATGAGGTTC CGAGCGGGATTCCTACTGGGTGG 
BoTLR4 TGGAGGACATGCCAGTGCT CACCGACACACTGATGATCGT AGTTTCAGGAACGCCACTTGTCAGCTG 
BoTLR5 CTAGACCTGGGTGGAAGTCAG AGGGATGAAGGTAAAGACTCTGAA TTCCTGTGGTCTCTCCGATGCTG 
BoTLR6  CCTGCCCATCTGTAAGGAAT TAGGTGCAAGTGAGCAATGG TTGGCAACTTGACCCAACTGAATTTC 
BoTLR10 TGGTTGGATGGTCAGATTCA CAGGGCAAATCAAAGTGGA CCATTGTTGTCATGCTCGTTCT 
BoCXCR1  AGGGGTTTGAGGATGAGTTTG CAGTGCTTATCTCACAGGGACT TCTTCTGTGGGTGGCGTGCC 
BoCXCR2  ACCTGCCCTCTATTCTAACAGA GCATGCTTATTGATATCCAGAATTT CTGCCCCATGTCGGCCAG 
BoGAPDH  CATGTTCCAGTATGATGATTC GAGCTTCCCGTTCTCTGC CGGCAAGTTCAACGGCAC 
BoRPLP2  TCAACAAGGTCATCAGTGAGC CCGATACCCTGAGCAATGA CGTCCTCGATGTTCTTTCCGTGG 
CXCL8 TGAAGCTGCAGTTCTGTCAA TGGAAAGGTGTGGAATGTGT TGAGTACAGAACTTCGATGCCAATGCA 
IL-6 CAGCTATGAACTCCCGCTTCA AGGAGCAGCCCCAGGG AAGCGCCTTCACTCCATTCGCTGTC 
IL-10 GGTGATGCCACAGGCTGAG AGCTTCTCCCCCAGTGAGTTC CACGGGCCTGACATCAAGGAGCA 
TNF-α CGGTGGTGGGACTCGTATG GCTGGTTGTCTTCAAGCTTCA CAATGCCCTCATGGCCAACGG 
Bcl2A1 TTTCTTTGTGGCGGAGTTC AAAAGTCAGCCAGCCAGATT ACAAACCCATTTTCCCAGCCTCC 
  
4
4
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2.16.1 Plasmid DNA purifications  
For preparation of quantitative PCR gene standards, a single colony of the appropriate 
transformed isolate expressing the target gene was grown in 10 mL of Luria-Bertani (LB) 
media with 100 U mL
-1
 of ampicillin. Plasmid DNA was purified using the QIAprep Spin 
Miniprep Kit (Qiagen) according to manufacturer’s protocol. 
 
2.17.1 Detection of CXCL8 
Levels of bovine CXCL8 were determined by luminescent ELISA, using a pair of 
commercial human IL-8-specific antibodies (R&D Systems, Oxon, UK) according to a 
modified luminescence-based ELISA described previously (Kwong, Hope et al. 2002). In 
brief, black Nunc MaxiSorp flat-bottom 96-well microplates were coated with 100 µL/well of 
capture antibody at 2 µg/mL diluted in coating buffer (0.05 M carbonate/bicarbonate buffer 
pH 9.6) (Sigma-Aldrich), and incubated overnight at RT. Wells were washed five times with 
300 µL of PBS + 0.05% Polyoxyethylensorbitan monolaurate (Tween-20) (Sigma-Aldrich), 
and then blocked with 300 µL PBS + 1% sodium casein (Sigma-Aldrich) solution, made 
fresh per assay, for 2 h at RT. Wells were washed five times before adding 100 µL of sample 
to be assayed, diluted in reagent diluent solution (PBS + 1% sodium casein + 0.05% Tween-
20) and incubated for 1 h at RT. Samples were tested in triplicate, with recombinant bovine 
CXCL8 (Kingfisher Biotech, Inc., MN, USA) as the standard. Wells were washed five times 
before adding 100 µL biotinylated secondary antibody, at 0.1 µg/mL in blocking buffer, and 
then incubated for 1 h at RT. Wells were washed five times before adding 1/500 streptavidin-
horseradish peroxidase (SA-HRP) (Amersham, GE Healthcare, Buckinghamshire, UK) in 
reagent diluent, and incubated for 45 min at RT. Wells were washed five times before the 
addition of 100 µL luminol - SuperSignal Femto Maximum Sensitivity Substrate (Pierce, 
46 
 
Thermo Fisher Scientific, Northumberland, UK). The relative light unit value was read on an 
Anthos LUCY 1.0 luminometer (Anthos Labtec, Salzburg, Austria).   
2.17 ELISA 
2.17.2 Detection of IL-6 
Levels of bovine IL-6 were determined using a commercial tetramethylbenzidine (TMB) 
ELISA kit according to the manufacturer’s protocol (Thermo Fisher Scientific), using clear 
Nunc MaxiSorp flat-bottom 96-well microplates, and reagents and incubation times as 
detailed in section 2.16.1. Samples were tested in triplicate, with the provided recombinant 
bovine IL-6 as the standard. After washing from SA-HRP incubation, TMB liquid substrate 
(Sigma-Aldrich) was added, and stopped with the addition of 2N H2SO4 once colourisation of 
the lowest standard was observed. The OD450nm was read using an Anthos LUCY 1.0 
luminometer (Anthos Labtec).  
2.17.3 Quantifying protein levels 
The amount of protein present in the samples was calculated using a standard curve generated 
from six standards of known concentrations. Standard curve analysis was carried out using 
Prism® 5.04 software (Graph Pad Software) using the average OD reading of the triplicates. 
A standard curve was generated by log transforming (X=Log(X)) the concentrations of the 
standards used and plotting these against the OD readings by nonlinear regression using a 
sigmoidal dose-response (variable slope) curve. The unknown concentrations of the samples 
were interpolated from their OD readings using the standard curve, and anti-log transformed 
(X=10^X) into concentration. 
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2.18 Statistical analyses 
2.18.1 Genotypic frequencies and LD between alleles 
Genotypic frequencies were tested for deviation from Hardy-Weinberg equilibrium according 
to Chi^2 test and level of significance at 1 degree of freedom. Haplotypes and linkage 
disequilibrium (LD) scores (based on the r
2
 statistic), were analysed using the Haploview 
programme (Barrett, Fry et al. 2005). r
2
, the square of the correlation coefficient, measures 
the specific relationship between the alleles of two loci. An r
2
 value ranges between 0, no LD, 
and 1, absolute LD. In the event of alleles sharing r
2 
scores of 0.9–1.0 (high to complete LD 
that allows for a small degree of spurious genotyping), a tagging SNP (tSNP) is selected as a 
proxy for the allele linkage group. 
2.18.2 Association analysis 
Owing to substantial positive skewness (due to zero values) of data distribution, the mean 
CM rate was transformed: NEWCM = LOG10 ([CM+1/milking days]*365) 
This is based upon the model NEWX=LOG10(X+1) as suggested for data transformation 
(Tabachnick and Fidell 2007). A genotypic model was used for separate genotype pair-wise 
comparisons. One-way analysis of variance (ANOVA) and Tukey’s multiple comparisons for 
CM rate, milking traits and functional data means (Q-PCR and ELISA) were performed using 
Prism® 5.04 software (Graph Pad Software). CM events across all lactations (CM 
recorded = 1, no recorded CM = 0) between genotypes were pair-wise tested for significance 
by a Chi^2 odds ratio test using Minitab® 16 software (Minitab Statistical Software, Inc, PA, 
USA). Calculation of Pearson correlation coefficients between factors and analysis of CM 
response in a General linear model (GLM) was performed using Minitab® 16 software.  
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Chapter 3.0 - Identification of bovine TLR1 SNPs 
– association with mastitis and production traits in 
cattle 
 
 
This chapter expands published data (Russell, Widdison et al. 2012).
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3.1 Introduction 
3.1.1 Bovine Toll-like receptor 1 
BoTLR1 is a member of a unique TLR sub-family that includes boTLR6 and boTLR10. 
Phylogenetic analysis of boTLR1, 6 and 10 reveals a common ancestry with all three genes 
located in tandem forming a ~69kb boTLR6-TLR1-TLR10 gene cluster on B. taurus 
chromosome 6 (bta6) (Opsal, Vage et al. 2006). All encoded proteins have the ability to form 
heterodimers with boTLR2 to expand the repertoire of recognised bacterial lipoproteins. 
TLR1/TLR2 complexes mediate cellular responses to natural triacylated lipoprotein 
structures (Takeuchi, Sato et al. 2002; Omueti, Beyer et al. 2005), which are cell wall 
constituents of Gram-positive and Gram-negative bacteria (Babu, Priya et al. 2006). 
TLR6/TLR2 complexes expand ligand recognition to diacylated lipoproteins, although in 
cattle the boTLR1/boTLR2 heterodimers may be further activated by diacylated lipoproteins 
(Werling, Jann et al. 2009). Whilst additional investigation is required to uncover their 
function, mammalian TLR10/TLR2 complexes may extend recognition of TLR1 agonists via 
an unknown signalling mechanism (Guan, Ranoa et al. 2010). Current evidence demonstrates 
that bovine MEC are able to sense triacylated lipoproteins through the boTLR1/boTLR2 
heterodimer (Porcherie, Cunha et al. 2012). Triacylated lipoproteins are present on cell 
membranes of important mastitis-causing pathogens including E. coli and S. aureus 
(Kurokawa, Lee et al. 2009; Kovacs-Simon, Titball et al. 2011), suggesting that boTLR1 
plays a significant role in mammary immune defence (Figure 3.1). 
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Figure 3.1 - Overview of TLR1/TLR2 heterodimer signalling 
Lipoproteins embedded within the cell membrane of bacterial pathogens constitute a major 
exogenous ligand group for mammalian TLR2, whereby association with TLRs 1 and 6 
expands ligand recognition to triacylated and diacylated lipoproteins respectively. TLR2 
heterodimerisation is important for specific ligand interactions with both TLR ectodomains 
and subsequent association of cytoplasmic TIR domains with adapter proteins MyD88 and 
TIRAP, initiating MyD88-dependent signalling cascades (generalised as dashed arrows) 
leading to the translocation of transcription factor NF-κB (others include AP-1 and IRF-5) 
into the nucleus. This initiates synthesis of cytokines leading to a mammary immune response 
that includes recruitment of leukocytes and lymphocytes into the gland to eliminate the 
pathogen.   
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TLR1 variants have been postulated to underlie altered immune responses to a wide 
spectrum of bacterial pathogens. In humans, a NS TLR1 SNP located within the 
transmembrane domain, which had an impact on TLR1 trafficking, NF-κB activity and 
cytokine output, was found to have strong associations with susceptibility to and progression 
of infection by Gram-positive bacteria and Mycobacterium leprae (Hawn, Misch et al. 2007; 
Johnson, Lyle et al. 2007; Misch, Macdonald et al. 2008; Wurfel, Gordon et al. 2008). 
Polymorphisms affecting boTLR1 may therefore predispose excessive or weakened immune 
responses to pathogens and hence could confer an increased risk of mammary infection.  
3.1.2 BoTLR1 and health and disease in cattle 
Genome-wide quantitative trait locus (QTL) studies revealed the boTLR6-TLR1-TLR10 gene 
cluster to be situated within a dense QTL region for CM and a number of milk production 
traits (Klungland, Sabry et al. 2001; Ogorevc, Kunej et al. 2009). Furthermore, boTLR1 has 
been highlighted as a strong candidate for underlying QTL regions for resistance to disease, 
such as mastitis (Jann, King et al. 2009). Despite strong QTL evidence, associative studies 
between boTLR1 and disease are limited. The boTLR1 coding sequence (CDS) is highly 
polymorphic, containing many SNPs across several cattle breeds (Seabury, Cargill et al. 
2007). Four SNPs within the CDS of boTLR1 were identified in Holstein cows (Li, Shi et al. 
2009), but only the previously identified (Seabury, Cargill et al. 2007) NS SNP +1762A>G 
(reported as +1596G>A) demonstrated highly significant differences in SCC between all 
genotype populations. The +1762A>G mutation, encoding an isoleucine to valine change 
within the receptor’s transmembrane domain, has also been associated with bovine TB in a 
Chinese Holstein herd (Sun, Song et al. 2012). Further investigation is required to verify such 
studies, and to establish associations with novel boTLR1 SNPs/haplotypes. More importantly, 
the ability to use data describing actual CM incidence, rather than a surrogate such as SCC, in 
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associations with specific genetic markers, has the potential to yield more accurate 
information.  
3.1.3 Rationale for research 
The existing limited study of boTLR1 SNPs provides scope for further investigation. Existing 
NS boTLR1 SNP +1762A>G associations can be expanded upon and extended into the 
identification of novel SNPs in the coding or non-coding regions, including introns, 5’UTR 
and 3’UTR, and adjacent genomic upstream/downstream regions. SNPs identified may 
interrupt gene promoters or microRNAs, splice sites or other regulatory motifs, potentially 
interfering with mRNA regulation and protein expression (Song, Chen et al. 2006). The 
influence of the +1762A>G SNP may be polygenic, linked with additional SNPs and 
inherited as a haplotype.  
The aims for this part of the research were to analyse the impact of existing and novel 
boTLR1 SNPs on CM incidence and milking traits in a Holstein-Friesian herd. In addition, 
potential differences in relative mRNA levels between observed genotypes were quantified. 
These differences may influence boTLR1 activity and support existing genotype associations.  
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3.2 Results
3.2.1 Characterisation of boTLR1 SNPs 
The genomic organisation of boTLR1 was confirmed using cDNA sequencing and analysis of 
NCBI EST data, mapped to the Btau_4.0 sequence (NC_007304.4). As described previously 
(Opsal, Vage et al. 2006), the full length boTLR1 mRNA transcript comprises five exons and 
four introns. The CDS for full length boTLR1; a 2379bp transcript corresponding to a 793 
amino acid (aa) chain (Farhat, Riekenberg et al. 2010), is located within exon 5. Sequencing 
of boTLR1 within a Holstein-Friesian herd (n = 246) revealed eleven SNPs; five of which are 
novel (Table 3.1). Eight of the eleven SNPs were exonic, six were located in the CDS, of 
which only one was a NS change (+1762A>G, Iso > Val) positioned within the 
transmembrane domain, while the remaining two were located in the non-coding 3’UTR. The 
three non-exonic SNPs were identified within the introns of the 5’ UTR (Figure 3.2). 
3.2.2 RFLP-PCR analysis 
The boTLR1 SNPs +798C>T and +1762A>G were genotyped using RFLP analysis of PCR 
products, using the restriction enzymes MboII and BclI respectively. These proved to be an 
effective method for genotyping animal samples, with representative results of a typical BclI 
digest illustrated in Figure 3.3. 
3.2.3 Analysis of LD patterns in boTLR1 for tagging SNP selection 
Seven boTLR1 SNPs: -79T>G, +798C>T, +1762A>G, +2097T>C, +2100C>T, +2463C>T, 
and +2731A>G (Figure 3.2) were detected within the herd (n = 156, 246, 202, 100, 100, 225 
and 232 cows respectively) and included for LD analysis and tagging SNP selection. A 
graphical representation of the LD between these SNPs is shown in Figure 3.4. All SNPs 
were defined as one haploblock, with one linkage group identified. 
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Table 3.1 - Identified SNPs within boTLR1 from Holstein-Friesians 
 
Abbreviations: Bta6 = B. taurus chromosome 6, dbSNP = Single Nucleotide Polymorphism 
Database (http://www.ncbi.nlm.nih.gov/projects/SNP). All boTLR1 sequences were aligned 
with the published Btau_4.0 sequence NC_007304.4 (underlined allele denotes the published 
sequence). Light shading - synonymous coding SNPs, dark shading - non-synonymous 
coding SNP. All boTLR1 SNP offsets are given relative to their position (bp) from the A 
nucleotide of the first ATG codon. *Restriction sites used for RFLP-PCR genotyping.  
1
Opsal, Vage et al. 2006, 
2
Seabury, Cargill et al. 2007. 
 
 
 
 
SNP 
 
 
Location 
Genomic 
(Bta6) 
position 
Amino 
acid  
position 
Amino 
acid 
Restriction 
site 
presence 
Previously 
reported 
 
dbSNP ID 
-1205A>G Intron3 60440366 - - - No  - 
-1151T>A Intron3 60440312 - - - No  - 
-79T>G Intron4 60439240 - - - No  - 
+798C>T Exon5 60438363 266 Phe-Phe MboII* Yes 
1
 ss73689409 
+1641A>C Exon5 60437520 547 Ser-Ser BstX-I Yes
 2
 ss73689413 
+1716G>A Exon5 60437445 572 Lys-Lys BsiY Yes 
2
 ss73689414 
+1762A>G Exon5 60437324 587 Ile-Val BclI* Yes 
2
 ss73689415 
+2100C>T Exon5 60436989 700 Phe-Phe - Yes 
2
 ss73689417 
+2103T>C Exon5 60436986 701 Val-Val BsmAI Yes 
2
 ss73689418 
+2463C>T 3’UTR 60436698 - - MsII No  - 
+2731A>G 3’UTR 60436430 - - - No  - 
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Figure 3.2 - Schematic illustrating the positions of identified SNPs within the bovine TLR1 gene 
Grey box represents coding exon (CDS = 2379bp), open boxes represent non-coding untranslated exonic regions (UTR). A TLR1 protein domain 
architecture diagram, designed using web-based programmes http://smart.embl-heidelberg.de/ and http://www.lrrfinder.com/, is illustrated below 
the CDS. The non-synonymous +1762A>G SNP (in bold), is located within the transmembrane domain (vertical black bar). LRR - leucine-rich 
repeat domains (19 in total), LRR C - leucine-rich repeat C terminal domain, TIR - Toll-interleukin 1-resistance domain. Sequence shown from 
Btau_4.0 sequence (NC_007304.4), Bta6: 60355k-60363k. Red line represents total sequencing coverage (~6.8kb). Boxed SNPs have been 
genotyped extensively. 
EXON 1 EXON 2 EXON 3 EXON 4 EXON 5
1 kB
BoTLR1
5’ 3’
Bta6: 60355k-60363k forward strand
1.5 kB Total contig length: 8.7kB
LRR
5
5
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Figure 3.3 - RFLP-PCR product patterns following BclI digest of the +1762A>G site 
Agarose (2%) gel separation of DNA digest products from nine animal samples (1-9 above 
gel) to determine the genotype (below gel) for the NS boTLR1 SNP +1762A>G. The 
restriction enzyme BclI cuts only in the presence of the A allele (isoleucine), whereby digest 
of a 316bp PCR transcript yielded the following product sizes (shown on the right) for each 
genotype: GG = 316bp (no cut), GA = 316bp, 206bp and 108bp, AA = 208bp and 108bp.   
GA GAAA GA AA GA GA GG GA
250bp
208bp
108bp
1kb
500bp
316bp
1 52 3 4 6 7 8 9
‘A’ allele
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Figure 3.4 - Linkage disequilibrium (LD) plot for seven extensively genotyped SNPs in 
relation to the boTLR1 gene model  
Grey box represents boTLR1 coding exon, open boxes represent non-coding UTR. The NS 
SNP is underlined. The graphical representation, generated by Haploview, of the r
2
 LD 
relationship between each SNP is expressed on a grey-scale gradient; where black = perfect 
LD (r
2
 = 1.0) and white = very low LD (<0.1). The r
2
 value for each pair-wise comparison is 
shown. SNP positions highlighted green represent a linkage group whereby each marker is in 
strong to near complete linkage disequilibrium (LD >0.9) with one another. All SNPs were 
defined as one haploblock.  
 
  
+
1
7
6
2
A
>
G
(I
le
-V
a
l)
EXON 4 EXON 5
BoTLR1
+
2
0
9
7
T
>
C
+
2
1
0
0
C
>
T
r2 = 1
0>r2<1
r2 = 0
1 kB
-7
9
T
>
G
+
7
9
8
C
>
T
•
+
2
4
6
3
C
>
T
•
+
2
7
3
1
A
>
G
58 
 
SNPs 1, 2, 4, 5, and 7 are in strong LD (>0.9) with each other, and include the intronic SNP -
79T>G, synonymous coding SNPs +798C>T, +2097T>C and +2100C>T, and the 3’UTR 
SNP +2731A>G. As a result, the -79T>G marker was selected as the tSNP for these five 
SNPs (Table 3.2). Two singleton SNPs were also identified, the NS +1762G>A, and the 
3’UTR +2463C>T. LD between the tSNP -79T>G and the NS +1762A>G was moderate 
(~0.8). LD between SNPs -79T>G and +2463C>T was lower. The lowest LD was observed 
between SNPs +1762A>G and +2463C>T (Figure 3.4). Consequently, analysis of association 
with traits for tSNP -79T>G, and SNPs +1762A>G and +2463C>T was performed 
individually. 
Table 3.2 – Summary of selected tSNP marker for boTLR1 linkage group 
Linkage group tSNP marker Tagged SNPS  
1 t-79T>G +798C>T 
  +2097T>C 
  +2100C>T 
  +2731A>G 
 
3.2.4 Analysis of genotypes and allelic frequencies of boTLR1 markers selected for 
association analysis 
The three boTLR1 SNPs, -79T>G, +1762A>G and +2463C>T, were detected within the herd 
(n = 246, 202 and 225 respectively). The genotypic and allelic frequencies for each SNP are 
similar, with the heterozygote consistently the most abundant genotype (Table 3.3). All SNPs 
were found to be in agreement with Hardy-Weinberg equilibrium. Preliminary haplotype 
construction for SNPs -79T>G, +1762A>G and +2463C>T yielded two major haplotypes of 
G79A1762C2463 (frequency 0.42) and T79G1762T2463 (frequency 0.41) (underlined allele denotes 
the published Btau_4.0 sequence NC_007304.4). Owing to the low numbers of typed 
individuals in each haplotype, association analysis cannot be performed. 
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Table 3.3 - Genotype and allele frequencies including significance from Hardy-
Weinberg equilibrium for boTLR1 SNPs selected for trait association 
 
SNP 
 
Genotype 
 
n = 
Genotype 
Frequency 
 
HWE 
 
Allele 
Allele 
Frequency  
-79T>G
1
 TT 78 0.32 0.885 T 0.543 
 TG 122 0.49  G 0.456 
 GG 46 0.19    
 Total 246     
+1762A>G
2
 AA 54 0.27 0.49 A 0.505 
 GA 96 0.47  G 0.495 
 GG 52 0.26    
 Total 202     
+2463C>T CC 64 0.28 0.163 C 0.507 
 CT 102 0.46  T 0.493 
 TT 59 0.26    
 Total 225     
1
SNP genotyped by RFLP-PCR using +798C>T proxy. 
2
SNP genotyped by RFLP-PCR. 
Hardy-Weinberg equilibrium (HWE) not significant at 1 degree of freedom. 
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3.2.5 Analysis of boTLR1 SNPs with clinical mastitis and milk production traits 
The three boTLR1 SNPs -79T>G, +1762A>G and +2463C>T were analysed for association 
with CM and milk production traits during their first three lactations, as illustrated in Table 
3.4. Each SNP was further tested for association with CM per individual parity (P1, P2 and 
P3), as illustrated in Table 3.5. 
 
3.2.5.1 Association analysis of boTLR1 tSNP -79T>G 
Analysis of the tSNP -79T>G revealed the TG and GG genotypes associated with an 
increased rate of CM (0.73 and 0.75 cases/cow/year, respectively) compared with the TT 
genotype (0.40 cases/cow/year) (Table 3.4). The association with CM rate was found to be 
significantly (P<0.05) higher for the heterozygote (TG) population, the most abundant 
genotype, when compared with homozygote (TT) animals. The proportion of animals within 
each genotyped population having any episodes of CM during their first three lactations was 
highest in the GG genotype (70%) compared with TT and TG genotypes (58% and 60%, 
respectively), although this was not statistically significant.  
Analysis per individual parity revealed the higher CM rate genotype, GG, to 
significantly associate with increased CM incidence during the second (P2) parity (P<0.05) 
when compared to the common homozygous TT genotype, with rates of 0.63 compared to 
0.24 respectively (Table 3.5). Although when compared to the lowered CM rate of TT cows 
at P2, TG animals also displayed raised incidence of 0.59, only near significance (P<0.1) was 
detected. However significance was detected between these genotypes for the proportion of 
animals within each population having any CM during P2; with the highest in the TG 
heterozygotes (35%) compared with TT (16%). TT and TG cows exhibited a highly 
significant increase in CM incidence by P3 when compared to P1 and P2 data (Figure 3.5). 
Over half of the genotyped TG population (56%) had at least one CM event during P3, 
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however only near significance was detected (P<0.1) when compared to the TT and GG 
genotypes (37% and 29% respectively).  
Analysis for association with production traits revealed that the TG and GG genotypes 
of the tSNP -79T>G associated significantly with reduced milk fat (TG = P<0.05, GG = 
P<0.01) and protein (TG = P<0.01, GG = P<0.001) concentrations when compared to those 
observed in the TT genotype (Table 3.4). No differences in either milk yield or mean SCC 
were detected between any of the genotyped populations described. 
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Table 3.4 – Association of boTLR1 SNP genotypes with CM and milk production traits over the first three lactations 
 
 
SNP 
 
 
Gen. 
 
 
n = 
P %  
with  
CM1 
 
Mean  
CM rate2 
 
 
P =3 
 
Mean  
SCC4 
 
 
P =3 
 
Mean 305d  
milk yield4 
 
 
P =3 
 
Mean milk  
fat (%)4 
 
 
P =3 
 
Mean milk 
protein (%)4 
 
 
P =3 
-79T>G TT 78 58% 0.40 (± 0.11)  2.88 (± 0.84)  7868 (± 1181)  4.15 (± 0.41)  3.28 (± 0.19)   
 TG 122 60% 0.73 (± 0.18)* < 0.05 2.76 (± 0.74) - 8058 (± 1139) - 4.02 (± 0.38)* < 0.05 3.2 (± 0.17)* < 0.01 
 GG 46 70% 0.75 (± 0.24) < 0.1 2.91 (± 0.78) - 7983 (± 1273) - 3.89 (± 0.41)* < 0.01 3.16 (± 0.18)*  < 0.001 
+1762A>G AA 54 62% 0.74 (± 0.27) < 0.1 2.87 (± 0.69) - 7836 (± 1104) - 3.95 (± 0.42) < 0.1 3.17 (± 0.18)  - 
 GA 96 61% 0.70 (± 0.18) < 0.1 2.84 (± 0.76) - 8104 (± 1282) - 4.04 (± 0.41) - 3.21 (± 0.19) - 
 GG 52 59% 0.38 (± 0.16)  2.84 (± 0.85)  8113 (± 1132)  4.13 (± 0.41)  3.25 (± 0.18)   
+2463C>T CC 64 67% 0.73 (± 0.22) - 2.90 (± 0.75) - 7841 (± 1067) - 4.02 (± 0.45) - 3.19 (± 0.18)* < 0.05 
 CT 102 61% 0.74 (± 0.17)* < 0.05 2.84 (± 0.81) - 8137 (± 1206) - 3.98 (± 0.45) - 3.18 (± 0.2)* < 0.05 
 TT 59 59% 0.36 (± 0.11)  2.82 (± 0.83)  7940 (± 1262)  4.13 (± 0.38)  3.27 (± 0.18)  
 
Abbreviations: Gen. = genotype, P % = population percentage, CM = clinical mastitis, SCC = somatic cell count. *Column presence indicates 
significant association (P<0.05). 
1
No significance was detected between genotypes by Chi^2 odds ratio test. 
2
Mean ± 95% confidence interval 
given in column parentheses. 
3
P values analysed by ANOVA and Tukey’s multiple comparisons, showing only results tested against the 
underlined (lower CM rate) genotype; – (dash) denotes no significance. 4Standard deviation from the mean given in column parentheses. 
 
6
2
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Table 3.5 - Association of boTLR1 SNP genotypes with CM at first (P1) second (P2) and third (P3) parity 
 
 
SNP 
 
 
Gen. 
 
 
n= 
 
P1 P %  
with CM
1
 
 
P1 Mean  
CM rate
2
 
 
 
P =
3
 
 
P2 P %  
with CM
1
 
 
P2 Mean  
CM rate
2
 
 
 
P =
3
 
 
P3 P %  
with CM
1
 
 
P3 Mean  
CM rate
2
 
 
 
P =
3
 
-79T>G TT 78 20% 0.26 (±0.18)  16% 0.24 (±0.12)  37% 0.87 (±0.33)  
 TG 122 19% 0.54 (±0.20) - 35%* 0.59 (±0.22) < 0.1 56%
┼
 1.15 (±0.51) - 
 GG 46 13% 0.53 (±0.42) - 26% 0.63 (±0.37)* <0.05 29% 0.88 (±0.61) - 
+1762A>G AA 54 22% 0.44 (±0.26) - 26% 0.60 (±0.35) - 47% 1.24 (±0.52) - 
 GA 96 27% 0.57 (±0.25) - 34% 0.62 (±0.23) < 0.1 44% 1.14 (±0.40) - 
 GG 52 18% 0.27 (±0.16)  22% 0.28 (±0.16)  41% 0.74 (±0.31)  
+2463C>T CC 64 32% 0.58 (±0.26) - 35% 0.80 (±0.42) < 0.1 47% 1.64 (±1.24) - 
 CT 102 25% 0.66 (±0.35) - 30% 0.69 (±0.31) < 0.1 48% 1.35 (±0.41) - 
 TT 59 22% 0.28 (±0.16)  19% 0.21 (±0.10)  42% 0.96 (±0.54)  
 
Abbreviations: Gen. = genotype, P % = population percentage, CM = clinical mastitis, P1 = parity 1, P2 = parity 2, P3 = parity 3. 
1
Column 
presence of * represents detection of significance between genotypes by Pearson Chi^2 odds ratio test (P<0.05), with positioning of * alongside 
the genotype contributing most to the Chi^2. Column presence of 
┼
 represents detection of near significance between genotypes (P<0.1), with 
positioning of 
┼
 alongside the genotype contributing most to the Chi^2. 
2
Mean±95% confidence interval given in column parentheses. 
3
P values 
analysed by ANOVA and Tukey’s multiple comparisons, showing only results tested against the underlined (most abundant) homozygous 
genotype; – (dash) denotes no significance. 6
3
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Figure 3.5 - Mean incidence of clinical mastitis across three parities for cows grouped 
into the three boTLR1 -79T>G tSNP variant populations: TT, TG and GG 
Data from each variant population are presented as a bar, with positive whiskers representing 
95% confidence interval of the mean. Grey bars – TT animals (n =78), hatched bars – TG 
animals (n =122) and open bars – GG animals (n =46). P1 = first parity, P2 = second parity, 
and P3 = third parity. 
a
 = tested against P1 data for same genotype. 
b
 = tested against P2 data 
for same genotype. 
c 
= tested between the indicated genotypes. Genotypic means differ 
significantly at the following levels: *P<0.05, **P<0.01 ***P<0.001, by ANOVA and 
Tukey’s multiple comparisons. 
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3.2.5.2 Association analysis of boTLR1 SNP +1762A>G 
Analysis of the NS transmembrane domain SNP +1762A>G, demonstrated AA and AG 
animals had higher rates of CM (0.74 and 0.70 cases/cow/year, respectively) compared with 
GG animals (0.38 cases/cow/year), although these differences were not significantly 
different. The proportion of animals within each genotyped population having any CM during 
their first three lactations was similar across all three genotypes (Table 3.4). 
Analysis of CM incidence per individual parity revealed the higher disease rate 
genotypes AA and AG demonstrated increased CM incidence at P1, P2 and P3 when 
compared to the homozygous GG genotype; however no significance was detected (Table 
3.5). The lower CM rate genotype GG exhibited a significant increase in CM incidence by P3 
when compared to their P1 and P2 data; AA and AG animals exhibited a significant P3 
increase when compared to their P1 data only (Figure 3.6). 
Similar to trends with the tSNP -79T>G genotypes, the genotypes of the NS SNP 
+1762A>G with higher CM rate, AA and AG, demonstrated with lower milk fat and protein 
concentrations; however these differences were not statistically significant (Table 3.4). No 
differences in either milk yield or mean SCC were detected between any of the genotyped 
populations described. 
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Figure 3.6 - Mean incidence of clinical mastitis across three parities for cows grouped 
into the three boTLR1 +1762A>G SNP variant populations: AA, AG and GG 
Data from each variant population are presented as a bar, with the positive whiskers 
representing 95% confidence interval of the mean. Grey bars – AA animals (n =54), hatched 
bars – AG animals (n =96) and open bars – GG animals (n =52). P1 = first parity, P2 = 
second parity, P3 = third parity, and ALL = all parities. 
a
 = tested against P1 data for same 
genotype. 
b
 = tested against P2 data for same genotype. Genotypic means differ significantly 
at the following levels: *P<0.05, **P<0.01 by ANOVA and Tukey’s multiple comparisons. 
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3.2.5.3 Association analysis of boTLR1 SNP +2463C>T 
Analysis of the SNP +2463C>T located within the 3’UTR revealed that CC and CT animals 
had higher rates of CM (0.73 and 0.74 cases/cow/year) compared to TT animals (0.36 
cases/cow/year) (Table 3.4). However, only the increase seen in the most abundant genotype, 
heterozygous CT cows, was shown to be statistically significant (P<0.05). The proportion of 
animals within each genotyped population having any CM during their first three lactations 
was highest in the CC genotype (67%) compared with CT and TT genotypes (61% and 59%, 
respectively), although this was found not to be statistically significant.  
Analysis of CM incidence per individual parity revealed the higher CM rate 
genotypes, CC and CT, tended to associate with increased CM incidence during P2 (P<0.1) 
when compared to the homozygous TT genotype, with rates of 0.80 and 0.69 cases/cow/year 
compared to 0.24 respectively (Table 3.5). Owing to lowered CM at P1 and P2, only TT cows 
exhibited a significant increase in incidence by P3 when compared to their P1 and P2 data 
(Figure 3.7).  
Analysis of production traits within the genotyped animals revealed that higher CM 
genotypes CC and CT produced milk with significantly lower fat and protein concentration 
(P<0.05) when compared with the TT population (Table 3.4). No differences in either milk 
yield or mean SCC were detected between any of the genotyped populations described.  
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Figure 3.7 - Mean incidence of clinical mastitis across three parities for cows grouped 
into the three boTLR1 +2463C>T SNP variant populations: CC, CT and TT  
Data from each variant population are presented as a bar, with the positive whiskers 
representing 95% confidence interval of the mean. Grey bars – CC animals (n =64), hatched 
bars – CT animals (n =102) and open bars – TT animals (n =59). P1 = first parity, P2 = 
second parity, P3 = third parity, and ALL = all parities. 
a
 = tested against P1 data for same 
genotype. 
b
 = tested against P2 data for same genotype. 
c 
= tested between the indicated 
genotypes. Genotypic means differ significantly at the following levels: *P<0.05, **P<0.01, 
by ANOVA and Tukey’s multiple comparisons. 
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3.2.6 Multiple comparisons 
Correlation coefficient analysis was performed revealing a weak positive correlation between 
CM and SCC (Pearson coefficient = 0.198) and weak negative correlations between CM and 
milk fat and protein percentages (Pearson coefficient = -0.2 and -0.1 respectively). All 
significant associations between individual SNP genotypes and CM were found to survive 
adjustments for each factor using a general linear model (GLM). 
 
3.2.7 Q-PCR analysis of basal boTLR1 mRNA abundance  
Milk somatic cells from cows with representative boTLR1 -79T>G tSNP genotypes were 
assessed for differences in basal boTLR1 expression. All animals were of similar age and 
stage of lactation and none had any known health issues. Q-PCR assays were performed 
using RNA from five representative animals of each genotype. Cows with the GG genotype 
demonstrated lower boTLR1 mRNA abundance (P<0.01) compared with either the TT or TG 
genotypes (Figure 3.8). Due to close homology and potential for co-expression, the 
abundance of boTLR6 and boTLR10 mRNA was also measured and revealed no significant 
differences. In addition, to exclude the influence of unidentified boTLR2 variance on boTLR1 
expression the abundance of boTLR2 mRNA was also measured and revealed no significant 
differences when segregated by boTLR1 -79T>G tSNP genotypes (Figure 3.9). 
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Figure 3.8 - Q-PCR data illustrating basal mRNA abundance levels of boTLR1, boTLR6 
and boTLR10 in milk somatic cells grouped into the three boTLR1 -79T>G tSNP variant 
populations: TT, TG and GG 
Grey boxes – TT animals, hatched boxes – TG animals, and open boxes – GG animals (n =5). 
**Genotypic means differ significantly (P<0.01 by ANOVA and Tukey’s multiple 
comparisons).  
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Figure 3.9 - Q-PCR data illustrating basal mRNA abundance levels of boTLR2 in milk 
somatic cells grouped into the three boTLR1 -79T>G tSNP variant populations: TT, TG 
and GG 
Grey boxes – TT animals, hatched boxes – TG animals, and open boxes – GG animals (n =5).  
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3.2.8 In-silico analysis for putative transcription binding sites  
The AliBaba2.1 (TRANSFAC 4.0 sites) software programme was used to search for putative 
transcription binding sites (TBS) located immediately upstream of the ATG start codon for 
boTLR1. The upstream boTLR1 SNPs identified in this study were analysed for any potential 
impact on predicted TBS. Figure 3.10 illustrates analysis of the 5’ intronic SNP -79T>G to 
determine the presence (T allele) or absence (G allele) of several putative DNA binding sites 
for transcription factors and enhancer proteins, including matched sites for AP-1-related c-
Jun, Octamer-1  (Oct-1), CCAAT/enhancer binding protein alpha (C/EBPalp) and TATA 
binding protein (TBP).  
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A 
Bos_taurus_ Btau_4.0  Primary Assembly Sequence 
 
 
B 
Alternate Allele Sequence 
 
                 
 
Figure 3.10 - Location and impact of upstream boTLR1 -79T>G SNP in relation to 
putative transcription binding sites for both published allele (A) and alternate allele (B) 
sequences 
The AliBaba 2.1 software programme was used to predict (75% match threshold or 70% match 
threshold) transcription factor binding sites (TBS) in the boTLR1 upstream region. Upstream 
nucleotide sequence shown in upper case, purple text represents 5’UTR. ATG start codon shown by 
lower case. Numbering indicates nucleotide position from the start codon. SNP position highlighted in 
red. Positions of putative TBS are aligned below the nucleotide sequence. TBS abbreviations: Hb = 
hunchback, AP-1 = Activator Protein-1, CRE-BP1 = cyclic AMP response element – binding protein 
1, c-jun and c-fos = JUN and FOS proteins which dimerise to form AP-1, Oct-2.1 and Oct-1 = 
Octamer transcription factor-1 and -2, GCN4 = General control protein GCN4, C/EBPalp = 
CCAAT/enhancer binding protein alpha, TBP = TATA-binding protein, GR = glucocorticoid 
receptor. 
 
 -155 TCATTTAATGAGTCTCTAGTAAAAAAATGTTTAATGTCAGTCATGCTTAATTTAATATAG 
                       =====Hb=== 
                                         ====AP-1=== 
                                            ==CRE-BP1= 
                                              ===c-Jun== 
                                              ===c-Fos== 
                                                    ==Oct-2.1= 
                                                              ==== 
                 SNP-79T>G 
  -95 TCATTTAATGCTGACTTTTTTACCCCTAGGATCTGTACTGTATCCAGATGCTCTGAAGAA 
      GCN4== 
             ===c-Jun== 
             =C/EBPalp= 
             ===Oct-1== 
                    ====TBP=== 
                     =C/EBPalp= 
                     =====Hb=== 
                                      =====GR=== 
 
  -35 TAGCAACTACCCTTAGGAATGTCTACTGTTACAAAatg... 
 
 
 -155 TCATTTAATGAGTCTCTAGTAAAAAAATGTTTAATGTCAGTCATGCTTAATTTAATATAG 
                       =====Hb=== 
                                         ====AP-1=== 
                                            ==CRE-BP1= 
                                              ===c-Jun== 
                                              ===c-Fos== 
                                                    ==Oct-2.1= 
                                                              ==== 
                 SNP-79T>G 
  -95 TCATTTAATGCTGACTGTTTTACCCCTAGGATCTGTACTGTATCCAGATGCTCTGAAGAA 
      GCN4== 
              
                                      =====GR=== 
 
  -35 TAGCAACTACCCTTAGGAATGTCTACTGTTACAAAatg... 
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3.3 Discussion 
Three SNPs within exonic and non-exonic regions of boTLR1 were analysed for association 
with susceptibility to CM, identifying significant associations for the tSNP -79T>G and the 
3’UTR SNP +2463C>T. Rates of CM for genotypes -79 TT and +2463 TT were much lower 
in comparison to the homozygous genotypes (-79 GG and +2463 CC) and significantly lower 
than their respective heterozygous genotypes. Dairy cows have been subjected to intense 
selection pressures for higher milk yields and reduced SCC that may unintentionally have 
been detrimental to CM susceptibility (Suriyasathaporn, Schukken et al. 2000). In this study 
no significant differences were observed between identified boTLR1 SNPs, including the NS 
SNP +1762A>G, for mean 305d milk yields or SCC. This contradicts a study of 208 Chinese 
Holsteins, in which the NS SNP +1762A>G associated with highly significant differences in 
milk SCC. Animals with an AA (isoleucine) at this position had lower SCC, and were 
described as more resistant to mastitis as a result (Li, Shi et al. 2009). In contrast, our results 
suggest the GG (valine) at this location is the more favourable genotype in terms of having a 
lower CM incidence in comparison to AA. Although this discrepancy may reflect breed and 
herd variation, it may also demonstrate the dichotomy that the SCC, which is the often used 
surrogate measure of mastitis, is also the presence of the effector cell which can eliminate 
infection in the absence of overt clinical signs. In agreement with GG animals being a more 
disease-resistant genotype, analysis of a further Chinese Holstein herd associated AA and AG 
variants with bovine TB susceptibility (Sun, Song et al. 2012). The raised CM rates observed 
in this study for +1762A>G AA and AG cows, although not significant, will benefit from 
genotyping in a larger herd. 
All boTLR1 SNP genotypes that were associated with a lowered rate of CM displayed 
significantly greater milk fat and protein concentrations when compared to the other two 
genotypes. It is unclear whether a functional association exists between milk fat and protein 
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concentrations and mastitis susceptibility. Interestingly the casein gene cluster is located 
~28Mb from the boTLR6-TLR1-TLR10 gene cluster on Bta6 (Threadgill and Womack 1990). 
Protein and fat contents are financially rewarded milk qualities and breeding for these factors 
could influence boTLR1 genotypes.  
In addition to being one of the first studies to examine association between boTLR1 
SNPs and actual CM incidence, evidence of variable receptor expression between the defined 
genotypes is also demonstrated. In this study animals segregated by -79T>G tSNP genotypes 
exhibited significantly lower boTLR1 expression in GG animals when compared with TT or 
TG. This difference, which appeared to be specific for boTLR1 as it was not seen for 
paralogues boTLR6 or boTLR10, or dimer partner boTLR2, may indicate interference with 
transcription. Preliminary analysis for causal mutations, using the programme MOTIF 
(http://motif.genome.jp) and TRANSFAC 4.0 programme AliBaba2.1 (www.gene-
regulation.com/pub/programs.htmL), highlighted the -79T>G SNP as part of several 
candidate DNA binding motifs, including putative matches for AP-1-related c-Jun, Octamer-
1 (Oct-1) and C/EBPalp. A similar search for putative sites immediately 5’ of the ATG start 
codon of TLR1 in the human system revealed almost identical presence of Oct-1, Hb, AP-1, 
and C/EBPalp sites. Several putative Oct-1 sites were also detected immediately 5’ of the 
ATG start codon in porcine TLR1, suggesting species conservation and importance for 
Octamer binding. Oct-1 is thought to work closely with AP-1 and GATA-1 as important 
regulatory elements for TLR expression (Roger, Miconnet et al. 2005). However this motif, 
along with others, was only identified with the T variant and was absent in those with the G 
substitution. Although the potential for -79T>G SNP determining Oct-1 regulation of 
boTLR1 expression is an attractive hypothesis, it is also possible that this tSNP may simply 
be a marker for other unidentified causal mutations. Furthermore, the animals used for the Q-
PCR assays in this study all conform to observed haplotypes: TT = T79G1762T2463 and GG = 
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G79A1762C2463, with TG animals heterozygous for each SNP. In essence +1762 AA and +2463 
CC variants, genotypes with increased CM, have reduced boTLR1 expression.  
Reduced boTLR1 stimulation by pathogens in -79 GG cows may equate to a 
dampened inflammatory response thus enabling establishment and persistence of infection. In 
terms of influence upon mastitis susceptibility, GG cows have a higher CM rate than TT 
cows; however heterozygous TG cows have a similar rate to GG cows, despite expressing 
boTLR1 at a similar level to a TT cow. This suggests that differences in boTLR1 transcript 
levels alone may not account for the variation in CM incidence, and/or that post-
transcriptional and post-translational regulation may also be affected by the cumulative 
presence of SNPs; a high level of linkage was observed within the herd between boTLR1 
SNPs identified in this study. The NS SNP +1762 Iso>Val substitution within the 
transmembrane domain warrants targeted structure/function studies to verify its impact on 
TLR1 signalling. SNPs within the 3’UTR, including the +2463C>T SNP that significantly 
associated with CM in this study, could also interfere with microRNA (miRNA) post-
transcriptional regulation. Although TLR1 miRNAs have been predicted for human and 
mouse systems (www.microrna.org/) there is no suitable bovine miRNA database. LD between 
the tSNP -79T>G and the 3’UTR SNP +2463C>T was moderate to high (~0.7) therefore their 
individual associations with disease and reduced gene expression could be influenced by their 
cumulative presence. Furthermore, influence of unidentified polymorphisms within boTLR1 
and additional related genes such as boTLR2 and boTIRAP should be considered. Despite this 
study not showing any correlation between boTLR2 mRNA levels and observed boTLR1 
variation, mutations within boTLR2 may still influence boTLR1 expression and function.  
In conclusion the findings presented here demonstrate an association between SNPs 
common to boTLR1 and CM susceptibility. Furthermore, we present evidence that several of 
these SNPs underpin variation in boTLR1 expression. The complexity of mastitis infection 
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suggests a polygenic and multi-factorial immune response comprising many different 
proteins which will in turn interact with one another. The ability to detect significant 
associations with CM for a single gene indicates the importance of boTLR1-related responses 
in the control of bacterial disease in cattle. A bovine population with impaired boTLR1 
expression may also be more susceptible to other diseases and health issues. Preliminary 
evidence for this comes from our study where it was observed that animals with the -79 GG 
variant seemed to be prematurely culled compared to other populations (data not shown). 
Furthermore the NS SNP +1762A>G, in moderate to high LD (>0.8) with the tSNP -79, has 
been associated  with TB susceptibility (Sun, Song et al. 2012).  
The potential of SNPs within boTLR1 to act as genetic markers for altered 
susceptibility to mastitis warrants further investigation. The favourable linkage of lowered 
CM with increased milk fat and protein concentrations in the boTLR1 variants demonstrated 
here indicates that selection for lowered CM using these markers would not be detrimental to 
milk quality, as has been previously suggested in studies linking SNPs with increased SCC as 
a marker for CM susceptibility. 
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Chapter 4.0 - SNPs in boTLR1 underlie the 
dampening of innate immune responses  
 
This chapter expands published data (Russell, Widdison et al. 2012). 
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4.1 Introduction and Rationale 
SNPs identified within boTLR1 are potential markers for impaired boTLR1 expression and 
CM susceptibility. Defined by their -79T>G tSNP genotype, the TT variant population was 
observed to have significantly lowered CM incidence when compared to heterozygotes, 
whilst a GG variant population, which tended to show raised incidence compared to TT cows, 
demonstrated lowered basal levels of boTLR1 transcripts in milk somatic cells. Currently 
there are no boTLR1 antibodies available to directly compare levels of protein expression. To 
ascertain the functional consequence of potentially reduced boTLR1 expression, production 
of cytokines known to be induced by TLR1 was determined from cells stimulated with the 
ligand PAM3, a lipoprotein which has an affinity for TLR1/TLR2 heterodimers (Jin, Kim et 
al. 2007), as illustrated in Figure 4.1. A recent chimeric study demonstrated the importance of 
the TLR1 TIR domain for the signalling of immune responses to PAM3 and heat-killed 
bacteria, since, although PAM3 can bind TLR10/TLR2, signalled production of cytokines 
CXCL8 and IL-6 requires a TLR1 cytoplasmic domain (Guan, Ranoa et al. 2010).  
In the human system, a number of functional studies facilitating the analysis of TLR1 
variants exist. The well-documented NS huTLR1 SNP 1805T>G, encoding an isoleucine to 
serine substitution within the receptor’s transmembrane domain, impacts signalling and 
function. It has been observed across several studies that cells from GG (serine) variants 
display impaired NF-κB activity, reduced receptor trafficking and surface expression and 
reduced cytokine responses (Hawn, Misch et al. 2007; Johnson, Lyle et al. 2007; Misch, 
Macdonald et al. 2008; Wurfel, Gordon et al. 2008; Randhawa, Shey et al. 2011). These 
investigations detected lowered cytokine production of IL-6, CXCL8 and TNF-α from whole 
blood and PBMCs provided by GG variants, following in vitro stimulation with PAM3 (at 
varying concentrations) and extracts of Mycobacterium tuberculosis and M. leprae.  
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Functional studies analysing differences in the response of boTLR1 between 
polymorphic variant populations have yet to be documented in cattle. Evidence of increased 
production of the important chemokine CXCL8 has recently been reported in bovine MEC 
exposed to PAM3 (Porcherie, Cunha et al. 2012). The objective of this part of the study was 
to ascertain any functional consequences of boTLR1 polymorphic variation on the resulting 
cytokine response, following ligand-receptor binding. In addition, variances in cytokine 
responses to HK pathogens of economic importance were analysed between the boTLR1 -
79T>G tSNP variants. 
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Figure 4.1 - Overall structure of the human (h) TLR1-TLR2-Pam3CSK4 complex 
(A) Side view of the complex; the TLR1 COOH-terminal (C-term), central and NH2-terminal 
(N-term) fragments are in green, the TLR2 fragments are in blue, and the triacylated 
Pam3CSK4 (PAM3) lipopeptide is in red. LRR domains belonging to the TLR1 proteins are 
labelled with apostrophes. (B) The shape of the PAM3-binding pocket is shown in mesh. 
Molecular surfaces that belong to TLR1 and TLR2, including LRR positions, are depicted in 
green and blue respectively. PAM3 is shown as a space-filling model (orange), with two 
‘tails’ specific for TLR2 and one ‘tail’ specific for TLR1. Images and information (Jin, Kim 
et al. 2007). 
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4.2 Results 
4.2.1 Variation in cytokine production to a TLR1 ligand in whole blood 
Whole blood samples from nine animals (three representatives from each boTLR1 -79T>G 
tSNP genotype) were stimulated for 24 h with the TLR1-specific ligand PAM3 and non-
specific ligands LPS (TLR4) and LTA (TLR2). Supernatants were assayed for CXCL8 
production by ELISA as a marker for receptor stimulation. CXCL8 data demonstrated 
significantly (P<0.05) higher levels of CXCL8 produced by cells from the cows with the TT 
genotype than those with the TG and GG genotypes, following stimulation with PAM3 
(Figure 4.2). Levels of CXCL8 production following LPS and LTA exposure were similar 
across all three genotypes, with no significant differences.   
 
4.2.2 Variation in cytokine production to a TLR1 ligand in PMNs 
PMN-enriched cell populations from 12 animals (four representatives from each boTLR1 -
79T>G tSNP genotype) were stimulated for up to 24 h with PAM3, at 100 ng/mL, 250 ng/mL 
and 500 ng/mL, and LPS (100 ng/mL) as a non-TLR1 stimulant. FACS analysis of PMN 
samples suggested minimal difference in cell populations and purity obtained from each 
animal (Figure 4.3). CXCL8 and IL-6 mRNA abundance and protein production were 
measured as primary markers for TLR1 stimulation. 
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Figure 4.2 - ELISA data following stimulation with TLR ligands in bovine whole blood 
from animals representing the three boTLR1 -79T>G SNP variant populations: TT, TG 
and GG  
ELISA data of CXCL8 production following +24 h stimulation. Data from each variant 
population (n = 3) are presented as a bar representing mean production, with error bars 
represent the SEM. Grey bars – TT animals, striped bars – TG animals, and open bars – GG 
animals. *Genotypic means differ significantly (P<0.05 by ANOVA and Tukey’s multiple 
comparisons). 
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Figure 4.3 - Cell populations and purity of enriched PMN samples 
Each red point represents FACS analysis data from one animal, with horizontal lines to 
indicate genotype mean and standard error. 
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Q-PCR analysis indicated that animals with the GG genotype had lower levels of 
CXCL8 mRNA post-stimulation with PAM3, at all concentrations, compared to equivalent 
samples from animals with either the TT or TG genotypes. Samples from animals that were 
homozygous TT showed significantly greater (P<0.05) CXCL8 mRNA abundance 4 h post-
stimulation with PAM3, at concentrations of 250 and 500 ng/mL, when compared to GG 
homozygotes (Figure 4.4A). Homozygous GG animals generally demonstrate reduced IL-6 
abundance 4 h post-stimulation; however no significant differences were detected between 
genotypes across all ligand concentrations (Figure 4.4B). A similar trend in CXCL8 and IL-6 
data was observed from cells stimulated for 8 h. Animals that were homozygous TT 
displayed significantly greater CXCL8 (P<0.05) and IL-6 (P<0.01) mRNA abundance 8 h 
post-stimulation with 500 ng/mL PAM3 when compared to GG homozygotes (Figure 4.5A 
and B). Analysis of an additional pro-inflammatory cytokine, TNF-α, demonstrated exposure 
to PAM3 at all ligand concentrations had little effect on TNF-α transcript levels at both 4 h 
and 8 h post-stimulation (Figure 4.4C and Figure 4.5C). 
Supernatants (24 h post-stimulation) were assayed for CXCL8 and IL-6 production by 
ELISA. CXCL8 data showed a similar trend to gene expression data obtained by Q-PCR, 
with significantly (P<0.05) lower levels of CXCL8 produced by cells from the GG variants 
than those with the TT genotype, following stimulation with 500 ng/mL PAM3 (Figure 4.6A). 
Individual variation was largest in samples from TG heterozygotes, with higher 
concentrations of PAM3 resulting in increased variability in CXCL8 production. IL-6 data 
showed significantly (P<0.05) lower levels produced by cows with the GG genotype than the 
TT genotype following stimulation with 500 ng/mL PAM3 (Figure 4.6B). Overall, 
stimulation with TLR1 ligand across all concentrations did not increase cytokine production 
in GG variants. The response to LPS, used to confirm the specificity of the observed response 
86 
 
to PAM3, was variable across all genotypes but did not segregate by the defined genotypes 
(Table 4.1).  
The mRNA abundance of the anti-apoptotic factor Bcl2A1 was investigated as an 
additional marker to highlight differences in boTLR1 stimulation. Microarray studies have 
demonstrated importance for Bcl2A1 during immune responses (Widdison, Watson et al. 
2011) and transcriptional differences have been observed between S. uberis-infected and non-
infected mammary glands (Coffey and Leigh unpublished). Following stimulation with 
PAM3, Q-PCR analysis showed greater levels of Bcl2A1 in animals with the TT genotype 
compared to those with either the TG or GG genotypes. Significantly (P<0.05) greater levels 
of mRNA were detected in samples from animals with the TT genotype compared to those 
with the TG genotype, following 4 h stimulation with PAM3 at 250 ng/mL (Figure 4.4D). A 
statistically significant difference between Bcl2A1 mRNA levels from TT animals compared 
to lowered levels from animals with either the TG or GG genotype was detected at 4 h and 8 
h post-stimulation with PAM3 at 500 ng/mL (Figure 4.4D and Figure 4.5D).  
Q-PCR analysis indicated no significant differences between genotypes for transcript 
levels of the anti-inflammatory cytokine IL-10. Homozygous GG animals tended to 
demonstrate reduced IL-10 levels at 4 h post-stimulation with PAM3, across all concentrations 
(Figure 4.4E); however by 8 h post-stimulation, a small increase in transcript levels was 
detected showing little variability between genotypes (Figure 4.5E). BoTLR1 transcripts 
increase slightly at 4 h post-stimulation, with the data trend showing marginally greater 
expression from TT animals compared to TG and GG following stimulation with PAM3 at 
100 ng/mL (no statistical significance detected); although boTLR1 levels and genotypic 
variance decreases following exposure at the higher concentrations (Figure 4.4F). BoTLR1 
transcript levels at 8 h post-stimulation are minimal with no significant variability between 
genotypes across all ligand concentrations (Figure 4.5F). 
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Figure 4.4 - Q-PCR data following +4 h stimulation with the TLR1 ligand PAM3 in bovine PMNs grouped into the three boTLR1 -79T>G SNP 
variant populations: TT, TG and GG  
Q-PCR data of CXCL8 (A), IL-6 (B), TNF-α (C), Bcl2A1 (D), IL-10  (E) and TLR1 (F)  mRNA abundance following +4 h stimulation. Data from each 
variant population (n = 4) is presented as a box and whisker plot, with the ends of the whiskers representing the minimum and maximum data values. 
Grey box plot – TT animals, hatched box plot – TG animals, and open box plot – GG animals. Lack of box plot indicates data missing from one 
animal. *Genotypic means differ significantly (P<0.05 by ANOVA and Tukey’s multiple comparisons). 
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Figure 4.5 - Q-PCR data following +8 h stimulation with the TLR1 ligand PAM3 in bovine PMNs grouped into the three boTLR1 -79T>G SNP 
variant populations: TT, TG and GG 
Q-PCR data of CXCL8 (A), IL-6 (B), TNF-α (C), Bcl2A1 (D), IL-10  (E) and TLR1 (F) mRNA  abundance following +8 h stimulation. Data from each 
variant population (n = 4) is presented as a box and whisker plot, with the ends of the whiskers representing the minimum and maximum data values. 
Grey box plot – TT animals, hatched box plot – TG animals, and open box plot – GG animals. Lack of box plot indicates data missing from one 
animal. Genotypic means differ significantly at levels *P<0.05 and **P<0.01, by ANOVA and Tukey’s multiple comparisons. 
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Figure 4.6 - ELISA data following stimulation with the TLR1 ligand PAM3 in bovine 
PMNs grouped into the three boTLR1 -79T>G SNP variant populations: TT, TG and 
GG 
ELISA data of CXCL8 (A) and IL-6 (B) production following + 24 h stimulation. Data from 
each variant population (n = 4) is presented as a box and whisker plot, with the ends of the 
whiskers representing the minimum and maximum data values. Grey box plot – TT animals, 
hatched box plot – TG animals, and open box plot – GG animals. *Genotypic means differ 
significantly (P<0.05 by ANOVA and Tukey’s multiple comparisons). 
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Table 4.1 - Cytokine expression and production levels following PMN stimulation with 
LPS 
 boTLR1 -79T>G SNP genotype 
 TT TG GG 
CXCL8 4 h 75 (48-126) 135 (47-186) 94 (34-160) 
IL-6 4 h 0.3 (0.21-0.41) 0.2 (0.19-0.22) 0.2 (0.11 -0.28) 
TLR1 4 h 0.08 (0.01-0.14) 0.06 (0.01-0.1) 0.018 (0.01-0.02) 
TNF-α 4 h - - - 
IL-10 4 h 0.34 (0.17-0.64) 0.24 (0.14-0.43) 0.2 (0.17-0.24) 
Bcl2 A1 4 h 4.4 (3.4-6.9) 4.4 (3.7-7.4) 5 (2.5-8.9) 
CXCL8 (ng/µL) 24 (19-50) 50 (20-59) 38 (31-50) 
IL-6 (pg/µL) 390 (220-656) 382 (167-407) 420 (346-462) 
 
Mean relative expression levels of CXCL8, IL-6 and Bcl2 A1 transcripts and mean CXCL8 
and IL-6 production levels (+24 h) following PMN stimulation with the TLR4 ligand LPS 
from animal samples segregated by tSNP boTLR1 -79T>G genotypes: TT, TG and GG. 
Minimum and maximum values are given in parenthesis (min-max). No significant 
differences (P<0.05) were observed between any of the genotype means using one-way 
ANOVA and Tukey’s multiple comparison tests. 
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4.2.3 Variation in cytokine production following pathogen stimulation in blood-derived 
CD14+ cells 
CD14+ cell populations isolated from nine animals, three representative animals for each 
boTLR1 -79T>G tSNP genotype, were stimulated for 24 h with the TLR1 ligand PAM3, 
TLR4 ligand LPS, and four strains of HK bacteria; E. coli P4, S. aureus M40, and S. uberis 
0140J and EF20, representing the leading causative agents of bacterial mastitis. Prior to 
stimulation, the purity of each isolated CD14+ cell population was evaluated by flow 
cytometric analysis following incubation with FITC-conjugated CD14+ antibodies (Figure 
4.7). All isolated CD14+ cell populations display >97% purity, with marginal differences in 
viable cell counts (Figure 4.8). 
Supernatants were assayed for CXCL8 production by ELISA. Data showed 
significantly (P<0.05) higher levels of CXCL8 production by cells from cows with the TT 
genotype than those with the TG and GG genotypes, following stimulation with PAM3 
(Figure 4.9). Levels of CXCL8 production following LPS exposure revealed no significant 
differences between the three genotypes. Significantly higher levels of CXCL8 were 
produced by cows with the TT (P<0.01) and TG (P<0.05) genotypes compared with GG 
animals, following stimulation with HK S. aureus. CXCL8 production in response to HK E. 
coli was high in all three genotypes, with greater levels observed from TT and TG cows 
compared to GG, however no significance was detected. CXCL8 responses from CD14+ 
cells to both strains of S. uberis were low, with no significance differences observed between 
the defined genotypes (Figure 4.9). 
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Figure 4.7 - Analysis of isolated CD14+ cell populations following incubation with FITC-conjugated CD14+ antibodies  
The purity of each isolated CD14+ cell population was evaluated by flow cytometric analysis. (A) An isolated CD14+ population following incubation 
with a FITC-conjugated mouse IgG2a isotype control antibody. Example displays lowered fluorescence from the gated CD14+ FITC antibody 
population. (B) An isolated CD14+ population following incubation with an anti-human (mouse IgG2a) CD14+ FITC antibody, showing a sample 
purity of >98%. (C) An isolated CD14+ population following incubation with propidium iodide (PI) for assessment of cell viability, with the example 
displaying an 87% viable population. 
B. CD14+
C. PI+
Population #Events %Total
All Events 10,000 100
A. CD14+  Isotype control FITC 352 3.5
B. CD14+ FITC 9,806 98.1
C. PI+ cells 1,297 13
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Figure 4.8 - Purity and viable cell percentages for isolated CD14+ cell populations 
grouped into the three boTLR1 -79T>G SNP variant populations: TT, TG and GG 
(A) Percentage of isolated CD14+ cell populations positive for CD14+ FITC. (B) Percentage 
of isolated CD14+ cell populations positive for propidium iodide (PI+). Each red point 
represents data from one animal/sort, with horizontal lines to indicate genotype mean and 
standard error.  
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Figure 4.9 - ELISA data of CXCL8 production in CD14+ cell populations  
Analysis of CXCL8 production following +24 h stimulation with TLR ligands and heat-killed bacteria of blood derived CD14+ cells grouped into the 
three boTLR1 -79T>G SNP variant populations: TT, TG and GG. Grey bars – TT animals, striped bars – TG animals, and open bars – GG animals (n = 
3). Data bars represent the mean of three animals, with error bars representing the SEM. Contributing data from each animal are averaged responses 
from three independent stimulations. Genotypic means differ significantly at the levels *(P<0.05) and **(P<0.01) by ANOVA and Tukey’s multiple 
comparisons. 
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4.3 Discussion 
To ascertain the functional consequence of potentially reduced boTLR1 expression, 
production of cytokines known to be induced by boTLR1 was determined from cells 
stimulated with the TLR1 ligand PAM3. An initial study using whole blood samples, three 
from each representative boTLR1 -79T>G tSNP genotype, revealed significantly greater 
CXCL8 production following stimulation with PAM3 from TT variants when compared to 
TG and GG cows. These differences were specific to boTLR1 as they were not observed 
following stimulation with boTLR4 or boTLR2 ligands. Enriched bovine PMN populations 
were obtained to expand these primary findings. Across all time-points and ligand 
concentrations analysed, PAM3 stimulation of PMNs from animals segregated by -79T>G 
tSNP genotypes revealed lower levels of CXCL8 and IL-6 mRNA and protein from animals 
of a GG genotype and consistently high CXCL8 and IL-6 response from those with TT 
genotypes. Cytokine production from cells from the TG animals was the most variable. Used 
as an additional marker of effective boTLR1 stimulation, significantly greater levels of 
Bcl2A1 were detected in animals with the TT genotype compared to those with the TG or GG 
genotypes. A target of NF-κB activity (Liang, Zhou et al. 2004), Bcl2A1 encodes a pro-
survival protein and is up-regulated in neutrophils following stimulation with TLR ligands 
including PAM3 (Francois, El Benna et al. 2005). All genotypes were additionally stimulated 
with LPS, and no differences were detected in levels of CXCL8, IL-6 or Bcl2A1. This further 
indicates that response differences observed following stimulation with PAM3 were 
influenced by variation in boTLR1. In addition, although potential binding of PAM3 with 
boTLR10 is unable to signal for CXCL8 or IL-6 synthesis (Guan, Ranoa et al. 2010), no 
genotypic variation was observed for boTLR10 transcript levels in previous data (Figure 3.8), 
further suggesting that boTLR10 expression and function will have limited influence on the 
production and measurement of cytokines in PAM3 assays. 
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Small amounts of CXCL8 protein were detected in media controls. This may be the 
result of cell agitation during the sorting process, or simply represent a basal level of 
expression in resting PMN. A study analysing neutrophil responses to bacteria demonstrated 
small yet detectable amounts of CXCL8 in granules from resting human neutrophils (Faldt, 
Dahlgren et al. 2002). 
Q-PCR data from the PMN studies suggests PAM3 had little effect on TNF-α and IL-
10 transcript levels at both 4 h and 8 h post-stimulation, and failed to segregate by the defined 
genotypes. This may be due to the manner by which TLRs respond and signal for cytokine. 
Induction of IL-10 is TLR ligand-specific and, in agreement with other findings 
(Samarasinghe, Tailor et al. 2006; Hawn, Misch et al. 2007; Wurfel, Gordon et al. 2008), this 
study demonstrates poor induction of IL-10 following LPS and PAM3 stimulation. Due to 
limited supernatant, quantification of TNF-α and IL-10 proteins were not performed. Results 
from these assays could have verified any genotypic variance between 24 h protein levels for 
these cytokines. A further interesting observation from the PMN assays was the detection of 
continually low levels of boTLR1 transcript following PAM3 exposure. This may result from 
the neutrophil’s inefficiency to induce boTLR1 expression and/or the result of boTLR1 being 
highly regulated following stimulation. A separate study demonstrated either unchanged or 
decreased boTLR expression profiles in bovine immune cells following ligand exposure, 
despite effective cytokine responses (Guo, Zhao et al. 2009). Inducible levels of boTLR1 may 
therefore have little impact on TLR1-directed inflammatory responses, and vice versa. 
PMNs contain a high proportion of neutrophils, short-lived cells whose primary role 
is the phagocytosis of microbes to contain and eliminate infection. The mass migration of 
neutrophils into the mammary gland, interpreted by an elevation in milk SCC, remains a 
critical immune event during mastitis. Pathogen interaction with neutrophil TLRs stimulates 
the cell to synthesise cytokines that influence their own activity and survival, recruit 
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additional immune cells and modulate the immune response (Hayashi, Means et al. 2003; 
Paape, Bannerman et al. 2003; Parker, Whyte et al. 2005; Kobayashi 2008). The greater 
expression of Bcl2A1 in animals with the TT genotype may promote PMN survival to 
complement the increased cytokine output. Reduced boTLR1 stimulation by pathogens in GG 
cows may equate to a dampened inflammatory response enabling establishment and 
persistence of infection.  
In terms of influence on mastitis susceptibility, data detailed in Chapter 3.0 revealed 
GG cows to have a higher CM rate than TT cows; however heterozygous TG cows have a 
similar rate to GG cows, despite expressing boTLR1 at a similar level to a TT cow. TG 
animals showed intermediary cytokine responses to TLR1 ligand and, like GG animals, lower 
expression of Bcl2A1. This may suggest that differences in boTLR1 transcript levels alone 
may not account for the variation in receptor response, and/or that post-transcriptional and 
post-translational regulation may also be affected by the cumulative presence of SNPs. As 
detailed in Chapter 3.0, a high degree of linkage was observed between boTLR1 SNPs, and 
included the identification of a linkage group represented by tSNP -79T>G. The animals used 
for the functional assays in this study all conform to observed haplotypes: TT = 
T79G1762T2463and GG = G79A1762C2463, with TG animals heterozygous for each SNP. In terms 
of being causative of a variable TLR1 response the NS SNP +1762 Iso>Val is an unlikely 
candidate; both isoleucine and valine are non-polar branched amino acids with hydrophobic 
properties. It is therefore unlikely that a substitution within the transmembrane domain would 
impact the tertiary structure; although further targeted structure/function studies are required 
to verify this. Furthermore, influence of the 3’UTR SNP +2463C>T, which was associated 
with CM (detailed in Chapter 3.0), unidentified polymorphisms within boTLR1 and 
additional related or target genes such as boTLR2, TIRAP, NF-κβ and CXCL8 should be 
considered. Mutations within boTLR2 may influence boTLR1 expression and function; a 
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recent study identified several NS boTLR2 SNPs within a Holstein-Friesian herd potentially 
impacting LRR and TIR protein domains important for interactions and responses to PAM3 
(Ruiz-Larranaga, Manzano et al. 2011).  
To assess for genotypic variance in a cytokine response to pathogens associated with 
mastitis, enriched CD14+ cell populations were isolated from blood collected from three 
representative animals from each boTLR1 -79T>G tSNP genotype, and stimulated for 24 h 
with ligand (PAM3 and LPS), HK E. coli, HK S. aureus and HK S. uberis (strains 0140J and 
EF20). E. coli and S. aureus strains were both virulent isolates from cases of bovine mastitis 
(BramLey 1976; Anderson 1977). S. uberis 0140J, a virulent strain, and S. uberis EF20, an 
isolate of low virulence, are frequently used in experimental models of infection in dairy 
cattle (Hill 1988; Leigh, Ward et al. 2004; Egan, Kurian et al. 2010; Moyes, Drackley et al. 
2010). Control data confirmed similar purity and viable cell counts between each CD14+ cell 
population. Increased CXCL8 production levels in response to TLR ligands were 
demonstrated in all cell populations. Although LPS responses were similar between -79T>G 
tSNP genotypes, significantly higher levels of CXCL8 were produced by CD14+ cells from 
cows with the TT genotype than those with the TG and GG genotypes, following stimulation 
with PAM3.   
Analysis of results following stimulation with the HK bacteria demonstrated a 
genotype-specific response to S. aureus but not to E. coli or S. uberis. Significantly higher 
levels of CXCL8 were produced by CD14+ cells from TT (P<0.01) and TG (P<0.05) variants 
than those from GG cows, following stimulation with S. aureus. While levels of CXCL8 
produced by cells from the TT and TG variants following stimulation with S. aureus were 
very similar, very low levels were detected in the cells from the GG animals. These findings 
may further support the importance of boTLR1 in the detection of S. aureus and the 
establishment of an immune response. The major structural form of lipoproteins in S. aureus 
99 
 
strains is triacylated (Asanuma, Kurokawa et al. 2011). These include triacyl forms of SitC 
that are likely targets for TLR1/TLR2; a separate study analysing cells co-transfected with 
TLR1/TLR2 demonstrated high CXCL8 activity following exposure to HK S. aureus (Guan, 
Ranoa et al. 2010). Blood-derived CD14+ cells consist mainly of monocytes, precursors of 
MØ (Ziegler-Heitbrock, Ancuta et al. 2010) that are the predominant cell type in ’healthy’ 
milk and important in the detection of pathogens invading the mammary gland (Oviedo-
Boyso, Valdez-Alarcon et al. 2007). The novel findings from this study suggest an impaired 
mammary boTLR1 response by somatic cells, including MØ, from a GG cow could have 
severe implications in the pathogenesis of S. aureus mastitis and potentially other bacterial 
diseases such as susceptibility to infection by Mycobacterium bovis; a recent study has linked 
boTLR1 variants to bovine TB (Sun, Song et al. 2012).  
Data from in vitro CD14+ cell assays also highlighted a pathogen-specific cytokine 
response which appeared to correlate with observations of pathogen-dependent immune 
responses during intramammary infection (Bannerman 2009). CXCL8 production in response 
to E. coli, mainly induced through boTLR4 following interactions with E. coli LPS, was 
significantly elevated for all three genotypes in this study, with trends for a larger increase in 
TT and TG variants despite no statistical significance. CXCL8 production from CD14+ cells 
exposed to S. aureus and S. uberis strains was greatly reduced in comparison to E. coli, 
similar to published observations (Bannerman 2009; Swanson, Stelwagen et al. 2009; 
Rinaldi, Li et al. 2010). These results may reflect the differences that exist in the pathogenesis 
of disease. An acute and heightened inflammatory response is more often attributed to E. coli 
infection whereas reduced inflammatory responses reflect the persistency of infection with S. 
aureus mastitis (Riollet, Rainard et al. 2001; Bannerman 2009).  
Responses to stimulation with each of the HK S. uberis strains were similar between 
the virulent 0140J and non-virulent EF20 strains, each resulting in low levels of CXCL8 
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production. Although potentially unexpected, work to characterise the cytokine response 
profiles of somatic cells following intramammary challenge with 0140J and EF20 is on-
going; with preliminary data suggesting CXCL8 production is substantially increased in cows 
infected with 0140J between 24 h and 48 h time-points, compared to only minor increases in 
cows infected with EF20 (Coffey and Leigh unpublished). The addition of a 36 h post-
stimulation time-point, therefore, further proven to be sufficient for raised production of 
CXCL8 during S. uberis infection (Bannerman, Paape et al. 2004; Bannerman 2009), may 
have identified differences in CXCL8 production between the different boTLR1 genotypes 
following stimulation with the two HK strains. 
It is important to emphasise that results from the CD14+ cell assays are from analysis 
of a single cytokine measured at a single time-point. These assays would benefit from greater 
sample numbers, an additional time-point, variation of MOI, and the analysis of further pro-
inflammatory and immunoregulatory cytokines, as well as cytokines such as the IL-1 family 
and IL-2, which are produced by activated MØ to stimulate T-cell lymphocytes. Influx of 
activated T lymphocytes has been observed during S. aureus and S. uberis mastitis (Soltys 
and Quinn 1999; Rivas, Schwager et al. 2007). In addition, it is important to note that HK 
pathogens will elicit different cytokine responses compared to the live pathogen, bacterial 
lysate preparations or even in vivo conditions.  
In conclusion, these findings present evidence that SNPs common to boTLR1, and 
associated with CM susceptibility, may underpin functional variation in boTLR1. To the 
author’s knowledge this is the first study to demonstrate genotype-specific variation in 
cytokine responses from bovine whole blood and enriched cell populations when exposed to 
PAM3. Furthermore, the potential impact of boTLR1 variation on the immune response to S. 
aureus is demonstrated here and has implications for other pathogens, warranting further 
study. A rapid immune response, conferred by the favourable boTLR1 SNP -79 TT variant 
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(Table 4.2), could reduce detrimental clinical manifestations of diseases via an efficient yet 
controlled influx of inflammatory cells to neutralise pathogens and control infection, with 
potential implications for S. aureus mastitis. An efficient boTLR1 response to S. aureus will 
be vital to limit its internalisation and survival in bovine mammary cells (Hebert, Sayasith et 
al. 2000). A bovine population with impaired boTLR1 expression and function may also be 
more susceptible to other diseases and health issues, as demonstrated in a recent study linking 
boTLR1 variants to bovine TB (Sun, Song et al. 2012). 
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Table 4.2 - Overview and comparison of results from boTLR1 functional studies  
 
Subject 
 
Measure 
Time- 
points 
BoTLR1 -79T>G tSNP genotype 
TT TG GG 
Milk somatic cells BoTLR1 (basal)  ++ ++ +/-* 
PMN cells challenged with PAM3 CXCL8  4 h, 8 h +++ ++ +* 
CXCL8 24 h +++ ++/+ +/-* 
IL-6  4 h, 8 h ++/+ ++/+ +/-* 
IL-6 (pg/µL) 24 h +++/+ + -* 
BoTLR1 (induced) 4 h, 8 h + +/- +/- 
Bcl2 A1 4 h, 8 h ++ -* +* 
CD14+ cells  CXCL8 E. coli 24 h +++ +++ ++ 
CXCL8 S. aureus 24 h ++/+ ++/+ -* 
CXCL8 S. uberis 24 h + + + 
Herd population CM incidence  
(cases/100 cows/year) 
 40 73* 75 
 
The tSNP -79 TT variants, with lowered CM incidence, demonstrated effective boTLR1 function and expression with favourable cytokine and 
survival factor responses to ligand and HK bacteria. Average relative expression levels of CXCL8, IL-6, Bcl2 A1 and boTLR1 transcripts and 
CXCL8 and IL-6 production levels (+24 h) following stimulation with the TLR1 ligand PAM3 and HK bacteria from animal samples segregated 
into boTLR1 tSNP -79T>G genotypes: TT, TG and GG. Milk somatic cell assay and herd population CM data detailed in Chapter 3.0. Level of 
expression/immune responses are graded +++, ++ or + (high to low), - denotes negligible expression. Blue shading corresponds to grading 
system from dark (+++) to light (+) *Significance differences between genotype means detected against TT genotype. 
1
0
2
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Chapter 5.0 - Identification of bovine TLR4, CD14 
and TLR5 SNPs – association with mastitis and 
production traits in cattle 
 
 
104 
 
5.1 Introduction 
5.1.1 Toll-like receptor 4 and CD14 
TLR4 was the first TLR to be described in mammals (Medzhitov, Preston-Hurlburt et al. 
1997) and, together with its co-receptor CD14, is involved
 
in the cell surface recognition of 
lipopolysaccharide (LPS), a cell wall constituent of Gram-negative bacteria (Chow, Young et 
al. 1999). TLR4/CD14 may further recognise mannan (Flo, Ryan et al. 2002) and fusion F 
protein from respiratory syncytial virus (RSV) (Kurt-Jones, Popova et al. 2000). Cell surface 
recognition of LPS by TLR4 requires additional accessory molecules; soluble LPS-binding 
protein (LBP) presents LPS to CD14, which in turn presents LBP/LPS to the myeloid 
differentiation factor 2 (MD-2) protein, which associates with TLR4 to optimise LPS 
interactions (Shimazu, Akashi et al. 1999; Park, Song et al. 2009). Complete presentation of 
LPS to TLR4 leads to receptor dimerisation and activation of MyD88-dependent signalling 
pathways, which mobilise nuclear factors such as NF-κB for inflammatory cytokine 
production. Unlike other TLR members, TLR4 then internalises in intracellular endosomes, 
and utilises MyD88-independent (TRIF adaptor protein) signalling pathways (Tanimura, 
Saitoh et al. 2008) to activate further nuclear factors, such as IRF3 for interferon production, 
inducing innate and adaptive immune responses to LPS (Figure 5.1).  
Polymorphic variation of TLR4 can alter signalling and affect receptor function, as 
demonstrated by the human mutation D299G, a NS SNP encoding an aspartic acid to glycine 
substitution within the TLR4 extracellular domain. Despite having no impact on LPS binding 
or TLR4 cell surface expression levels, the mutation compromises MyD88 and TRIF 
recruitment to the TIR domain following LPS interaction, subsequently impacting TLR4 
signalling (Figueroa, Xiong et al. 2012). These findings are important as they provide an 
underlying immunological mechanism for previous studies associating D299G with disease  
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Figure 5.1 - Overview of the TLR4/CD14 and TLR5 signalling pathway 
LBP, CD14 and MD-2 help TLR4 interact with LPS at the plasma membrane, activating 
intracellular adaptor molecule MyD88 via the TIR adaptor protein (TIRAP) which associates 
with the receptor’s TIR domain (Fitzgerald, Rowe et al. 2003).  Controlled by CD14 (Zanoni, 
Ostuni et al. 2011), TLR4 then internalises within an endosome and replaces MyD88 with 
TRIF, which is activated by the TIR domain via TRIF-related adaptor molecule (TRAM) 
(Fitzgerald, Rowe et al. 2003). MyD88-dependent and -independent (TRIF) pathways initiate 
specific signalling cascades (generalised as grey dashed arrows), leading to the translocation 
of transcription factors NF-κB and IRF-3 into the nucleus. This induces transcriptional 
activity and up-regulation of effector molecules such as inflammatory cytokines and 
interferons (IFNs). TLR5 recognises flagellin, a monomeric component of flagella, and 
signals via MyD88 only. 
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susceptibility including Gram-negative bacterial infection, sepsis, RSV and malaria (Misch 
and Hawn 2008). As well as coding SNPs, non-coding TLR4 SNPs located within the 3’UTR 
impact on gene expression and function (Song, Chen et al. 2006). Polymorphisms within 
CD14 have also been associated with diseases and inflammatory conditions such as asthma 
(Smit, Siroux et al. 2009) and heart disease (Shimada, Watanabe et al. 2000).   
In cattle, there are numerous reports linking boTLR4 variation with disease, including 
infectious bovine keratoconjunctivitis (IBK) (Kataria, Tait et al. 2011) and MAP infection 
(Mucha, Bhide et al. 2009; Ruiz-Larranaga, Manzano et al. 2011). BoTLR4 has been 
implicated in the initiation of mammary immune responses towards Gram-negative infections 
such as E. coli mastitis (De Schepper, De Ketelaere et al. 2008; Buitenhuis, Rontved et al. 
2011). In vitro studies, investigating bovine MEC responses, have demonstrated increased 
expression of boTLR4 following LPS exposure (Ibeagha-Awemu, Lee et al. 2008) and during 
S. aureus mastitis (Goldammer, Zerbe et al. 2004). Intriguingly, significant up-regulation of 
boTLR4 was similarly observed in neutrophils following intramammary challenge with S. 
uberis (Moyes, Drackley et al. 2010), implicating a potential role for boTLR4 in Gram-
positive mammary infections. 
5.1.2 Association of bovine TLR4 and CD14 SNPs with health and disease in cattle 
Due to the importance of the TLR4 response in mammary defence, the presence of SNPs 
within boTLR4 and boCD14 has been implicated in dairy health and disease. BoTLR4, a large 
gene (~12kb) located on chromosome 8, comprises three exons, with two introns dividing a 
CDS that is 2523bp in length corresponding to an 841aa chain, with 5’ and 3’UTRs 
identified. This gene is highly polymorphic, revealing over 30 SNPs across several cattle 
breeds (White, Taylor et al. 2003). A more recent study genotyped boTLR4 SNPs in a 
Canadian Holstein bull population and analysed data for associations with dairy health 
(Sharma, Leyva et al. 2006). The NS +2021C>T SNP, causing a Thr to Ile substitution within 
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the transmembrane domain, was associated with SCC, with the authors observing an increase 
in SCC in heterozygous CT genotyped cows when compared to CC cows. Another study, 
genotyping six breeds that included a small Holstein-Friesian herd, failed to find associations 
for +2021C>T with SCC although the CC genotype was associated with decreased milk fat 
and protein percentages (Beecher, Daly et al. 2010).  
Non-coding boTLR4 SNPs have been identified and tested as markers for dairy health. 
An intronic boTLR4 SNP common to three Chinese cattle breeds associate with SCC (Wang, 
Xu et al. 2007). A non-coding 5’ SNP, encoding a transverse mutation (G<>C) at position -
226bp relative to the boTLR4 start codon, lies within a potential promoter region and likely 
transcription factor binding site. Analysis of SNP -226G>C in Holstein bulls associated the 
rarer C allele with a 2% decline in lactation persistency when compared with the G allele 
(Sharma, Leyva et al. 2006). Persistency of lactation refers to the rate of decline in daily milk 
production following peak yield, with cows that are lactation persistent generally more 
disease resistant (Sharma, Leyva et al. 2006).  
The boTLR4 -226G>C SNP may prove a potential target for future association studies 
as it has a negative functional impact on boTLR4 at the transcriptional level following LPS 
exposure (Sharma, Mount et al. 2008), and predisposes animals to MAP infection (Ruiz-
Larranaga, Manzano et al. 2011). The -226G>C SNP, along with others, could be genotyped 
in the Mayfield herd to determine whether its frequency can be related to further 
physiological/health traits, milk standards and susceptibility and persistence of mastitis. 
Additionally, novel boTLR4 SNPs may also exist since SNP identification to date has only 
involved small DNA pools from differing breeds.  
The TLR4 co-receptor CD14 will provide an additional potential target for disease-
associated SNPs. BoCD14, 1.4kb in length and located on chromosome 7, comprises two 
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exons with an intron dividing a CDS that is 1122bp in length corresponding to a 374aa chain, 
with short 5’ and 3’UTRs identified. A previous study identified variation within boCD14 
and impaired expression of its protein on the surface of neutrophils (Ibeagha-Awemu, Lee et 
al. 2008a). A NS SNP, causing an asparagine to aspartic acid substitution at +612 to the start 
codon (reported as 1908A>G), is located in an LRR domain that could potentially affect 
protein expression and pathogen recognition. SNP +612A>G was genotyped in another herd 
but failed to associate with SCC, although the G allele did associate with lowered milk fat 
and protein percentages (Beecher, Daly et al. 2010). BoCD14 has been highlighted as a 
‘mutational hotspot’ in cross-breed cattle (Pal, Sharma et al. 2011), and may impact on TLR4 
responses to IMI. 
Despite a comparative marker map study finding no significant association between 
clinical mastitis and boTLR4 in a study of 768 Norwegian Red bulls (Opsal, Lien et al. 2008), 
the authors acknowledged the possibility of boTLR4 influencing mastitis in other populations 
and cattle breeds. Indeed, a cattle database of candidate genes for milk production and 
mastitis has recently been developed to support future genomic approaches to udder health 
studies. The review highlights boTLR4 and boCD14 as promising candidates for association 
with mastitis resistance/susceptibility (Ogorevc, Kunej et al. 2009). 
5.1.3 Toll-like receptor 5 
TLR5 is important for the recognition of, and inducing MyD88-signalling in response to, 
flagellin (Figure 5.1), the protein monomer that makes up the filament of bacterial flagella 
found on nearly all motile bacteria. TLR5 has demonstrated links to disease in humans; a 
common stop codon polymorphism, located within the ligand-binding domain of human 
TLR5, compromises the receptor’s ability to signal flagellin. This SNP has been associated 
with susceptibility to pneumonia caused by Legionella pneumophila (Hawn, Verbon et al. 
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2003), and  conversely with protection against systemic lupus erythematosus (Hawn, Wu et 
al. 2005).  
BoTLR5 is located on chromosome 16, and comprises a single exon containing the 
CDS that is 2577bp in length corresponding to an 859aa chain. 5’ and 3’UTRs have yet to be 
identified. BoTLR5 has been studied in several cattle breeds, with coding and non-coding 
regions shown to be highly polymorphic (Seabury, Cargill et al. 2007). However, little is 
known of the functional impact of these SNPs. Furthermore, evidence of a role for boTLR5 
responses during mastitis have yet to be verified, especially as it is yet not known if mastitis-
causing bacteria, such as E. coli, are flagellated within the mammary gland. 
5.1.4 Rationale for research 
Existing evidence of genetic variability within boTLR4 and boCD14 can be expanded on and 
tested for correlation with CM and production traits. The ability to use actual recorded CM 
data may lend more accuracy to existing associations between boTLR4/boCD14 SNPs and 
SCC. Extended gene coverage and subsequent analysis of further SNPs yet to be identified in 
the coding or non-coding regions, that may be breed-specific, could reveal additional disease-
associated markers. Functional impact from boTLR4 -226C>G and boCD14 +612A>G SNPs 
could be polygenic, linked with further SNPs and inherited as a haplotype. In addition, little 
work exists associating boTLR5 SNPs with disease and production traits in cattle, providing 
potential for further work.  
The aims for this part of the research were to analyse the impact of existing and novel 
boTLR4, boCD14 and boTLR5 SNPs on CM incidence and production traits in the Mayfield 
Holstein-Friesian herd. Candidate genes were investigated for SNPs within coding and non-
coding regions including introns, 5’UTR and 3’UTR, and adjacent genomic 
upstream/downstream regions. SNPs identified may interrupt gene promoter sites or micro 
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RNA sites, splice sites or other regulatory motifs, potentially interfering with mRNA 
regulation and protein expression (Song, Chen et al. 2006). Any differences in relative 
mRNA levels between observed genotypes will be quantified, and may correlate with 
existing evidence of TLR functional variation, and contribute towards differences in mastitis 
disease pathology and milk quality and quantity. 
 
5.2 Results 
5.2.1 Characterisation of boTLR4, boTLR5 and boCD14 SNPs 
The genomic organisation of the three bovine genes, boTLR4, boTLR5 and boCD14, were 
confirmed using internal cDNA sequencing and NCBI EST data, mapped to the Ensembl 
prediction build, Bos_taurus_UMD_3.1 assembly. Sequencing of 5’ and 3’ flanking gene 
regions (traversing both coding and non-coding parts) using a Holstein-Friesian DNA pool 
revealed a total of 13 SNPs, one of which is novel, and one insertion/deletion (in/del) (Table 
5.1). Three SNPs were identified within boTLR4, the well characterised 5’UTR SNP, -
226G>C, the novel +96C>T SNP and +4620A>G SNP, which lie intronic between exons 1 
and 2 (Figure 5.2). Three non-coding exonic SNPs were identified in boCD14, one located 
within the 5’ UTR and two within the 3’UTR, all previously reported (Figure 5.3). BoTLR5 
was more polymorphic, with seven SNPs and one in/del identified, all previously reported 
(Seabury 2007). As illustrated in Figure 5.4, three of these SNPs and the in/del are located 5’ 
upstream from the ATG start codon. A further three SNPs are 3’ downstream of the stop 
codon. The remaining SNP, the coding synonymous boTLR5 +2459G>A, is located at amino 
acid position +820 (glutamine).  
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Table 5.1 - Identified SNPs within analysed bovine gene regions from Holstein-Friesians 
 
Abbreviations: Chr:bp = Bta chromosome: chromosomal positioning in base pairs, refSNP = 
Reference Single Nucleotide Polymorphism Database (http://www.ncbi.nlm.nih.gov/projects/SNP). 
Genomic positioning according to the Bos_taurus_UMD_3.1 assembly (underlined allele denotes the 
published sequence). Light shading - synonymous coding SNPs. All SNP offsets are given relative to 
their position (bp) from the A nucleotide of the first ATG codon. 
1
Sharma, Leyva et al. 2006, 
2
White, 
Taylor et al. 2003, 
3
Ibeagha-Awemu, Lee et al. 2008a, 
4
Seabury, Cargill et al. 2007.
 
 
Bo 
Gene SNP 
 
Type 
Genomic 
position 
(Chr:bp) 
Amino 
acid 
position 
Amino 
acid 
Previously 
reported 
 
RefSNP ID 
TLR4 -226G>C 5’ UTR 8:108829143 - - Yes1  rs29017188 
 +96C>T Intronic 8:108829465 - - No - 
 +4620A>G Intronic 8:108833989 - - Yes
2
 - 
CD14 -5C>T 5’UTR 7:53448908 - - Yes3 rs41255516 
 +1305A>G 3’UTR 7:53447598 - - Yes3 rs136324317 
 +1325G>T 3’UTR 7:53447578 - - Yes3 rs109566936 
TLR5 -311G>A 5’Upstream 16:27306627 - - Yes4 rs55617432 
 -277T>C 5’Upstream 16:27306593 - - Yes4 rs55617326 
 -235T>C 5’Upstream 16:27306551 - - Yes4 rs55617294 
 -211-/A 5’Upstream 16:27306527 - - Yes4 rs55617154 
 +2459G>A Coding 16:27303858 820 Glu-Glu Yes
4
 rs55617337 
 +2620A>G 3’ /Intronic 16:27303697 - - Yes4 rs55617176 
 +2672C>T 3’ /Intronic 16:27303645 - - Yes4 rs55617288 
 +3019G>C 3’/ Intronic 16:27303298 - - Yes4 rs55617158 
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Figure 5.2 - Schematic showing the positions of identified SNPs within the bovine TLR4 gene  
Grey boxes represent coding exons (CDS = 2523bp), open boxes represent exonic non-coding untranslated regions (UTR). A TLR4 protein 
domain architecture diagram (designed using http://smart.embl-heidelberg.de/) is illustrated below the CDS, showing the transmembrane domain 
(vertical blue bar), LRR - leucine-rich repeat domains, LRR C - leucine-rich repeat C terminal domain, TIR - Toll-interleukin 1-resistance 
domain. Red lines represent sequencing coverage (total = 2904bp). Sequence and alignment from Bos_taurus_UMD_3.1 Primary Assembly 
(AC_000165.1).  
EXON 1 EXON 2
1 kB
BoTLR4
5’ 3’
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Total contig length: 12kB
EXON 3
1
1
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Figure 5.3 - Schematic showing the positions of identified SNPs within the bovine CD14 gene  
Grey boxes represent coding exons (CDS = 1122bp), open boxes represent exonic non-coding untranslated regions (UTR). Red lines represent 
sequencing coverage (total = 1259bp). Sequence and alignment from Bos_taurus_UMD_3.1 Primary Assembly (AC 000164.1_minus strand).  
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Figure 5.4 - Schematic showing the positions of identified SNPs within the bovine TLR5 gene 
Grey box represents the coding exon (CDS = 2577bp). A TLR5 protein domain architecture diagram (designed using http://smart.embl-
heidelberg.de/) is illustrated below the CDS, showing the transmembrane domain (vertical blue bar), LRR - leucine-rich repeat domains, LRR C 
- leucine-rich repeat C terminal domain, TIR - Toll-interleukin 1-resistance domain. Red lines represent sequencing coverage (total = 1656bp). 
Sequence and alignment from Bos_taurus_UMD_3.1 Primary Assembly (AC_000173.1_minus strand).  
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5.2.2 Analysis of LD patterns in boTLR5 for tSNP selection 
All seven SNPs within the boTLR5 candidate region were included for initial LD analysis and 
tSNP selection. A graphical representation of the LD between SNPs is shown in Figure 5.5. 
One haploblock was defined containing SNPs 1, 2 and 3, all in perfect LD (r
2
=1) with each 
other. As a result, the -311G>A marker was selected as the tSNP for this linkage group, 
which also contains SNPs -277T>C and –235T>C. The A in/del at position -211 was in 
complete LD with the tSNP -311G>A. An A nucleotide insertion occurred only in the 
presence of the G allele. The four remaining boTLR5 SNPs (4-7) are in moderate to low LD 
with -311G>A tSNP (Figure 5.5).  
  
5.2.3 Analysis of genotypic and allelic frequencies of markers selected for association 
analysis 
Four markers were selected for further study, two candidate SNPs from boTLR4, -226G>C 
and +96C>T, the boCD14 SNP -5C>T, and the boTLR5 tSNP -311G>A; all were extensively 
genotyped within the herd (n =103, 101, 131 and 112 respectively). The genotypic and allelic 
frequencies for all four selected markers are shown in Table 5.2. Two SNP markers, boTLR4 
-226G>C and boCD14 -5C>T, display a common homozygous population whereby one allele 
is more abundant (boTLR4 - G and boCD14 - C allele frequencies 0.62 and 0.69 respectively) 
compared to their rarer respective allele. The other two SNPs, boTLR4 +96C>T and boTLR5 
-311G>A, were not in agreement with the Hardy-Weinberg equilibrium, with the former 
having a very low T allele frequency (0.08) and the latter a low heterozygous population 
(0.20), when compared to their respective homozygous populations (Table 5.2). However, all 
four SNPs were taken forward for association analysis. 
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Figure 5.5 - Linkage disequilibrium (LD) plot for genotyped SNPs in relation to the 
boTLR5 gene model 
Grey box represents boTLR5 coding exon. The graphical representation, generated by 
Haploview, of the r
2
 LD relationship between each SNP is expressed on a grey-scale 
gradient; where black = perfect LD (r
2
 = 1.0) and white = very low LD (<0.1). The r
2
 value 
for each pair-wise comparison is shown, where no value indicates r
2
 = 1. SNPs 1-3 were 
defined as a haploblock.  
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Table 5.2 - Genotype and allele frequencies including significance from Hardy-
Weinberg equilibrium for candidate gene SNPs selected for trait association 
 
Gene 
 
SNP 
 
Genotype 
 
n = 
Genotype 
Frequency 
 
HWE 
 
Allele 
Allele 
Frequency  
BoTLR4 -226G>C GG 45 0.44 2.46 G 0.62 
  GC 40 0.39  C 0.38 
  CC 18 0.17    
  Total 103     
 +96C>T CC 88 0.87 10.42* C 0.92 
  CT 10 0.10  T 0.08 
  TT 3 0.03    
  Total 101     
BoCD14 -5C>T CC 64 0.48 0.62 C 0.69 
  CT 52 0.40  T 0.31 
  TT 15 0.12    
  Total 131     
BoTLR5 -311G>A GG 43 0.38 38.25* G 0.49 
  GA 23 0.20  A 0.51 
  AA 46 0.42    
  Total 112     
*Hardy-Weinberg equilibrium (HWE) significant at 1 degree of freedom (P<0.001).  
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5.2.4 Association of selected bovine SNPs with CM and milk production traits 
The four SNPs, boTLR4 -226G>C and +96C>T, boCD14 -5C>T, and boTLR5 tSNP -
311G>A, were analysed for association with CM and milk production traits during the first 
three lactations, as illustrated in Table 5.3. The four SNPs were further tested for association 
with CM per individual parity (P1, P2 and P3), as illustrated in Table 5.4.  
5.2.4.1 Association analysis of boTLR4 SNP -226G>C 
Association analysis of the boTLR4 SNP -226G>C with CM revealed no significant 
differences between genotypes over the first three lactations. The data trend showed the rarer 
CC genotype to have higher CM incidence (0.57 cases/cow/year) when compared with 
heterozygous GC and the abundant GG population (both 0.47 cases/cow/year) (Table 5.3). 
The proportion of animals within each genotyped population having any CM during their first 
three lactations was lowest for GC cows (47%) when compared with homozygous GG and 
CC genotypes (67% and 61% respectively). 
Analysis for SNP association with CM per individual parity revealed no significant 
differences between genotypes (Table 5.4). In all three genotypes, CM incidence was 
significantly increased at P3 when compared to their P1 and P2 incidence (Figure 5.6). 
Analysis of production traits revealed no significant differences between genotypes for milk 
SCC, yield, fat and protein concentrations (Table 5.3). 
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Table 5.3 - Association of SNP genotypes with CM and milk production traits over the first three lactations 
 
 
  
SNP 
 
 
Gen. 
 
 
n = 
P %  
with  
CM
1
 
 
Mean  
CM rate
2
 
 
 
P =
3
 
 
Mean 
SCC
4
 
 
 
P =
3
 
 
Mean 305d  
milk yield
4
 
 
 
P =
3
 
 
Mean milk  
fat (%)
4
 
 
 
P =
3
 
 
Mean milk 
protein (%)
4
 
 
 
P =
3
 
BoTLR4 GG 45 67 0.47 (±0.16)  2.93 (±0.70)  8289 (±1239)  4.05 (±0.47)  3.22 (±0.18)   
-226G>C GC 40 47 0.47 (±0.20) - 2.88 (±0.72) - 8380 (±1081) - 4.05 (±0.38) - 3.20 (±0.17) - 
 CC 18 61 0.57 (±0.31) - 3.02 (±1.01) - 7957 (±1315) - 4.23 (±0.51) - 3.29 (±0.20)  - 
BoTLR4 CC 88 56 0.47 (±0.12)  2.93 (±0.77)  8266 (±1176)  4.08 (±0.45)  3.23 (±0.18)   
+96C>T CT 10 78 0.70 (±0.49) - 2.94 (±0.84) - 8363 (±1365) - 4.13 (±0.56) - 3.23 (±0.21) - 
 TT 3 33 0.37 (±1.53) - 2.61 (±0.76) - 7985 (±1657) - 4.04 (±0.10) - 3.06 (±0.11)  - 
BoCD14 CC 64 53 0.59 (±0.19)  2.89 (±0.73)  8297 (±1170)  3.99 (±0.43)  3.20 (±0.17)  
-5C>T CT 52 52 0.47 (±0.20) - 2.77 (±0.84) - 8186 (±995) - 4.09 (±0.41) - 3.21 (±0.19) - 
 TT 15 67 0.47 (±0.27) - 2.67 (±0.78) - 8170 (±1462) - 3.83 (±0.48) - 3.09 (±0.16) - 
BoTLR5 GG 43 60 0.57 (±0.20) - 2.78 (±0.73) - 7748 (±1081) - 4.06 (±0.44) - 3.23 (±0.19)  - 
t-311G>A GA 23 70 0.58 (±0.26) - 3.03 (±0.71) - 8158 (±1369) - 4.01 (±0.52) - 3.26 (±0.18) - 
 AA 46 61 0.57 (±0.20)  2.72 (±0.76)  7837 (±1367)  4.07 (±0.50)  3.23 (±0.21)   
 
Abbreviations: Gen. = genotype, P % = population percentage, CM = clinical mastitis, SCC = somatic cell count. 
1
No significance was detected 
between genotypes by Chi^2 odds ratio test. 
2
Mean±95% confidence interval given in column parentheses. 
3
P values analysed by ANOVA and 
Tukey’s multiple comparisons, showing only results tested against the underlined (most abundant) homozygous genotype; – (dash) denotes no 
significance.
 4
Standard deviation from the mean given in column parentheses. 
1
1
9
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Table 5.4 - Association of SNP genotypes with CM at first (P1) second (P2) and third (P3) parity 
 
 
 
SNP 
 
 
Gen. 
 
 
n = 
 
P1 P % 
with CM
1
 
 
P1 Mean  
CM rate
2
 
 
 
P =
3
 
 
P2 P %  
with CM
1
 
 
P2 Mean  
CM rate
2
 
 
 
P =
3
 
 
P3 P %  
with CM
1
 
 
P3 Mean  
CM rate
2
 
 
 
P =
3
 
TLR4 GG 45 13 0.26 (±0.21)  20 0.30 (±0.19)  47 1.02 (±0.44)  
-226G>C GC 40 10 0.19 (±0.20) - 25 0.32 (±0.21) - 38 0.97 (±0.48) - 
 CC 18 17 0.20 (±0.23) - 22 0.34 (±0.35) - 59 1.11 (±0.63) - 
TLR4 CC 88 13 0.24 (±0.14)  21 0.29 (±0.13)  44 0.97 (±0.30)  
+96C>T CT 10 10 0.14 (±0.33) - 40 0.66 (±0.63) - 60 1.34 (±1.26) - 
 TT 3 0 0.00 (±0.00) - 0 0.00 (±0.00) - 33 1.51 (±6.51) - 
CD14 CC 64 21 0.39 (±0.22)  28 0.46 (±0.24)  38 1.04 (±0.42)  
-5C>T CT 52 17 0.25 (±0.18) - 27 0.52 (±0.32) - 37 0.71 (±0.32) - 
 TT 15 20 0.25 (±0.29) - 21 0.31 (±0.31) - 50 1.06 (±0.82) - 
TLR5 GG 43 27 0.30 (±0.17) - 23 0.35 (±0.24) - 48 1.04 (±0.42) - 
t-311G>A GA 23 22 0.35 (±0.31) - 43 0.67 (±0.42) - 41 0.71 (±0.32) - 
 AA 46 15 0.34 (±0.26)  24 0.29 (±0.18)  51 1.06 (±0.82)  
Abbreviations: Gen. = genotype, P % = population percentage, CM = clinical mastitis. 
1
No significance was detected between genotypes by 
Chi^2 odds ratio test. 
2
Mean±95% confidence interval given in column parentheses. 
3
P values analysed by ANOVA and Tukey’s multiple 
comparisons, showing only results tested against the underlined (most abundant) homozygous genotype; – (dash) denotes no significance. 
1
2
0
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Figure 5.6 - Mean incidence of clinical mastitis across three parities for cows grouped 
into the three boTLR4 -226G>C SNP variant populations: GG, GC and CC 
Data from each variant population are presented as a bar, with the positive whiskers 
representing 95% confidence interval of the mean. Grey bars – GG animals (n =45), hatched 
bars – GC animals (n =40) and open bars – CC animals (n =18). P1 = first parity, P2 = second 
parity and P3 = third parity. 
a
 = tested against P1 data for same genotype. 
b
 = tested against 
P2 data for same genotype. Genotypic means differ significantly at the following levels: 
*P<0.05, **P<0.01, by ANOVA and Tukey’s multiple comparisons. 
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5.2.4.2 Association analysis of boTLR4 SNP +96C>T 
Association analysis of the boTLR4 SNP +96C>T with CM revealed no significant 
differences between genotypes over the first three lactations. The data trend showed the rare 
CT genotype to have higher CM incidence (0.70 cases/cow/year) when compared to the 
abundant CC population (0.47 cases/cow/year) (Table 5.3). The proportion of animals within 
each genotyped population having any CM during their first three lactations was again higher 
for CT cows (78%) when compared to homozygous CC genotypes (56%). Due to low 
population numbers for the even rarer TT genotype, no trend was observed.  
Analysis of SNP association with CM per individual parity revealed no significant 
differences between genotypes (Table 5.4). Animals from the CC genotype displayed 
significantly increased CM incidence at P3 when compared to their P1 and P2 incidence 
(Figure 5.7). The rare TT population contributed data to P3 only, which displays an 
exaggerated CI whisker because of the low animal numbers (Figure 5.7). Analysis of 
production traits revealed no significant differences between genotypes for milk SCC, yield, 
fat and protein concentrations (Table 5.3).  
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Figure 5.7 - Mean incidence of clinical mastitis across three parities for cows grouped 
into the three boTLR4 +96C>T SNP variant populations: CC, CT and TT 
Data from each variant population are presented as a bar, with the positive whiskers 
representing 95% confidence interval of the mean. Grey bars – CC animals (n =88), hatched 
bars – CT animals (n =10) and open bars – TT animals (n =3). P1 = first parity, P2 = second 
parity and P3 = third parity. 
a
 = tested against P1 data for same genotype. 
b
 = tested against 
P2 data for same genotype. ***P<0.001 by ANOVA and Tukey’s multiple comparisons. 
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5.2.4.3 Association analysis of boCD14 SNP -5C>T 
Association analysis of the boCD14 -5C>T SNP with CM revealed no significant differences 
between genotypes over the first three lactations. The data trend showed the most abundant 
CC genotype to have higher CM incidence (0.59 cases/cow/year) when compared to 
heterozygous CT and the rarer TT population (both 0.47 cases/cow/year) (Table 5.3). The 
proportion of animals within each genotyped population having any CM during their first 
three lactations was higher for TT cows (67%) when compared to CT and CC genotypes 
(52% and 53% respectively). 
Analysis for SNP association with CM per individual parity revealed no significant 
differences between genotypes (Table 5.4). The highest CM incidence for each genotype was 
observed at P3 (Figure 5.8). However, only the CC population showed a significantly 
increased P3 incidence of 1.04 cases/cow/year when compared with a P1 incidence of 0.39 
cases (P<0.01), and a P2 incidence of 0.46 cases (P<0.05). Analysis of production traits 
revealed no significant differences between genotypes for milk SCC, yield, fat and protein 
concentrations (Table 5.3); however, the TT genotype tended to associate with reduced milk 
protein when compared to CC and CT cows (P<0.1). 
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Figure 5.8 - Mean incidence of clinical mastitis across three parities for cows grouped 
into the three boCD14 -5C>T SNP variant populations: CC, CT and TT 
Data from each variant population are presented as a bar, with the positive whiskers 
representing 95% confidence interval of the mean. Grey bars – CC animals (n =64), hatched 
bars – CT animals (n =52) and open bars – TT animals (n =15). P1 = first parity, P2 = second 
parity, and P3 = third parity. 
a
 = tested against P1 data for same genotype. 
b
 = tested against 
P2 data for same genotype. Genotypic means differ significantly at the following levels: 
*P<0.05, **P<0.01, by ANOVA and Tukey’s multiple comparisons. 
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5.2.4.4 Association analysis of boTLR5 tSNP -311G>A  
Association analysis of the boTLR5 -311G>A tSNP with CM revealed no significant 
differences between genotypes over the first three lactations. The data trends revealed all 
three genotypes to have similar CM incidences (0.57-0.58 cases/cow/year) (Table 5.3). 
Analysis for SNP association with CM per individual parity revealed no significant 
differences between genotypes (Table 5.4). The highest CM incidence for each genotype was 
observed at P3 (Figure 5.9). However, only GG and AA populations showed a significantly 
increased P3 incidence when compared with their respective P1 and P2 incidences (P<0.01). 
Analysis of production traits revealed no significant differences between genotypes for milk 
SCC, yield, fat and protein concentrations (Table 5.3).  
 
5.2.5 In-silico analysis for putative transcription binding sites 
The AliBaba2.1 (TRANSFAC 4.0 sites) software programme was used to search for putative 
TBS located immediately upstream of the ATG start codon for boTLR5. The 5’ upstream 
SNPs identified in this study were then analysed for any potential impact on predicted TBS. 
BoTLR5 SNPS, -311G>C, -277T>C and –235T>C, and an in/del at -211, are surrounded by 
several putative TBS, including matched sites for the transcription enhancing factor 
Specificity Protein 1 (Sp1), and gene up-regulators GATA-binding factor-1 (GATA-1) and 
Activator Protein-1 (AP-1) (Figure 5.10). However, both published and alternate allele 
sequences suggest these polymorphisms have no obvious impact on the presence or absence 
of TBS. Due to both allele sequences having identical predictions of surrounding TBS, only 
the published allele sequence is shown (Figure 5.10).  
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Figure 5.9 - Mean incidence of clinical mastitis across three parities for cows grouped 
into the three boTLR5 -311G>A variant populations: GG, GA and AA 
Data from each variant population are presented as a bar, with the positive whiskers 
representing 95% confidence interval of the mean. Grey bars – GG animals (n =40), hatched 
bars – GA animals (n =23) and open bars – AA animals (n =43). P1 = first parity, P2 = 
second parity, and P3 = third parity. 
a
 = tested against P1 data for same genotype. 
b
 = tested 
against P2 data for same genotype. **Genotypic means differ significantly (P<0.01) by 
ANOVA and Tukey’s multiple comparisons. 
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Bos_taurus_UMD_3.1 Primary Assembly Sequence 
 
 
Figure 5.10 - Location of upstream boTLR5 SNPs in relation to putative transcription 
binding sites for the published allele sequence 
The AliBaba 2.1 software programme was used to predict (75% match threshold) 
transcription factor binding sites (TBS) in the boTLR5 upstream region. Upstream nucleotide 
sequence shown in upper case, ATG start codon shown by lower case. Numbering indicates 
nucleotide position from the start codon. SNP positions are highlighted in red, with SNP 
names above. Positions of putative TBS are aligned below the nucleotide sequence. TBS 
abbreviations: Sp1 = Specificity Protein 1, GATA-1 = GATA-binding factor-1, AP-1 = 
Activator Protein-1, NF-1 = Nuclear Factor-1, C/EBP = CCAAT-Enhancer-Binding Protein, 
Pit-1a = POU class 1 homeobox-1. 
 
  -500 TAGGAAGTGAGGATGGATAAATAGAGATGACTTAGTATCTTTGGCAGATTAGAGGGGAAA 
                     ===GATA-1= 
                                            ====NF-1== 
                                               =C/EBPalp= 
                                                      ====Sp1=== 
 
  -440 GAAAAATCAGTGGATTTATTTTCTAGTCCTCAGCAGAGGCTGCCTTGGGAAAGGAATGGG 
                                                   =C/EBPdel= 
                                                          =C/EBPalp 
                                                           ====Sp1= 
                                                                  = 
 
  -380 GTCCCTGGCTGGGCTGAAGTTCAAATATATCTCTTCCTAATGTTTTCCCCAACTTCCATC 
       = 
       == 
             ====Sp1=== 
                        =C/EBPalp= 
                                 ===GATA-1= 
                                                                 =C 
             SNP-311G>C                       SNP-277T>C 
  -320 AGCAAATCTTGAATGAATGAATTCACAACCTTATGAATGAATGCTGAGTTATCACAAAGA 
       /EBPalp= 
                   ===Pit-1a= 
                                       ===Pit-1a= 
                                                    ====AP-1== 
                                                     ===GATA-1= 
                             SNP-235T>C              -211-/A 
  -260 TTAAATATTTTCTGAAGTACTTACAATCATGCTTGCTATTTTTTAAAAA-TGCAACATAA 
                                            =C/EBPalp= 
                                                   ====Sp1=== 
 
  -200 TAGATAAAAAGAGAGAAAAGCTCTGTCTGCATCACACAGTATCTGCCAATAGGCATGGCC 
        ===GATA-1= 
                                ====AP-1== 
                                                =C/EBPalp= 
                                                ====NF-1== 
                                                         ====Sp1=== 
                              
  -140 ACGGACCCAGAGGAACACAGGGTCTAAGAAGCAACCACATCACAAAGGGGTCCCCCAGGC 
                                                          =====Sp1= 
                                     
   -80 CCTAACACCCTCAAGGCTGTTGCTCAGTGCCTTGAGCTTAGATGTCTGTGTCTTCACTCT 
       == 
                                                 ====AP-1== 
                                                              ==== 
 
   -20 CCCTTCTTCTCCATAGGATCatg... 
       ===Sp1===== 
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5.2.6 Q-PCR analysis of basal boTLR4 and boTLR5 mRNA abundance 
Milk somatic cells from cows representing boTLR4 and boTLR5 genotypes were assessed for 
differences in basal boTLR4 and boTLR5 expression. All contributing animals were of similar 
age and stage of lactation and none had any known health issues or recorded any incidence of 
mastitis two weeks preceding/following the collection. Q-PCR assays were performed using 
RNA from 15 animals, five from each boTLR4/5 SNP genotype. Analysis of boTLR4 
expression by representative SNP -226G>C genotypes revealed no significant differences or 
trends in basal expression levels between the three genotypes (Figure 5.11). BoTLR5 basal 
expression levels in mammary somatic cells was generally much lower in comparison to 
boTLR4 expression, and further revealed no significant differences in expression levels 
between the three boTLR5 tSNP -311G>A variant populations: GG, GA and AA. A marginal 
trend in the data suggests lowered expression in somatic cells from AA cows when compared 
with cells from GG animals. 
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Figure 5.11 - Q-PCR data showing basal mRNA abundance levels of boTLR4 and 
boTLR5 in milk somatic cells grouped into their respective SNP variant populations 
The three boTLR4 -226G>C SNP variant populations, GG, GC and CC, are indicated, as are 
the three boTLR5 -311G>A SNP variant populations, GG, GA and AA. Data from each 
variant population (n = 5) is presented as a box and whisker plot, with the ends of the 
whiskers representing the minimum and maximum data values. Genotypic means do not 
differ significantly (P>0.05 by ANOVA and Tukey’s multiple comparisons). 
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5.3 Discussion 
The importance of the boTLR4 and boCD14 complex to mediate inflammatory responses 
during mammary infection has been highlighted previously (De Schepper, De Ketelaere et al. 
2008; Buitenhuis, Rontved et al. 2011). Preliminary studies have so far linked the presence of 
boTLR4 and boCD14 SNPs with SCC (Sharma, Leyva et al. 2006; Wang, Xu et al. 2007; 
Ibeagha-Awemu, Lee et al. 2008). However, some of these SNP associations lacked 
significance when studied in other herds and breeds (Beecher, Daly et al. 2010), highlighting 
the need for further work to clarify their potential as a marker for CM. In this study, boTLR4, 
boCD14 and boTLR5 were analysed for SNPs within their 5’ and 3’ regions, allowing 
assessment of non-exonic and exonic UTR and CDS SNPs. Identified SNPs were then 
investigated as markers for dairy health using actual recorded CM and production data.  
Sequencing pooled DNA from Holstein-Friesian cows of high and low CM incidence 
histories revealed thirteen SNPs between the candidate genes. Seven SNPs (one coding) and 
one in/del polymorphism were identified within boTLR5, all previously reported (Seabury, 
Cargill et al. 2007). Complete linkage was observed within the herd between the three 
boTLR5 5’ upstream SNPs, defined into a single haploblock, and represented by tSNP -
311G>A. LD between -311G>A and the remaining coding +2459G>A SNP and three 3’ 
downstream SNPs, was low. Due to low animal numbers for both the CDS mutation (a 
synonymous change unlikely to have functional impact) and for the 3’ downstream SNPs, 
association analysis was not performed. However, the 3’ SNPs may provide a future target 
for study. Likewise the boTLR4 SNP +4620A>G, one of three boTLR4 SNPs identified 
within the herd, requires greater animal numbers for association analysis. This SNP has 
recently been associated with IBK infection rates in American cattle (Kataria, Tait et al. 
2011), and may also provide a future target for study. The 5’UTR boCD14 SNP -5C>T, and 
the 3’ UTR SNPs +1305A>G and +1325G>T reported in this study have previously been 
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found to be in complete linkage with one another (Ibeagha-Awemu, Lee et al. 2008a). 
Therefore, only the boCD14-5C>T SNP was genotyped extensively. The observed genotypic 
frequencies for SNPs boTLR4 +96C>T and boTLR5 -311G>A were not in agreement with the 
Hardy-Weinberg equilibrium, indicating potential for false-positive genotyping (Xu, Turner 
et al. 2002). However, these two SNPs were still put forward, along with the boTLR4 SNP -
226G>C and the boCD14 SNP -5C>T, for association analysis.  
No associations for CM or milk production were found for any of the SNPs studied. 
The overall CM trend demonstrates increased incidence for cows in their third lactation for 
most of the SNP genotypes studied, demonstrating the positive correlation between age and 
CM. Significantly increased CM rates were observed for all boTLR4 SNP -226G>C 
genotypes during P3, however, there are no genotypic variation or trends. This upstream 
boTLR4 SNP is located within a putative c-Ets-1 DNA-binding site, and further surrounded 
by GATA-like sites (Sharma, Leyva et al. 2006). In previous studies, the -226G>C mutation 
impacted boTLR4 mRNA levels, with the GG genotype demonstrating increased expression 
following LPS exposure (Sharma, Leyva et al. 2006; Sharma, Mount et al. 2008). This study 
did not observe any significant differences or trends between -226G>C genotypes for basal 
boTLR4 mRNA levels in mammary somatic cells. It is therefore likely that this mutation 
affects inducible expression levels only. In terms of impact on disease, the GG population has 
been suggested as being more disease-resistant owing to better lactation persistency (Sharma, 
Leyva et al. 2006), although a recent study has associated the G allele with increased 
susceptibility to paratuberculosis (Ruiz-Larranaga, Manzano et al. 2011). Trends from this 
study suggest GG cows to have lowered CM incidence when compared to CC cows but no 
significance was detected, potentially due to low numbers of animals of the latter genotype. 
In agreement with Sharma et al (2006), no associations with SCC were observed. As a 
potential functional SNP impacting inducible boTLR4 levels, -226G>C warrants further 
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study. In addition, the boTLR4 SNP +96C>T will benefit from further work to improve 
numbers for the rare T allele, which will then reveal whether it has potential as a marker for 
dairy disease.  
Variation in inducible boTLR4 expression could be the result of polymorphic 
influence from additional proteins important for TLR4 signalling, for example variants of the 
TLR4-associating protein MD-2. A rare MD-2 SNP in humans affecting gene promoter 
activity impedes MD-2 and cytokine expression levels following LPS exposure, and was 
linked to sepsis in patients (Gu, Shan et al. 2007). Similarly, polymorphic variation within the 
human LBP protein has been linked to disease susceptibility (Chien, Boeckh et al. 2008). 
Bovine MD-2 and LBP could therefore provide additional marker candidates for impaired 
TLR4 function and disease association. 
The TLR4 co-receptor CD14 is important for complete LPS signalling and has 
previously demonstrated polymorphic variation in CD14 expression. The boCD14 SNP -
5C>T (reported as 1291C>T) has been associated with reduced CD14 protein expression by 
bovine monocytes from TT variant cows (Ibeagha-Awemu, Lee et al. 2008a). CD14 
expression correlates with apoptosis in cells from bovine mammary glands (Sladek and 
Rysanek 2011), suggesting reduced expression for this receptor could impact mammary cell 
survival as well as TLR4 function. Although no significance was detected, trends for the TT 
population in this study show a lowered CM rate, but a higher herd percentage with CM 
when compared to CC cows. More genotyped animals could reveal genotypic differences if 
they exist and/or improve interpretation of the trends and accuracy of the association analysis. 
In addition, basal boCD14 mRNA levels between the -5C>T genotypes will be useful to 
compare with previously observed variation in protein expression levels. The -5C>T SNP 
may be linked with further upstream promoter SNPs yet to be identified. Analysis for 
putative DNA binding sites within a 1.2kb promoter region immediately 5’ of the boCD14 
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start codon has been performed (Ibeagha-Awemu, Lee et al. 2008a), revealing several 
species-conserved predicted binding sites. However, the -5C>T SNP had no impact on any of 
these. Extended sequencing into this promoter region may identify additional SNPs. In the 
human system SNPs located in a CD14 promoter region, shown to enhance transcription, 
have links with heart disease (Shimada, Watanabe et al. 2000). 
This study did not observe any significant differences or trends between boTLR5 -
311G>A genotypes for basal boTLR5 mRNA levels in mammary somatic cells. Searches for 
putative DNA binding sites within a 500bp genomic region immediately upstream of the start 
codon revealed that the presence or absence of the -311G>A SNP, the two tagged SNPs and 
an in/del polymorphism had no obvious impact on the predicted binding sites. The overall 
level of boTLR5 expression when compared to boTLR4 was very low, agreeing with 
observations from another study analysing bovine mammary cells exposed to E. coli 
(Porcherie, Cunha et al. 2012). These mammary cells further demonstrated an inability to 
initiate inflammatory responses to the TLR5 ligand flagellin. Whilst a role for boTLR5 
during mastitis has yet to be fully determined, this study did not find any associations or 
trends for CM with boTLR5 SNPs. Verification of mastitic pathogens that are flagellated 
inside the mammary gland, and whether flagella is highly immunogenic in milk, will improve 
our understanding of the role of boTLR5, which currently demonstrates no significant 
activity in the early stages of mastitis. In addition, a number of previously reported NS SNPs 
(Seabury, Cargill et al. 2007) could provide markers for protein function variation and 
susceptibility to other diseases. 
In conclusion, no associations for CM or milk production were found for any of the 
selected SNP markers within the bovine genes boTLR4, boCD14 and boTLR5. However, 
these findings would benefit from larger sample populations and extensive coverage and 
analysis of gene regions may reveal disease-associated SNPs missed by this study. Due to the 
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importance of boTLR4 signalling during mastitis, boTLR4 SNPs remain potential candidates 
for investigations into CM susceptibility in other herds/breeds, and warrant further study 
which could extend to markers within boCD14 and the genes for the accessory molecules 
MD-2 and LBP. Combined analysis of SNPs from these TLR4-related genes could then yield 
greater accuracy when associating with polygenic diseases such as mastitis, an approach that 
has associated the presence of both a TLR4 and a CD14 SNP, instead of them individually, 
with human atherosclerotic disease (Vainas, Stassen et al. 2006). Furthermore, investigating 
CM incidence by the causative pathogen may reveal significant associations between boTLR4 
SNPs and susceptibility to E. coli mastitis.  
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Chapter 6.0 - Identification of bovine CXCR1 and 
CXCR2 SNPs - association with mastitis and 
production traits in cattle 
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6.1 Introduction 
6.1.1 Chemokine Receptors CXCR1 and CXCR2 
The chemokine receptors CXCR1 and CXCR2 have pivotal roles in leukocyte motility as 
they both recognise the chemokine CXCL8, the most potent chemoattractant for neutrophils 
(Murdoch and Finn 2000). Increased transcript and protein levels of CXCL8 have been 
demonstrated during mastitis (Lee, Bannerman et al. 2006). The receptors’ immunological 
function of activating and directing effector cells to regions of increased CXCL8 are vital in 
cell-mediated resolution of IMI and mastitis. CXCR1 activity is strongly correlated with 
inflammatory responses towards both Gram-negative and Gram-positive infection. TLR4 
binding of E. coli LPS, for example, led to the up-regulation of boCXCR1, giving increased 
cell sensitivity to CXCL8 and improved migratory efficiency  (Olson and Ley 2002). Another 
study however, demonstrated that S. aureus may inhibit neutrophil responsiveness to CXCL8 
via TNF-α-mediated (induced by the bacteria) down-regulation of CXCR1 and CXCR2 
(Tikhonov, Doroshenko et al. 2001). 
Both CXCR1 and CXCR2 share a similar structure and function with all other 
chemokine receptors, whereby an extracellular NH2-terminus, an intracellular COOH-
terminus and seven transmembrane domains are connected by three extracellular loops 
(ECLs) and three intracellular loops (ICLs), as illustrated in Figure 6.1. The NH2-terminal 
region and ECLs, each containing a conserved and structurally important cysteine residue, 
interact with the chemokine ligand. In a human CXCR1 study the NH2-terminal amino acids 
1-38 were mainly responsible for binding CXCL8, with ECLs 1 and 2 stabilising this 
interaction (Park, Casagrande et al. 2011). The study demonstrated CXCL8 binding signals 
from a truncated receptor lacking ECLs, but no signal from protein lacking an NH2-terminal. 
Chemokine receptors are G protein-coupled receptors, whereby the COOH-terminus and 
ICLs associate with inactivated intracellular G protein components (α/βγ) within the cell. 
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Following ligand binding, the receptor activates the G protein subunits by facilitating the 
exchange of guanosine diphosphate (GDP) for guanosine triphosphate (GTP) in the Gα 
subunit, leading to its dissociation from the Gβγ subunit. Subsequently this then activates 
complex and partially characterised pathways leading to inactivation and internalisation of 
the receptor protein (via phosphorylation of COOH-terminal serine and threonine residues), 
and activation of cell mechanisms for cell motility, degranulation and release of superoxide 
anions (Murdoch and Finn 2000; Allen, Crown et al. 2007) (Figure 6.1). Internalisation of 
activated CXCR1/CXCR2 for ‘desensitisation’ before their recycling to the cell surface is 
important to maintain a cell's responsiveness and chemotactic efficiency (Borroni, Mantovani 
et al. 2010). 
High homology (84% identity) exists between bovine CXCR1 and CXCR2 proteins, 
with each sharing >70% identity to their respective human homologues. However, boCXCR1 
and boCXCR2 share 100% identity at the COOH-terminus, which differ in the human system 
and other species (Lahouassa, Rainard et al. 2008). Although close identity between 
boCXCR1 and boCXCR2 is reflected in their shared ability to detect chemokines CXCL6, 
CXCL7 and CXCL8, boCXCR2 has the added capacity to recognise a further four CXCL 
chemokines (Table 1.3). High homology has led to confusion in previous studies, with the 
misidentification of genes boCXCR1 (previously known as IL8RA) and boCXCR2 (previously 
known as IL8RB) (Pighetti and Rambeaud 2006). Both genes are of similar size; the CDS for 
boCXCR1 is 1080bp in length, corresponding to a 360aa chain, while boCXCR2 is 1089bp, 
corresponding to a 363aa chain. Both genes are located in close proximity, approximately 
90.3cM on chromosome two (Bta 2), with boCXCR1 (reading antisense) and boCXCR2 
(reading sense) separated by 22.6kb. Both receptors are similarly expressed on human 
neutrophils (Chuntharapai, Lee et al. 1994), and expressed at variable levels in bovine MØ, 
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Figure 6.1 - Schematic of CXCR1 structure, activation and signalling 
The basic tertiary structure of CXCR1 is outlined by the seven transmembrane domains (in 
blue), connecting three intracellular loops (ICLs) and three extracellular loops (ECLs) with N 
and C termini. The conserved cysteine residues (C) and a DRYLAIV motif important for 
signalling are highlighted. The N terminus and ECLs interact with the ligand (CXCL8), 
whilst the C terminus and ICLs associate with inactivated G proteins comprised of an α 
(orange) subunit and a βγ (red) subunit. Receptor/ligand interaction results in the replacement 
of GDP with GTP within Gα, dissociating the G-protein into the two active Gα and Gβγ 
components to initiate a complex series of intracellular signalling events (generalised as 
dashed arrows). Both Gα and Gβγ direct calcium mobilisation (Ca2+), diacyl-glycerol (DAG) 
formation and activation of the enzyme phospholipase C-β (PKCβ). Gα further directs 
MAPK phosphorylation of C terminus residues leading to receptor internalisation and 
recycling (desensitisation). MAPK activity leads to phospholipase A2 (PLA2) activation. 
PLA2, Ca
2+, DAG and PKCβ are all important for specific cell activation mechanisms. 
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monocytes and dendritic cells (Widdison, Siddiqui et al. 2010). Polymorphic variation 
impacting CXCR1 and CXCR2 expression in neutrophils has been linked to human disease 
(Qiu, Zhu et al. 2003; Kormann, Hector et al. 2011), and due to the importance of the 
neutrophil response in mammary defence, the presence of SNPs within boCXCR1 and 
boCXCR2 has been implicated in dairy health and disease. 
 
6.1.2 Association of boCXCR1 SNPs with health traits in dairy cattle 
There have been a number of disease association studies linking SNPs within boCXCR1 with 
mastitis and health. An initial study from the USA associated a previously reported and 
misidentified SNP within boCXCR2 (Grosse, Kappes et al. 1999; Youngerman, Saxton et al. 
2004b) with significant differences in the incidence of subclinical mastitis (Youngerman, 
Saxton et al. 2004a). This SNP, which has now been correctly annotated within boCXCR1 
causing a coding G>C base substitution at position +735bp relative to the ATG start codon 
(SNP position previously reported as +777bp relative to the study’s sequenced transcript) 
results in a NS glutamine to histidine amino acid change. Cows expressing the CC 
polymorphism were observed to have a significant (P<0.05) increase in subclinical mastitis 
incidence as determined by microbial status, a slight decrease in CM and a greater milk yield. 
However, these associations may strengthen (or weaken) with a larger sample size, since only 
4 of the 37 Holsteins genotyped expressed the CC allele.  
The boCXCR1 +735G>C NS SNP is located in a structural region important for 
receptor signalling, as demonstrated in a follow-up study where carriers of the C base (CC 
and GC genotype) had significantly lower neutrophil migration towards human recombinant 
CXCL8 than those with the GG genotype (Rambeaud and Pighetti 2005). In addition, 
neutrophils from homozygous CC cows demonstrated decreases in receptor numbers, calcium 
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signalling, generation of reactive oxygen species and adhesion molecule expression, yet 
increased neutrophil survival (Rambeaud and Pighetti 2005; Rambeaud, Clift et al. 2006; 
Rambeaud and Pighetti 2007). The influence of the boCXCR1+735 SNP may be polygenic, 
as another initial study focusing on the UTRs identified three novel polymorphisms in a 
2.1kb upstream region of boCXCR1 (Leyva-Baca, Schenkel et al. 2008). The SNP boCXCR1 
-1768T>A substitution significantly decreased EBV for SCC by a fifth for the first and 
second lactations. The Canadian dairy industry currently select against bulls with EBV for 
increased SCC. The -1768T>A SNP site was surrounded by a host of potential transcription 
binding sites, including NF-κB, and may therefore be cis-acting; further work will be 
required to verify this. The findings from the above studies involving boCXCR1 SNPs -
1768T>A and +735G>C are sound evidence to support the additional investigations as 
detailed in this chapter, as they provide an existing immunological mechanism to explain 
potential genetic differences in mastitis susceptibility.  
Since the initial associative reporting of boCXCR1 SNPs -1768T>A and +735G>C by 
Leyva-Baca et al. (2008) and Youngerman et al. (2004a) respectively, further studies 
analysing these and additional boCXCR1 SNPs have had conflicting results. Whilst the 
Leyva-Baca et al. (2008) study observed no significant association with SCC for the NS 
+735G>C SNP, another study found that SNP +735G>C  tended to associate with SCC in a 
Holstein-Friesian dataset (Beecher, Daly et al. 2010). A large scale German Holstein study 
revealed no significant associations for -1768T>A and +735G>C SNPs with SCC on a 
population-wide basis using a suitably adjusted dataset (Goertz, Baes et al. 2009). A study 
analysing -1768T>A and +735G>C SNPs in Black Japanese cattle (n = 150) for association 
with clinical intestinal or respiratory disease revealed no significance. However, there were 
significant differences between -1768T>A genotypes for white blood cell counts (Tsuchida, 
Yamad et al. 2010). Another study analysing Chinese Holstein cattle (n = 610) associated the 
142 
 
upstream -1768T>A SNP, as well as two additional SNPs (-1830A>G and -344T>C), with 
SCC (Chen, Yang et al. 2011a). The +735G>C SNP, however, was not detected within their 
sample herd.  
Discrepancies for -1768T>A and +735G>C SNP associations are likely due to the 
differences in sampling methods and criteria for measuring phenotype. With regard to 
+735G>C SNP associations, Youngerman et al. (2004) sampled a small cohort and used both 
CM and SCC recordings, Leyva-Baca et al. (2008) sampled one large herd and measured 
SCC, whilst Goertz et al. (2009) sampled many herds and measured SCC. Additional 
differences in breeds, causative pathogen/s (undetermined in many/previous studies) and herd 
management must also be taken into consideration. Furthermore there are limitations when 
relying on SCC data, as arguably the use of current SCC recordings as a proxy for IMI is not 
absolutely correlated with bacterial presence (Heringstad, Gianola et al. 2006; Koeck, Miglior 
et al. 2012). The use of actual recorded CM data may therefore be more accurate. Analysis of 
350 cows from up to 23 commercial Holstein dairy farms in New York State, USA, revealed 
the SNP +735G>C associated with CM incidence, as measured by recorded clinical 
observations (Galvao, Pighetti et al. 2011). Interestingly cows of CC and GC genotypes, 
previously associated with lowered neutrophil migration, demonstrated a significant decrease 
in CM when compared with GG cows. The GG cows also had significantly lowered milk 
yields.  
The association of two boCXCR1 SNPs with impaired neutrophil function and potential 
mastitis susceptibility demonstrates the potential of boCXCR1 (and boCXCR2) SNPs as 
markers for disease in cattle. 
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6.1.3 Rationale for research 
Although a large body of work exists regarding boCXCR1 polymorphisms, these findings 
provide scope and potential for further work. Existing boCXCR1 SNP associations can be 
expanded upon and extended into the study of SNPs yet to be identified in the coding or non-
coding regions. The influence of CXCR1 SNPs +735G>C and -1768T>A may be polygenic, 
linked with additional SNPs and inherited as a haplotype. QTL evidence supports the 
potential of both CXCR genes as suitable markers for CM. A genome-wide association study 
to identify QTL associated with CM in first lactating cows in Norwegian Red cattle observed 
potential significant associations from a genomic region of ~8.5 Mb on chromosome 2 (Bta2) 
that contains boCXCR1 and boCXCR2 (Sodeland, Kent et al. 2011). 
The aims for this part of the research were to analyse the impact of existing and novel 
boCXCR1 and boCXCR2 SNPs on CM incidence and production traits in the Mayfield 
Holstein-Friesian herd. The two candidate genes were investigated for SNPs within coding 
and non-coding regions including introns, 5’UTR and 3’UTR, and adjacent genomic 
upstream/downstream regions. In addition, potential differences in relative mRNA levels 
between observed genotypes were quantified. These differences could influence CXCR 
activity and support existing evidence of boCXCR1 functional variation.  
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6.2 Results 
6.2.1 Characterisation of boCXCR1 and boCXCR2 SNPs 
The genomic organisation of boCXCR1 and boCXCR2 was confirmed using internal cDNA 
sequencing and NCBI EST data, mapped to the Ensembl prediction build 
Bos_taurus_UMD_3.1. Both full length boCXCR1 and boCXCR2 mRNA transcripts 
comprise two exons with an intron dividing their 5’UTR; however, a 3’UTR has yet to be 
identified in boCXCR2. Sequencing 5’ and 3’ regions of both candidate genes within a 
Holstein-Friesian herd (n = 186) revealed a total of 21 SNPs, of which three are novel (Table 
6.1). BoCXCR1 was found to be more polymorphic, with 19 SNPs identified compared to 
only two within boCXCR2. 16 of the 19 boCXCR1 SNPs were exonic; 10 were located in the 
CDS including six NS changes, while the remaining six were located in the non-coding 
3’UTR. The three non-exonic SNPs were identified within the intron of the 5’ UTR (Figure 
6.2). The two identified boCXCR2 SNPs are upstream of the 5’ UTR (Figure 6.3).   
6.2.2 Analysis of LD patterns in boCXCR1 for tSNP selection 
All 19 SNPs within the boCXCR1 region analysed were included for LD analysis and tSNP 
selection. A graphical representation of the LD between these SNPs is shown in Figure 6.4. 
All 19 SNPs were defined as one haploblock, with three linkage groups identified. SNPs 3, 4, 
5, 6, 7, 9, 13, 14, 15, 16, 17 and 19 are in perfect LD (r
2
=1) with each other. This linkage 
group of 12 SNPs includes four NS SNPs: +37A>T, +38T>A, +68G>A, and the well-
documented +735G>C. As a result, the +735G>C marker was selected as the tSNP for these 
12 SNPs. The SNPs 2, 10, 11 and 18, are all in complete LD (r
2
=1) with each other. This 
linkage group of four includes the remaining two NS SNPs, +980A>G and +995A>G. The 
marker -181T>C was selected as the tSNP to represent these four SNPs. SNPs 8 and 12 are in 
complete LD (r
2
=1) with one another, and the marker +816C>A was selected as the tSNP for 
this linkage group (Table 6.2). A singleton marker, -205C>T, was also identified. 
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LD between tSNPs t+735G>C, t-181T>C and t+816C>A was low (LD~0.3). The 
lowest LD was observed between t-181T>C and t+816C>A (LD~0.15). LD between the three 
tSNPs and the one singleton SNP -205C>T was low to moderate. Consequently, t-181T>C, 
t+735G>C, t+816C>A and singleton SNP -205C>T were used for association analysis and 
haplotype reconstruction. No LD was observed between boCXCR2 and boCXCR1 SNPs. 
Both boCXCR2 SNPs were used for association analysis but excluded from boCXCR1 
haplotypes.  
6.2.3 Analysis of genotypic and allelic frequencies of markers selected for association 
analysis 
The four boCXCR1 SNPs, -205C>T, t-181T>C, t+735G>C and t+816C>A, and two 
boCXCR2 SNPs, -512T>C and -496G>A, were analysed within the herd (n = 139, 182, 183, 
182, 129 and 132 respectively). The genotypic and allelic frequencies for all six selected 
markers are shown in Table 6.3. The boCXCR1 SNP marker t+735G>C identifies 
heterozygotes as the most abundant genotype, with G and C alleles of near equal frequency 
(Table 6.3). The remaining SNPs all display a common homozygous population whereby one 
allele is by far the most abundant (frequency ranges 0.71- 0.81) compared to the rarer allele 
(frequency ranges 0.19-0.29). With the exception of the boCXCR2 SNP -496G>A, all SNPs 
were found to be in agreement with the Hardy-Weinberg equilibrium. Despite this, the 
boCXCR2 SNP -496G>A was still put forward for association analysis. 
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Table 6.1 - Identified SNPs within boCXCR1 and boCXCR2 from Holstein-Friesians 
 
Abbreviations: Bta2 = Bos taurus chromosome 2, dbSNP = Single Nucleotide Polymorphism 
Database (http://www.ncbi.nlm.nih.gov/projects/SNP). All sequences were aligned with the 
Bos_taurus_UMD_3.1 assembly AC_000159.1 (underlined allele denotes the published 
sequence). Light shading - synonymous coding SNPs, dark shading - non-synonymous 
coding SNP. All SNP offsets are given relative to their position (bp) from the A nucleotide of 
the first ATG codon. Prior publication for reported SNPs /or SNP equivalent: 
1
Youngerman, 
Saxton et al. 2004b, 
2
Leyva-Baca, Schenkel et al. 2008, 
3
Pighetti, Kojima et al. 2012, 
4
Grosse, Kappes et al. 1999. 
 
Gene SNP 
 
 
Location 
Genomic 
(Bta2) position 
Amino 
acid 
position Amino acid 
Previously 
reported 
 
dbSNP ID 
BoCXCR1 -205C>T Intron1 106938784 - - Yes
3
  - 
 -181T>C Intron1 106938760 - - Yes
2
  - 
 -41A>C Intron1 106938620 - - No  - 
 +37A>T Exon2 106938542 13 Ile-Phe Yes  rs110296731 
 +38T>A Exon2 106938541 13 Ile-Asn Yes
 
 rs134770474 
 +68G>A Exon2 106938511 23 Gly-Glu Yes rs133273369 
 +735G>C Exon2 106937845 245 Glu-His Yes
1, 4
 rs137681722 
 +816C>A Exon2 106937764 272 Ile-Ile Yes
1
 - 
 +819G>A Exon2 106937761 273 Ala-Ala Yes
1
  rs134348371 
 +980A>G Exon2 106937600 327 Lys-Arg Yes
3
 rs136740306 
 +995A>G Exon2 106937585 332 His-Arg Yes
3
 rs135131046 
 +1008C>T Exon2 106937572 336 Ser-Ser Yes
3
 rs43323014 
 +1068G>A Exon2 106937512 356 Thr-Thr Yes
3
 rs132989373 
 +1089C>A 3’UTR 106937491 - - Yes3 - 
 +1090A>C 3’UTR 106937490 - - Yes3 - 
 +1093C>T 3’UTR 106937487 - - Yes3 - 
 +1098C>T 3’UTR 106937482 - - Yes3 - 
 +1180G>A 3’UTR 106937400 - - Yes3  rs134970823 
 +1282G>A 3’UTR 106937298 - - Yes3  rs137732683 
BoCXCR2 -512T>C 5’ to gene 106904491 - - No - 
 -496G>A 5’ to gene 106904507 - - No - 
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Figure 6.2 - Schematic showing the positions of identified SNPs within boCXCR1  
Grey box represents coding exon (CDS = 1080bp), open boxes represent exonic non-coding untranslated regions. A CXCR1 protein domain 
architecture diagram (designed using http://smart.embl-heidelberg.de/) is illustrated below the CDS, showing the seven transmembrane domains 
(vertical blue bars). All NS SNPs are boxed in bold. Red lines represent sequencing coverage (total = 1500bp). Sequence and alignment from 
Bos_taurus_UMD_3.1 Primary Assembly (AC_000159.1). 
Bta 2: 106,936,887 - 106,940,905 reverse strand.
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1 kB
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Figure 6.3 - Schematic showing the positions of identified SNPs within boCXCR2  
Grey box represents coding exon (CDS = 1089bp), open boxes represent exonic non-coding 
untranslated regions (UTR). Coding portion of exon1 = ATG start codon only. A CXCR2 
protein domain architecture diagram (designed using http://smart.embl-heidelberg.de/) is 
illustrated below the CDS, showing the seven transmembrane domains (vertical blue bars). 
Red lines represent sequencing coverage (total = 1557bp). Sequence and alignment from 
Bos_taurus_UMD_3.1 Primary Assembly (AC_000159.1).  
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Figure 6.4 - Linkage disequilibrium (LD) plot for genotyped SNPs in relation to the 
boCXCR1 gene model 
Grey box represents boCXCR1 coding exon, open boxes represent non-coding UTR exonic 
regions. The six NS SNPs are underlined. The graphical representation, generated by 
Haploview, of the r
2
 LD relationship between each SNP is expressed on a grey-scale 
gradient; where black = perfect LD (r
2
 = 1.0) and white = very low LD (<0.1). The r
2
 value 
for each pair-wise comparison is shown, where no value is indicated r
2
 = 1. SNP positions 
highlighted as blue, green or red, to show patterns of perfect LD (r
2
 = 1) between matching 
colours, represent the three linkage groups. All 19 SNPs were defined as one haploblock.  
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Table 6.2 - Summary of tSNP markers for boCXCR1 linkage groups 
Linkage group tSNP marker Tagged SNPS  
1 -181T>C -181T>C 
  +980A>G 
  +995A>G 
  +1180G>A 
2 +735G>C -41A>C 
  +37A>T 
  +38T>A 
  +68G>A 
+735G>C 
  +819G>A 
  +1068G>A 
  +1089C>A 
  +1090A>C 
  +1093C>T 
  +1098C>T 
  +1282G>A 
3 +816C>A +816C>A 
  +1008C>T 
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Table 6.3 - Genotype and allele frequencies including significance from Hardy-
Weinberg equilibrium for boCXCR1 and boCXCR2 SNPs selected for trait association 
Bovine 
Gene 
 
SNP 
 
Genotype 
 
n = 
Genotype 
Frequency 
 
HWE 
 
Allele 
Allele 
Frequency  
CXCR1 -205C>T CC 74 0.53 2.09 C 0.71 
  CT 50 0.36  T 0.29 
  TT 15 0.11    
  Total 139     
 t-181T>C TT 8 0.04 0.02 T 0.21 
  TC 59 0.32  C 0.79 
  CC 115 0.64    
  Total 182     
 t+735G>C GG 50 0.27 0.66 G 0.51 
  GC 86 0.47  C 0.49 
  CC 47 0.26    
  Total 183     
 t+816C>A CC 93 0.51 0.01 C 0.71 
  CA 74 0.41  A 0.29 
  AA 15 0.08    
  Total 182     
CXCR2 -512T>C TT 8 0.06 2.7 T 0.19 
  TC 35 0.27  C 0.81 
  CC 86 0.67    
  Total 129     
 -496G>A GG 91 0.69 13.13* G 0.80 
  GA 29 0.22  A 0.20 
  AA 12 0.09    
  Total 132     
*Hardy-Weinberg equilibrium (HWE) significant at 1 degree of freedom (P>0.001).  
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6.2.4 Association of boCXCR1 and boCXCR2 SNPs with CM and milk production traits 
The four boCXCR1 SNPs, -205C>T, t-181T>C, t+735G>C and t+816C>A, and the two 
boCXCR2 SNPs, -512T>C and -496G>A, were analysed for association with CM and milk 
production traits during the first three lactations, as illustrated in Table 6.4. The six SNPs 
were further tested for association with CM per individual parity (P1, P2 and P3), as 
illustrated in Table 6.5. 
6.2.4.1. Association analysis of boCXCR1 SNP -205C>T 
Analysis of the singleton SNP -205C>T revealed the heterozygote CT genotype significantly 
associated (P<0.05) with an increased rate of CM (0.69 cases/cow/year) compared with the 
most abundant CC genotype (0.39 cases/cow/year), as illustrated in Table 6.4. A CM 
incidence of 0.41 cases/cow/year was detected in the rarer TT genotype. The proportion of 
animals within each genotyped population having any CM during their first three lactations 
was significantly greater in the CT genotype (68%) compared with CC and TT genotypes 
(both 47%).  
Analysis of CM incidence per individual parity revealed the higher CM rate genotype, 
CT, significantly associated with increased CM incidence for both second (P2) and third (P3) 
parities (P<0.05) when compared to the common homozygous CC genotype, as illustrated in 
Table 6.5. CM incidence between the three genotype populations was similar for the first 
parity (P1), with rates of 0.32, 0.27 and 0.26, cases/cow/year for CC, CT and TT cows 
respectively. However by P2, CT cows exhibited a significant increase in CM incidence, to 
0.52 cases/cow/year (P<0.05), when compared to their P1 data. By contrast only a slight 
increase in incidence for TT cows (0.38), and a moderate but non-significant decrease for CC 
cows (0.20) was detected. Significance was detected between genotypes for the proportion of 
animals within each population having any CM during P2; with the highest in the CT 
genotype (35%) compared with CC (16%) and TT (27%).  
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By P3, CT cows continued to demonstrate an increase in CM incidence, to 1.42 
cases/cow/year, in comparison to CT incidence data at P1 (P<0.001) and P2 (P<0.01) (Figure 
6.5). Over half of the genotyped CT population (56.5%) had at least one CM event during P3, 
however only near significance was detected (P<0.1) when compared to the CC and TT 
genotypes (37% and 29% respectively). CC cows also display a significant increase in CM 
incidence, to 0.80 cases/cow/year (Table 6.5), in comparison to CC incidence data from P1 
(P<0.05) and P2 (P<0.01). The rare TT genotype shows a steady increase in CM incidence at 
P3 (0.52 cases/cow/year) however this was not significant (Figure 6.5).  
Analysis of the production traits revealed that heterozygous CT animals, characterised 
by higher CM rates, associated significantly with lowered milk fat concentration (P<0.05) 
and highly significantly with increased milk yields (P<0.001) when compared to the CC 
genotype (Table 6.4). Lowered milk yield and fat percentage was shown in TT animals when 
compared with CC, but this was not significant. The CC genotype tended to associate with 
increased SCC when compared to TT cows (P<0.1). However, no significant differences 
were observed between all three genotypes despite the demonstrated association with CM 
incidence from heterozygotes. No significant differences between genotypes for milk protein 
concentrations were detected.  
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Table 6.4 – Association of boCXCR1 and boCXCR2 SNP genotypes with CM and milk production traits over the first three lactations 
 
  
SNP 
 
 
Gen. 
 
 
n = 
P %  
with  
CM
1
 
 
Mean  
CM rate
2
 
 
 
P =
3
 
 
Mean 
SCC
4
 
 
 
P =
3
 
 
Mean 305d  
milk yield
4
 
 
 
P =
3
 
 
Mean milk  
fat (%)
4
 
 
 
P =
3
 
 
Mean milk 
protein (%)
4
 
 
 
P =
3
 
BoCXCR1 CC 70 47 0.39 (±0.17)  2.97 (±0.71)  7961 (±1238)  4.14 (±0.46)  3.23 (±0.19)   
-205C>T CT 48 68* 0.69 (±0.20)* <0.05 2.74 (±0.85) - 8577 (±1220)** <0.01 3.93 (±0.38)* <0.05 3.18 (±0.10) - 
 TT 15 47 0.41 (±0.31) - 2.54 (±0.71) <0.1 7583 (±1292) - 3.93 (±0.32) - 3.22 (±0.16)  - 
 TT 8 50 0.37 (±0.37) - 2.53 (±0.69) - 8223 (±1130) - 3.92 (±0.59) - 3.16 (±0.13) - 
t-181T>C TC 59 56 0.62 (±0.22) - 3.01 (±0.78) <0.1 7983 (±1204) - 4.07 (±0.43) - 3.24 (±0.20) - 
 CC 115 57 0.54 (±0.13)  2.76 (±0.76)  8135 (±1299)  4.06 (±0.43)  3.21 (±0.17)  
 GG 50 60 0.54 (±0.16)  2.72 (±0.79)  8195 (±1319)  4.02 (±0.39)  3.24 (±0.18)   
t+735G>C GC 86 57 0.64 (±0.19) - 2.80 (±0.80) - 8091 (±1202) - 4.07 (±0.42) - 3.21 (±0.18) - 
 CC 47 47 0.57 (±0.28) - 2.98 (±0.69) - 7937 (±1275) - 4.08 (±0.51) - 3.21 (±0.19)  - 
 CC 93 60 0.54 (±0.12)  2.76 (±0.79)  8225 (±1207)  4.01 (±0.41)  3.23 (±0.19)  
t+816C>A CA 74 55 0.62 (±0.20) - 2.91 (±0.79) - 7858 (±1303) - 4.12 (±0.43) - 3.23 (±0.18) - 
 AA 15 40 0.41 (±0.35) - 2.87 (±0.54) - 8329 (±1261) - 4.06 (±0.40) - 3.14 (±0.16) - 
BoCXCR2 TT 8 75 0.65 (±0.80) - 2.94 (±1.06) - 8422 (±1295) - 4.07 (±0.45) - 3.23 (±0.20) - 
-512T>C TC 35 49 0.53 (±0.34) - 2.86 (±0.71) - 8222 (±1173) - 4.00 (±0.30) - 3.24 (±0.17) - 
 CC 86 60 0.72 (±0.15)  2.73 (±0.71)  8269 (±1183)  4.08 (±0.47)  3.21 (±0.19)  
 GG 91 60 0.62 (±0.21)  2.81 (±0.74)  8210 (±1149)  4.07 (±0.37)  3.23 (±0.17)  
-496G>A GA 29 55 0.74 (±0.50) - 2.77 (±0.65) - 8371 (±1139) - 4.06 (±0.43) - 3.20 (±0.21) - 
 AA 12 42 0.44 (±0.40) - 2.77 (±0.80) - 7950 (±1611) - 4.00 (±0.60) - 3.16 (±0.22) - 
Abbreviations: Gen. = genotype, P % = population percentage, CM = clinical mastitis, SCC = somatic cell count.
1
Column presence of * represents detection 
of significance between genotypes by Pearson Chi^2 odds ratio test (P<0.05), with positioning of * alongside the genotype contributing most to the Chi^2. 
2
Mean±95% confidence interval given in column parentheses. 
3
P values analysed by ANOVA and Tukey’s multiple comparisons, showing only results tested 
against the underlined (most abundant) homozygous genotype; – (dash) denotes no significance. 
1
5
5
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Table 6.5 - Association of boCXCR1 and boCXCR2 SNP genotypes with CM at first (P1) second (P2) and third (P3) parity 
 
 
SNP 
 
 
Gen. 
 
 
n = 
 
P1 P %  
with CM
1
 
 
P1 Mean  
CM rate
2
 
 
 
P =
3
 
 
P2 P %  
with CM
1
 
 
P2 Mean  
CM rate
2
 
 
 
P =
3
 
 
P3 P %  
with CM
1
 
 
P3 Mean  
CM rate
2
 
 
 
P =
3
 
BoCXCR1 CC 70 20 0.32 (±0.18)  16 0.20 (±0.12)  37 0.80 (±0.33)  
-205C>T CT 48 19 0.27 (±0.20) - 35* 0.52 (±0.22)* <0.05 56
┼
 1.42 (±0.51)* <0.05 
 TT 15 13 0.26 (±0.42) - 27 0.38 (±0.37) - 29 0.58 (±0.61) - 
 TT 8 12 0.18 (±0.43) - 12 0.10 (±0.23) - 43 1.08 (±1.51) - 
t-181T>C TC 59 22 0.38 (±0.21) - 24 0.61 (±0.43) - 44 1.09 (±0.45) - 
 CC 115 18 0.31 (±0.13)  30 0.42 (±0.14)  43 1.18 (±0.42)  
 GG 50 14 0.18 (±0.15)  39
┼
 0.54 (±0.22)  42 0.96 (±0.41)  
t+735G>C GC 86 20 0.34 (±0.16) - 25 0.43 (±0.23) - 49 1.45 (±0.55) - 
 CC 47 23 0.44 (±0.28) - 19 0.45 (±0.45) - 31 0.76 (±0.42) - 
 CC 93 18 0.26 (±0.13)  31 0.51 (±0.20)  44 1.06 (±0.32)  
t+816C>A CA 74 20 0.32 (±0.17) - 23 0.46 (±0.32) - 47 1.43 (±0.61) - 
 AA 15 33 0.71 (±0.70) - 20 0.26 (±0.29) - 14
┼
 0.28 (±0.45) - 
BoCXCR2 TT 8 50* 0.51 (±0.63) - 27 0.23 (±0.59) - 41 1.74 (±2.5) - 
-512T>C TC 35 11 0.35 (±0.38) - 24 0.41 (±0.43) - 32 0.82 (±0.51) - 
 CC 86 24 0.40 (±0.25)  17 0.58 (±0.31)  60 1.56 (±0.99)  
 GG 91 21 0.45 (±0.26)  24 0.33 (±0.16)  38 0.97 (±0.43)  
-496G>A GA 29 22 0.41 (±0.40) - 34 0.91 (±0.76) <0.1 43 0.87 (±0.68) - 
 AA 12 25 0.50 (±0.71) - 18 0.19 (±0.29) - 18 0.61 (±0.93) - 
Abbreviations: Gen. = genotype, P % = population percentage, CM = clinical mastitis, P1 = parity 1, P2 = parity 2, P3 = parity 3. 
1
Column presence of * 
represents detection of significance between genotypes by Pearson Chi^2 odds ratio test (P<0.05), with positioning of * alongside the genotype contributing 
most to the Chi^2. Column presence of 
┼
 represents detection of near significance between genotypes (P<0.1), with positioning of 
┼
 alongside the genotype 
contributing most to the Chi^2. 
2
Mean±95% confidence interval given in column parentheses. 
3
P values analysed by ANOVA and Tukey’s multiple 
comparisons, showing only results tested against the underlined (most abundant) homozygous genotype; – (dash) denotes no significance. 15
6
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Figure 6.5 - Mean incidence of clinical mastitis across three parities for cows grouped 
into the three boCXCR1 -205C>T SNP variant populations: CC, CT and TT 
Data from each variant population are presented as a bar, with the positive whiskers 
representing 95% confidence interval of the mean. Grey bars – CC animals (n = 70), hatched 
bars – CT animals (n = 48) and open bars – TT animals (n = 15). P1 = first parity, P2 = 
second parity, and P3 = third parity. 
a
 = tested against P1 data for same genotype. 
b
 = tested 
against P2 data for same genotype. 
c 
= tested between genotypes indicated below capped line. 
Genotypic means differ significantly at the following levels: *P<0.05, **P<0.01 
***P<0.001, by ANOVA and Tukey’s multiple comparisons. 
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6.2.4.2 Association analysis of boCXCR1 tSNP -181T>C 
Association analysis of the -181T>C tSNP with CM revealed no significant differences 
between genotypes over the first three lactations. The data trend showed the more frequent 
CC and TC animals to have higher CM incidence (0.54 and 0.62 cases/cow/year, 
respectively) when compared with the rarer TT population (0.37 cases/cow/year) (Table 6.4). 
The proportion of animals within each genotyped population having any CM during their first 
three lactations was marginally higher in the CC and TC genotypes (57% and 56% 
respectively) compared with TT genotypes (50%). 
Analysis for SNP association with CM per parity also revealed no significant 
differences between genotypes (Table 6.5). The CC population did show a significant 
increase in P3 incidence when compared with P1 and P2 (P<0.001), whereas the 
heterozygote TC population showed a significant increase in P3 incidence compared with P1 
(P<0.05) only (Figure 6.6).  
Analysis of production traits revealed the TC genotype tended to associate with 
increased SCC when compared to CC cows (P<0.1). No significant differences between 
genotypes for milk yield, fat and protein concentrations were detected (Table 6.4).  
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Figure 6.6 - Mean incidence of clinical mastitis across three parities for cows grouped 
into the three boCXCR1 -181T>C SNP variant populations: TT, TC and CC 
Data from each variant population are presented as a bar, with the positive whiskers 
representing 95% confidence interval of the mean. Grey bars – TT animals (n = 8), hatched 
bars – TC animals (n = 59) and open bars – CC animals (n = 115). P1 = first parity, P2 = 
second parity, and P3 = third parity. 
a
 = tested against P1 data for same genotype. 
b
 = tested 
against P2 data for same genotype. Genotypic means differ significantly at the following 
levels: *P<0.05, ***P<0.001, by ANOVA and Tukey’s multiple comparisons. 
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6.2.4.3 Association analysis of boCXCR1 tSNP +735G>C 
Association analysis of the NS boCXCR1 +735G>C tSNP demonstrated heterozygote GC 
animals had higher rates of CM (0.74 cases/cow/year, respectively) across three lactations 
when compared with GG and CC animals (0.54 and 0.57 cases/cow/year respectively), 
although these differences were not significant (Table 6.4). The proportion of animals within 
each genotyped population having any CM during their first three lactations was higher for 
the GG and GC genotypes (60% and 57% respectively) compared with the CC genotype 
(47%). 
Analysis of CM data per individual parity identified no significant differences for CM 
incidence between genotypes at P1, P2 and P3 (Table 6.5). The data trend showed the highest 
CM incidence for each genotype occurs at P3 compared with P1 and P2. For the GG 
population, CM incidence significantly increased from 0.18 cases/cow/year at P1, to 0.54 by 
P2 (P<0.05) and to 0.96 by P3 (P<0.001). The heterozygous GC animals display significantly 
increased CM incidence (P<0.001) of 1.45 cases/cow/year at P3 when compared with 
incidences at P1 and P2 (0.34 and 0.42 respectively). CC cows displayed a steady rise in 
incidence per parity; however no significance was detected (Figure 6.7). A higher percentage 
of animals having CM during P2 was demonstrated by the GG population (39%) when 
compared with GC and CC populations (25% and 19% respectively), with near significance 
(P<0.1) detected (Table 6.5). Analysis of the production traits revealed no significance 
between genotypes for milk yield, SCC, fat and protein concentrations (Table 6.4).  
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Figure 6.7 - Mean incidence of clinical mastitis across three parities for cows grouped 
into the three boCXCR1 +735G>C SNP variant populations: GG, GC and CC 
Data from each variant population are presented as a bar, with the positive whiskers 
representing 95% confidence interval of the mean. Grey bars – GG animals (n = 50), hatched 
bars – GC animals (n = 86) and open bars – CC animals (n = 47). P1 = first parity, P2 = 
second parity, and P3 = third parity. 
a
 = tested against P1 data for same genotype. 
b
 = tested 
against P2 data for same genotype. Genotypic means differ significantly at the following 
levels: *P<0.05, ***P<0.001, by ANOVA and Tukey’s multiple comparisons. 
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6.2.4.4 Association analysis of boCXCR1 tSNP +816C>A 
Association analysis of the +816C>A tSNP with CM revealed no significant differences 
between genotypes over the first three lactations. The data trend suggests heterozygous CA 
cows have a higher CM incidence (0.62 cases/cow/year), than CC and the rarer AA 
populations (0.54 cases and 0.41 cases respectively) (Table 6.4). The proportion of animals 
within each genotyped population having any CM during their first three lactations was 
higher for the CC and CA populations (60% and 55% respectively) compared with AA 
(40%). 
Analysis of CM data per individual parity revealed no significant differences between 
genotypes at P1, P2 and P3 (Table 6.5). The data trend demonstrates high CM incidence for 
genotypes CC and CA occurring at P3 compared with P1 and P2, whereas AA population 
incidence declines at P3 compared to P1 (Figure 6.8). CM incidence for CC cows 
significantly increases to 1.06 cases/cow/year at P3, compared with 0.26 at P1 (P<0.001); and 
0.51 at P2 (P<0.05). Heterozygous CA animals display significantly increased CM incidence 
of 1.45 cases/cow/year at P3, when compared with incidences of 0.34 and 0.42 at P1 and P2 
respectively (P<0.001) (Figure 6.8). Analysis of the production traits revealed no significance 
between genotypes for milk yield, SCC, fat and protein concentrations (Table 6.4). 
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Figure 6.8 - Mean incidence of clinical mastitis across three parities for cows grouped 
into the three boCXCR1 +816C>A SNP variant populations: CC, CA and AA  
Data from each variant population are presented as a bar, with the positive whiskers 
representing 95% confidence interval of the mean. Grey bars – CC animals (n = 93), hatched 
bars – CA animals (n = 74) and open bars – AA animals (n = 15). P1 = first parity, P2 = 
second parity, and P3 = third parity. 
a
 = tested against P1 data for same genotype. 
b
 = tested 
against P2 data for same genotype. Means differ significantly at the following levels: 
*P<0.05, ***P<0.001, by ANOVA and Tukey’s multiple comparisons. 
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6.2.4.5 Association analysis of boCXCR2 SNP -512T>C 
Association analysis of the boCXCR2 -512T>C SNP with CM revealed no significant 
differences between genotypes over the first three lactations. The data trend suggests the most 
abundant genotype population CC had higher rates of CM (0.72 cases/cow/year) across three 
lactations when compared with TC animals (0.53 cases/cow/year), and the rare TT population 
(0.65 cases/cow/year) (Table 6.4). The proportion of animals within each genotyped 
population having any CM during their first three lactations was highest for the rare TT 
genotype (75%), intermediate for the abundant CC genotype (60%) and lower for the 
heterozygous TC genotype (49%). 
Analysis of CM data per individual parity revealed no significant differences for CM 
incidence between genotypes at P1, P2 and P3 (Table 6.5). CM incidence is increased for 
each genotype at P3 compared with P1 and P2. For the CC population, CM incidence is 
significantly increased at P3 to 1.56 cases/cow/year when compared to a P1 incidence of 0.40 
(P<0.05) and a P2 incidence of 0.58 (P<0.05). The heterozygous TC animals display 
marginal increases of CM incidence per parity, whilst TT cows display a steady rise in 
incidence per parity, with large variation at P3; however, no significance was detected 
(Figure 6.9). Significant differences were detected between the proportion of animals within 
each genotyped population having any CM during P1 (P<0.05), with the TT population 
displaying a greater percentage having CM (50%) compared with the TC and abundant CC 
populations (11% and 24% respectively) (Table 6.5). Analysis of the production traits 
revealed no significance between genotypes for milk yield, SCC, fat and protein 
concentrations (Table 6.4). 
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Figure 6.9 - Mean incidence of clinical mastitis across three parities for cows grouped 
into the three boCXCR2 -512T>C SNP variant populations: TT, TC and CC 
Data from each variant population are presented as a bar, with the positive whiskers 
representing 95% confidence interval of the mean. Grey bars – TT animals (n = 8), hatched 
bars – TC animals (n = 35) and open bars – CC animals (n = 86). P1 = first parity, P2 = 
second parity, and P3 = third parity. 
a
 = tested against P1 data for same genotype. 
b
 = tested 
against P2 data for same genotype. *Means differ significantly (P<0.05) by ANOVA and 
Tukey’s multiple comparisons. 
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6.2.4.6 Association analysis of boCXCR2 SNP -496G>A 
Association analysis of the boCXCR2 -496G>A SNP with CM revealed no significant 
differences between genotypes over the first three lactations. The data trend demonstrates that 
the heterozygous genotype population GA have an increased rate of CM, 0.74 cases, 
/cow/year, when compared with the most abundant genotype population GG (0.62 cases) and 
the rare AA population (0.44 cases) (Table 6.4). The proportion of animals within each 
genotyped population having any CM over three lactations were similar for the abundant GG 
(60%) and GA (55%) genotypes; although both were higher when compared with the rare AA 
genotype population (42%). 
Analysis of CM data per individual parity revealed no significant differences for CM 
incidence between genotypes at P1, P2 and P3, however, at P2 the GA genotype tended to 
associate with increased CM when compared to GG cows (P<0.1) (Table 6.5). Trends 
suggest a decrease in CM incidence for GG and AA genotypes at P2 compared with P1; 
however, incidence increases and peaks at P3. For the GG population, P3 CM incidence 
significantly increased to 0.97 cases/cow/year when compared to a P1 incidence of 0.45 
(P<0.05) and a P2 incidence of 0.33 (P<0.01). The heterozygous GA animals display a large 
increase of CM incidence at P2 compared to P1 and a marginal decrease at P3 compared with 
P2 (Figure 6.10). Analysis of the production traits revealed no significant differences between 
genotypes for milk yield, SCC, fat and protein concentrations (Table 6.4). 
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Figure 6.10 - Mean incidence of clinical mastitis across three parities for cows grouped 
into the three boCXCR2 -496G>A SNP variant populations: GG, GA and AA 
Data from each variant population are presented as a bar, with the positive whiskers 
representing 95% confidence interval of the mean. Grey bars – GG animals (n = 91), hatched 
bars – GA animals (n = 29) and open bars – AA animals (n = 12). P1 = first parity, P2 = 
second parity, and P3 = third parity. 
a
 = tested against P1 data for same genotype. 
b
 = tested 
against P2 data for same genotype. Means differ significantly at the following levels: 
*P<0.05, **P<0.01, by ANOVA and Tukey’s multiple comparisons. 
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6.2.5 Multiple comparisons 
Correlation coefficient analysis was performed revealing a weak positive correlation between 
CM and SCC (Pearson coefficient = 0.198) and weak negative correlations between CM and 
milk fat and protein percentages (Pearson coefficient = -0.2 and -0.1 respectively). All 
significant associations between individual SNP genotypes and CM were found to survive 
adjustments for each factor using a GLM. 
 
6.2.6 BoCXCR1 haplotype analysis 
The four boCXCR1 SNPs, -205C>T, t-181T>C, t+735G>C and t+816C>A, were used for 
haplotype reconstruction to reveal four major haplotypes with their frequencies displayed in 
Table 6.6, along with the genotypes of all tagged boCXCR1 SNPs. The most abundant 
haplotype, carrying alleles CCCA, was designated Haplo1 and had a frequency of 0.3. 
Haplo2, carrying alleles TGCA, had a marginally lower frequency of 0.27, Haplo3, carrying 
alleles CTCC, had frequency 0.27, Haplo4, the rarer haplotype carrying alleles CCGC, had a 
frequency of 0.16. Owing to low genotyped numbers for each haplotype, association analysis 
was not performed. 
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Table 6.6 - BoCXCR1 haplotype frequencies in the Mayfield Holstein-Friesian herd 
 
BoCXCR1 SNP 
 
 
 
 
Haplotype -2
0
5
C
>
T
 
-1
8
1
T
>
C
 
-4
1
A
>
C
 
+
3
7
A
>
T
 
+
3
8
T
>
A
 
+
6
8
G
>
A
 
+
7
3
5
G
>
C
 
+
8
1
6
C
>
A
 
+
8
1
8
G
>
A
 
+
9
8
0
A
>
G
 
+
9
9
5
A
>
G
 
+
1
0
0
8
C
>
T
 
+
1
0
6
8
G
>
A
 
+
1
0
8
9
C
>
A
 
+
1
0
9
0
A
>
C
 
+
1
0
9
3
C
>
T
 
+
1
0
9
8
C
>
T
 
+
1
1
8
0
G
>
A
 
+
1
2
8
2
G
>
A
  
 
 
 
Frequency 
Haplo1 C C A A T G C A G G G T G C A C C A G 0.30 
Haplo2 T C C T A A G C A G G C A A C T T A A 0.27 
Haplo3 C T A A T G C C G A A C G C A C C G G 0.27 
Haplo4 C C C T A A G C A G G C A A C T T A A 0.16 
 
Prediction of phased haplotypes reconstructed using Haploview 4.2 (2008) (http://www.broadinstitute.org/haploview/haploview) (Barrett, Fry et al. 
2005). Underlined SNPs are tSNPs from genotypic associations. SNP positions are colour coded as blue, green or red, to represent the three 
linkage groups. 
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6.2.7 Q-PCR analysis of basal boCXCR1 and boCXCR2 mRNA abundance  
Milk somatic cells from cows with representative boCXCR1 and boCXCR2 genotypes were 
assessed for differences in basal boCXCR1 and boCXCR2 expression. All contributing 
animals were of similar age and stage of lactation and none had any known health issues and 
did not record any incidence of mastitis two weeks preceding/following the collection. Q-
PCR assays were performed using RNA from animals of each boCXCR1/2 SNP genotype.  
Analysis of boCXCR1 expression by representative SNP+735G>C genotypes revealed 
significant differences in expression levels. Cows with the CC genotype demonstrated 
reduced basal boCXCR1 mRNA expression (P<0.05) compared with either the GG or GC 
genotypes (n = 6). Due to close homology and the potential for co-expression, the abundance 
of boCXCR2 mRNA was also measured and revealed no significant differences (Figure 6.11).  
Q-PCR data, segregated by representative SNP-205C>T genotypes (n = 5), revealed 
significant differences in expression levels, with cows from the CC variant population having 
lowered (P<0.01) boCXCR1 mRNA expression compared with TC cows (Figure 6.12). The 
absence of data for the TT variant population is due to the low frequency of TT cows (0.11) 
within the herd. BoCXCR2 mRNA was also measured and revealed no significant differences 
or trends.  
Analysis of boCXCR2 mRNA levels between representative boCXCR2 SNP-496G>A 
genotypes (n = 6) indicates lowered boCXCR2 expression in the AA cow when compared 
with GG and GA animals; however, results were affected by the low frequency of the AA 
cows (Figure 6.13).  
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Figure 6.11 - Q-PCR data showing basal mRNA abundance levels of boCXCR1 and 
boCXCR2 in milk somatic cells grouped into the three boCXCR1 +735G>C SNP variant 
populations: GG, GC and CC 
Data from each variant population (n = 6) are presented as a box and whisker plot, with the 
ends of the whiskers representing the minimum and maximum data values. Grey box plot – 
GG animals, hatched box plot – GC animals, and open box plot – CC animals. *Genotypic 
means differ significantly (P<0.05 by ANOVA and Tukey’s multiple comparisons). 
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Figure 6.12 - Q-PCR data showing basal mRNA abundance levels of boCXCR1 and 
boCXCR2 in milk somatic cells grouped into the two boCXCR1 -205C>T SNP variant 
populations: CC and CT  
Data from each variant population (n = 5) are presented as a box and whisker plot, with the 
ends of the whiskers representing the minimum and maximum data values. Grey box plot – 
CC animals, hatched box plot – CT animals. **Genotypic means differ significantly 
(P<0.01) by unpaired t test. 
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Figure 6.13 - Q-PCR data showing basal mRNA abundance levels of boCXCR2 in milk 
somatic cells grouped into the three boCXCR2 SNP-496G>A variant populations: GG, 
GA and AA 
Each point represents data from one animal, with a horizontal line to indicate genotype mean.
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6.2.8 In silico analysis for putative transcription binding sites  
The AliBaba2.1 (TRANSFAC 4.0 sites) software programme was used to search for putative 
TBS located immediately upstream of the ATG start codon for both boCXCR1 and 
boCXCR2. The upstream SNPs identified in this region from each gene were then analysed 
for any potential impact on predicted TBS. 
The three upstream boCXCR1 SNPS, -205T>C, -181C>T and -41A>C, are 
surrounded by several putative TBS, including two binding sites for the transcription 
enhancing factor, Specificity Protein 1 (Sp1), and single matched sites for gene up-regulators 
GATA-binding factor-1 (GATA-1) and Activator Protein-1 (AP-1) (Figure 6.14A). 
Importantly, the boCXCR1 SNP-205T>C determines the presence (C allele) or absence (T 
allele) of one of the Sp1 binding sites. Further, the boCXCR1 -41A>C SNP, in complete LD 
with the tagging NS SNP +735G>C, repositions an AP-1 binding site (Figure 6.14B).  
The two upstream boCXCR2 SNPs, -512T>C and -496G>A, are surrounded by many 
putative TBS, including several binding sites for the Sp-1 protein (Figure 6.15). However, 
both published and alternate allele sequences suggest boCXCR2 SNPs -512T>C and -
496G>A have no obvious impact on the presence or absence of TBS. Due to both allele 
sequences having identical predictions of surrounding TBS, only the published allele 
sequence is shown (Figure 6.15).  
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A 
Bos_taurus_UMD_3.1 Primary Assembly Sequence 
 
 
 
B 
Alternate Allele Sequence 
 
 
Figure 6.14 - Location and impact of upstream boCXCR1 SNPs in relation to putative 
transcription binding sites for both published allele (A) and alternate allele (B) 
sequences 
The AliBaba 2.1 software programme was used for the prediction (75% match threshold) of 
transcription factor binding sites (TBS) in the boCXCR1 upstream region. Upstream 
nucleotide sequence shown in CAPS, purple text represents 5’UTR. ATG start codon shown 
by lower case. Numbering indicates nucleotide position from the start codon. SNP positions 
are highlighted in red, with SNP names above colour coded according to their LD group 
(Figure 6.3). Positions of putative TBS are aligned below the nucleotide sequence. TBS 
abbreviations: Sp1 = Specificity Protein 1, Elk-1 = E twenty-six (ETS)-like transcription 
factor-1, GATA-1 = GATA-binding factor-1, Erg-1 = ETS Related Gene-1, AP-1 = Activator 
Protein-1. 
 
                SNP-205C>T             SNP-181T>C 
     -215 ATTTAGGCCTCGGGGTTCTGGAAAGCTGACAACATGATGAAGCTGATCCTTAAAGCAGCC 
               ====Sp1=== 
    
     -155 TGTGACAGAGGTGAAGGAAGGGCTCTTCAGTTACCAAGCTAGCAGATAAGCACAAGATAA 
                ===Elk-1==                                              
                      ====Sp1=== 
                                                  ===GATA-1= 
                                                    ===Erg-1== 
                                                            SNP-41A>C 
      -95 CCTAGTAACAGTTATCACATCCTTGATGAGAGTGATTTGGATCTGAGTTACTAAATCACC 
                                                   ====AP-1==           
 
      -35 TTTCTTTCCTTCTAGTCTTTCAACCAGATCACACCatg... 
 
 
                SNP-205C>T             SNP-181T>C 
     -215 ATTTAGGCCTTGGGGTTCTGGAAAGCTGACAACACGATGAAGCTGATCCTTAAAGCAGCC 
                
    
     -155 TGTGACAGAGGTGAAGGAAGGGCTCTTCAGTTACCAAGCTAGCAGATAAGCACAAGATAA 
                ===Elk-1==                                              
                      ====Sp1=== 
                                                  ===GATA-1= 
                                                    ===Erg-1== 
                                                            SNP-41A>C 
      -95 CCTAGTAACAGTTATCACATCCTTGATGAGAGTGATTTGGATCTGAGTTACTAACTCACC 
                                                            ====AP-1==           
 
      -35 TTTCTTTCCTTCTAGTCTTTCAACCAGATCACACCatg... 
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Bos_taurus_UMD_3.1 Primary Assembly Sequence 
 
 
 
Figure 6.15 - Location of upstream boCXCR2 SNPs in relation to putative transcription 
binding sites for the published allele sequence 
The AliBaba 2.1 software programme was used for the prediction (75% match threshold) of 
transcription factor binding sites (TBS) in the boCXCR2 upstream region. Alternate SNP allele 
sequence had no impact upon the presence of further TBS (sequence not shown). Upstream 
nucleotide sequence shown in CAPS, purple text represents 5’UTR. ATG start codon shown by 
small caps. Numbering indicates position of the nucleotide from the start codon. SNP positions 
are highlighted in red with the SNP identification above. Positions of putative TBS are aligned 
below the nucleotide sequence. TBS abbreviations: PR = Progesterone Receptor, RAP1 = Ras-
related Protein 1, Sp1 = Specificity Protein 1, C/EBP = CCAAT-Enhancer-Binding Protein, 
USF = Upstream transcription Factor, NF-kappa = Nuclear Factor-kappa, TEC-1 = TEA/ATTS 
domain protein, NF-1 = Nuclear Factor 1, ICSBP = Interferon Consensus Sequence-Binding 
Protein, IRF-1 = Interferon Regulatory Factor-1, Pit-1a = POU class 1 homeobox-1, MIG1 = 
Regulatory protein MIG1, PU.1 = PU-box (purine-rich sequence).  
     
     -600 GTGGCGTGGAGAAGGAATTTATGAGGATTTAAGAACACCGGGGGTGTGTGGGGTGGAGAT 
                                      =====PR=== 
                                                 ====RAP1== 
                                                  ====Sp1=== 
                                                     ====RAP1== 
                                                          ====Sp1===                                     
                                 SNP-512T>C     SNP-496G>A 
     -540 GAGAGGCCAGGGAAGAAAACCACCAGATGTGCCAAAGGCTAACGCTCCATTTCTGGTGCC 
           ====Sp1=== 
 
     -480 TTCAAGAGCTGTTCCCTTTGAGATGGGAAAAAATGTTGAAGGGCCATAGAACTGCTGGGG 
                                =C/EBPalp=            
 
     -420 GGTAAGCACGGGAAGCCCGACACAACTGGAATGCAGGGAGAAACAGGCAGGGCAGCTGAA 
             ====USF=== 
                   =NF-kappa= 
                                    ====TEC1== 
                                    ====NF-1==           
 
     -360 AGAGCCCGGGGCTGCTGAGCTCAAGGCAAAGACGAGAAATCTGTGCCAAGCAGGGCCAAC 
              ====Sp1=== 
                                                 ====NF-1== 
                                  
     -300 TACTTCCTTTGGGTGGGCCTCAGTTTCTTCATCTGGGAAATGGAAAGATTGGCTAGGAAA 
                   ====Sp1=== 
                          ===ICSBP== 
                                              ===IRF-1==                                    
 
     -240 CCCCTTCCCAAAATGAACTCTGCCAGTTCATAAAAGGACGACTAGTTGTTAAAGAGCTGA 
          ====Sp1===                                                       
 
     -180 CCTGGGAATTAATTATTCAAACTATCAAAAGCATCCCGCACCCTCAGGGGCTCCACCCCA 
                       ===Pit-1a= 
                                            ====Sp1=== 
                                                          =====Sp1=== 
                                                                 ====M                                                            
 
     -120 GAATTGAGCAATATAATCCACCACTCACTTCCTCACTGTGTTCTCAGCACCGCCGCCCTT 
          IG1== 
                                 ====Sp1=== 
                                  ====PU.1==                                                        
 
      -60 TCTTCAGTCAGACACATCTGCCTTTCCTGGAGGTGTCCCACAGGTGACAAGCCCAGAATC       
       
        0 atg...  
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6.2.9 Evaluating the influence of existing NS SNP mutations within bovine CXCR1 
All NS boCXCR1 SNPs are illustrated in an amino acid model of boCXCR1 in Figure 6.16. 
The W206X mutation encoded by the boCXCR1 SNP +621G>A introduces a stop codon 
mutation. This SNP was not detected in this study although it is potentially linked to the 5’ 
intronic SNP -205C>T (Pighetti, Kojima et al. 2012), which has been associated with CM. 
Although a truncated protein would contain a DRYLAIV motif important for signalling (start 
of the second ICL), lack of a COOH terminus may severely impact function. Mutation 
Q245H = +735G>C SNP, linked with CM and impaired neutrophil signalling/migration in 
prior studies, belongs to a separate linkage group to SNP -205C>T. Q245H is in linkage with 
the three NH2 terminus mutations I13F, I13N, and E23G. COOH terminus mutations K327R 
and H332R are inherited as a pair belonging to another linkage group. Although no 
associations with CM were detected for these mutations, any functional consequence has yet 
to be evaluated. 
  
178 
 
 
 
Figure 6.16 - Schematic of an amino acid model for boCXCR1 
Blue circles represent conserved amino acid residues between cow and human, black circles 
represent non-conserved residues, open circles represent additional residues in cow, green 
circles represent cysteine residues important to structure, red circles highlight NS SNP 
mutation with amino acid change at AA position indicated. Mutation W206X = +621G>A 
SNP that introduces a stop codon mutation was not detected in this study. The DRYLAIV 
motif that is important for intracellular signalling can be observed at the start of the second 
ICL loop. 
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6.3 Discussion 
The importance of the chemokine receptors CXCR1 and CXCR2 as mediators of the 
inflammatory response has been highlighted in several disease studies linking SNP presence 
to susceptibility and severity. Analyses of boCXCR1 SNPs have already shown associations 
with impaired neutrophil migration and susceptibility to mastitis (Youngerman, Saxton et al. 
2004a; Rambeaud and Pighetti 2005; Rambeaud, Clift et al. 2006; Galvao, Pighetti et al. 
2011). However, these SNP associations lacked significance when studied in other herds 
(Goertz, Baes et al. 2009) underlining the need for further work to clarify their reliability as a 
marker for CM. The inconsistencies of sampling methods coupled with the use of differing 
phenotypic measures (CM and SCC data) may have contributed towards these discrepancies.  
In this study, both boCXCR1 and boCXCR2 were analysed for SNPs at their 5’ and 3’ 
ends, allowing assessment of non-exonic SNPs and exonic UTR and CDS SNPs as markers 
for mastitis using actual recorded CM and potential impact on production data. BoCXCR1, 
encoding the less promiscuous receptor, was found to be more polymorphic than boCXCR2, 
with nineteen reported SNPs compared to two respectively. BoCXCR1 has previously been 
reported as a highly polymorphic gene (Pighetti, Kojima et al. 2012), possibly due to a high 
degree of evolutionary pressure from the environment and pathogens; CXCR1 is evolving 
rapidly in the human system due to Darwinian positive selection (Liu, Yang et al. 2005). A 
high degree of linkage was observed within the herd between boCXCR1 SNPs, defined into a 
single haploblock. LD patterning revealed three distinct boCXCR1 linkage groups; group 1 
contained four SNPs and was represented by the tSNP -181T>C, group 2 contained twelve 
SNPs and was represented by the well documented NS tSNP +735G>C, and group 3 
contained two SNPs and was represented by the tSNP +816C>A. No linkage was observed 
between any of the boCXCR1 and boCXCR2 SNPs. The three boCXCR1 tSNPs, a remaining 
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singleton boCXCR1 SNP -205C>T, and the two boCXCR2 SNPs were each used for 
association analysis.  
The singleton boCXCR1 SNP -205C>T was found to be the only marker to associate 
significantly with CM susceptibility, and to the author's knowledge this is the first study to 
report this. Rates of CM for CC genotyped cows were significantly lower than heterozygous 
CT cows over the first three lactations. Analysis of the individual parities revealed rates of 
CM for CC cows were significantly lowered for the second and third lactations. This is 
important as overall CM incidence usually rises per successive parity, as observed for all 
SNP genotypes. In addition, the percentage of the CC genotyped population having any CM 
within the first three lactations was significantly lower (47%) than the CT genotyped 
population (68%). Recurrence rates for CT and CC populations are similar (~23% of CM 
cases requiring repeated treatment), demonstrating little difference in chronic mastitis rates 
between both genotypes. This pattern therefore suggests that CT population incidence is 
impacted more highly by environmental causes of acute mammary infection; further evidence 
comes from a preliminary observation revealing a larger ratio of E. coli cases reported in the 
CT population.  
Dairy cows are subjected to intense selection pressures for higher milk yields and 
reduced SCC that may unintentionally increase CM incidence (Suriyasathaporn, Schukken et 
al. 2000). CT cows strongly associated with increased milk yields, and high CM may be a 
consequence of this. CT cows further associated with lowered milk fat percentages, 
suggesting breeding for this marker may impact milk quality and production. Although no 
significance was detected between genotypes for SCC, the trend shows this trait is increased 
in CC cows despite a lowered incidence of CM. This finding continues to demonstrate the 
dichotomy that the surrogate measure of mastitis is also the presence of the effector cell 
which can at times eliminate infection in the absence of overt clinical signs.  Due to their low 
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herd frequency (11%), it is difficult to ascertain a confident CM and production trend for TT 
cows from a limited sample population (n =15).  
In addition to the reporting of boCXCR1 SNP -205C>T associations with CM 
susceptibility, this study may be the first to report a functional consequence. In this study 
animals segregated by -205C>T SNP genotypes exhibited significantly lower basal boCXCR1 
mRNA levels in milk somatic cells from CC animals when compared with CT (P<0.05). The 
absence of TT cow data may strengthen or weaken this difference, which appeared to be 
specific for boCXCR1 as it was not seen for boCXCR2,  indicating potential SNP interference 
with boCXCR1 transcription. Preliminary in silico analysis for causal mutations using the 
TRANSFAC 4.0 programme AliBaba2.1 (www.gene-regulation.com/pub/programs.htmL) 
highlighted the -205C>T SNP as part of a Sp1 motif, where a C allele confers presence. Sp1 
sites within a 300bp region immediately 5’ to CXCR1 start codons appear to be conserved 
across several species. Further in silico analysis matched Sp1 motifs within similar regions 
from pig, dog, mouse and human, with the latter matching a Sp1 site -208bp from the ATG 
start site, almost identical to the aforementioned bovine -205C>T SNP affected site. 
 Sp1 sites regulate transcription by either repressing or boosting transcript production. 
SNPs adjacent to a repressive Sp1 site in the human system affect IL-10 promoter function by 
impacting Sp1 interactions with additional regulatory proteins (Steinke, Barekzi et al. 2004), 
enhancing transcription (Larsson, Johansson et al. 2009).  Presence of the T allele (-205C>T 
SNP) may relieve the repressive role of Sp1, increasing boCXCR1 expression as observed in 
T allele-carrying CT cows. Impairment of CXCR1 expression and activity suppresses the 
immune response. This has been demonstrated in humans where reduced expression of 
CXCR1 causes larger aggregates of cells adhering to vessel membranes, impeding migration 
efficiency (Hu, Westra et al. 2011). By contrast, over-expression of CXCR1 has also been 
linked to disease severity, for example in human glomerular diseases (Segerer, Henger et al. 
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2006). In terms of the impact of the -205C>T SNP on disease, data in this study showed CC 
cows with reduced mRNA levels have less CM. Whether CC cows have decreased CXCR1 
protein expression requires verification. Although speculative, excessive CXCR1 due to 
impaired Sp1 regulation may contribute towards an excessive or aggravated mammary 
response to pathogen, leading to more inflammatory tissue damage to the udder and increased 
susceptibility to CM.  
Whilst this poses an attractive hypothesis, further work is required to elucidate any 
causative impact of SNP -205C>T. It may also be possible that additional SNPs in linkage 
with -205C>T have a contributing role. Evidence of this  may come from a very recent study 
characterising boCXCR1 SNPs (Pighetti, Kojima et al. 2012). The authors report the 
introduction of an early stop codon at the expense of a tryptophan residue at amino acid 206 
(T206X mutation) with the presence of the A allele of the SNP +621G>A. The T206X 
mutation is located within the protein’s second extracellular loop (Figure 6.16). SNP 
+621G>A is reported to be in complete LD with the singleton marker -205C>T, providing an 
additional fourth linkage group to the three shown in this study (Pighetti, Kojima et al. 2012). 
The +621G>A SNP was not detected in this study due to incomplete sequencing coverage of 
the boCXCR1 CDS, therefore both its presence and inheritance with the T allele (-205C>T) 
requires verification. Whether a shortened CXCR1 protein can effectively signal through its 
second ICL (containing the DRYLAIV motif), or whether expression is simply non-
functional remains to be determined. The measure of downstream boCXCR1 signalling 
events, such as activation of MAPK, Gα and Gβγ subunits, phospholipase C-β or calcium 
mobilisation (Figure 6.1), could indicate whether a truncated boCXCR1 variant can signal. 
Lack of a COOH terminus will ultimately impede receptor internalisation (desensitisation), 
resulting in repeated receptor exposure to ligand. This may lead to the breakdown of potential 
feedback loops and up-regulation of CXCR1 to compensate, resulting in increased mRNA 
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levels of boCXCR1. Impaired CXCR1 protein expression and function due to the inheritance 
of a stop codon may therefore underlie the increased mRNA levels of boCXCR1 and higher 
CM rates associated with the T allele carrying CT cows (-205C>T). These preliminary 
findings present an immunological mechanism for the differences identified in CM rates, and 
further present boCXCR1 as a suitable marker for susceptibility to other diseases.  
The boCXCR1 SNP +735G>C, identified in this study, and employed as a tSNP for 
boCXCR1 linkage group 2, has been previously demonstrated to impact neutrophil function 
and has been analysed for association with intestinal, respiratory, uterine and mammary 
health. The CC genotype displayed reduced migration of neutrophils responding to ligand in 
vitro (Rambeaud and Pighetti 2005). Taqman data from this study shows lowered basal 
mRNA levels in milk somatic cells from CC cows, potentially complementing the above 
evidence. However, this study did not identify any significant associations between SNP 
+735G>C and traits for CM incidence or milk production. Previous studies (Youngerman, 
Saxton et al. 2004a; Galvao, Pighetti et al. 2011) have associated CC genotyped cows with 
lowered CM when compared with GC and GG genotyped animals. In this study, the 
incidence between CC and GG genotypes was similar. However, the CC population do 
display a lower percentage of animals experiencing at least one CM event across the three 
lactations, with near significance detected at P2, when compared with the GG population. 
Furthermore, CC cows were the only genotype to show no significant increases in CM rate 
from P1 through to P3. Data from lactations post P3 may strengthen any potential trend of 
lowered CM in CC cows. Galvao et al (2011) failed to specify exact lactation details for each 
genotyped (+735G>C) population, only that they contain a mixture of primiparous and 
multiparous animals. Furthermore, their study measured population incidence as number of 
cases per 10,000 days at risk, whereas this study measured the population mean for individual 
incidence as number of cases per year (365days) at risk, over the first three lactations. 
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The influence of SNP -205T>C may contribute to associations of +735G>C with CM. 
In this study, LD between the markers -205T>C and +735G>C was moderate (0.5), but may 
be sufficient to influence any CM associations with the +735G>C SNP in other herds. 
Reconstruction of boCXCR1 haplotypes using linkage groups in this study and the work of 
Pighetti et al (2012) show the T allele of -205T>C SNP (potentially linked with an early stop 
codon) to be present in haplotypes containing the G allele of +735G>C. Both the T allele of -
205T>C SNP and the G allele of +735G>C have been associated with increased boCXCR1 
mRNA levels in this study. Further work will be required to substantiate the influence of the -
205T>C SNP, and comprehensive sequencing of boCXCR1 and boCXCR2 may identify other 
causative candidates. The additive effect from additional boCXCR1 SNPs and SNPs from 
other linked genes should also be considered. For example, the bovine gene encoding the 
ligand CXCL8 is highly polymorphic, with promoter and coding SNPs impacting relative 
mRNA levels and transcriptional responsiveness to ligand stimulation (Chen, Yang et al. 
2011a; Meade, O'Gorman et al. 2012). BoCXCL8 SNPs are further strongly associated with 
milk yield, protein and SCC within a large Chinese Holstein (n =610) cohort (Chen, Yang et 
al. 2011). BoCXCL8 variation may therefore influence boCXCR1 genotype associations.  
No significant differences between +735G>C genotypes for SCC were detected 
within the herd, agreeing with previous findings (Leyva-Baca, Schenkel et al. 2008; Goertz, 
Baes et al. 2009; Beecher, Daly et al. 2010; Galvao, Pighetti et al. 2011). Whilst increased 
milk yield from GG cows had been observed (Youngerman, Saxton et al. 2004a; Galvao, 
Pighetti et al. 2011), no significant differences in milking yield between +735G>C genotypes 
were detected within this herd. The continued discrepancy between findings for SNP 
+735G>C from this and previous studies may reflect breed and herd variation, sampling 
method and pathogen-specific causes of disease. Although not detected, the boCXCR1 SNP -
1768T>A, identified and associated with SCC in previous studies (Leyva-Baca, Schenkel et 
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al. 2008; Chen, Yang et al. 2011), was still represented due to its linkage with SNP +980A>G 
(Pighetti, Kojima et al. 2012), a mutation represented by tSNP -181T>C in linkage group 1 
for this study. Data from this study indicated no association between SNP -1768T>A (t-
181T>C) and CM, or SCC, as demonstrated by Goertz et al (2009). The two boCXCR2 5’ 
upstream SNPs identified in this study did not associate with CM or milk production traits, 
and did not appear to impact any putative TBS. Whilst data potentially revealed lowered 
boCXCR2 expression in AA cows segregated by their -496G>A genotype, this is speculative 
since only one AA individual was analysed.  
In conclusion, the findings presented here demonstrate an association between the 
boCXCR1 SNP -205C>T and CM susceptibility. Furthermore, evidence suggests that this 
SNP may contribute towards functional variation by influencing Sp1-regulated transcription. 
In addition, this marker may be inherited with the introduction of a stop codon determined by 
the boCXCR1 SNP +621G>A, a marker shown to be in linkage with -205C>T in a separate 
study. Any causative impact from SNPs -205C>T and +621G>A on transcription and 
receptor expression/activity warrants further investigation, along with the additive impact of 
the +735G>C SNP that has been associated with impaired neutrophil migration. Figure 6.16 
illustrates the location and impact of mutations within the CXCR1 structure. Rapid but 
controlled influx of neutrophils into the mammary gland to kill organisms often determines 
the outcome of bacterial infection. However, data from this and other studies show positive 
correlation between CM, boCXCR1 levels and neutrophil migration rate, suggesting increased 
protein expression may influence excessive inflammation, greater risk of permanent tissue 
damage and increased susceptibility to infection. Taken together, boCXCR1 SNPs -205C>T 
(+621G>A) and +735G>C can be used in a tagging SNP haplotype approach to identify cattle 
more susceptible to CM, similar to a human study analysing CXCR1/2 genetic variation and 
influence in Cystic Fibrosis (Kormann, Hector et al. 2011).  
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The favourable boCXCR1 SNP -205 CC variant could reduce detrimental clinical 
manifestations of diseases via an efficient yet controlled influx of inflammatory cells to 
neutralise pathogens and control infection, particularly during  E. coli mastitis whereby 
rapidly multiplying bacteria demand neutrophil control. The complexity of mastitis infection 
suggests a polygenic and multi-factorial immune response comprising many different 
proteins which will in turn interact with one another. The ability to detect significant 
associations with CM for a single gene indicates the importance of the CXCR1-related 
response in the control of bacterial disease in cattle. A bovine population with impaired 
boCXCR1 expression may also be more susceptible to other diseases and health issues. The 
potential use of SNPs within boCXCR1 to act as genetic markers for altered susceptibility to 
mastitis warrants further investigation. However, the non-favourable linkage of lowered CM 
with decreased milk yield and fat concentrations demonstrated here indicates selection for 
lowered CM using this marker would be detrimental to milk quality, as previously suggested 
in studies linking SNPs with increased SCC as a marker for CM susceptibility. 
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Chapter 7.0 - General Discussion and 
Conclusions  
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7.1 Discussion  
Bovine mastitis is recognised worldwide as the most important and costly disease affecting 
dairy cattle. Widespread measures to improve hygiene and disease control have had little 
impact on UK mastitis rates over the past 20 years. The latest UK figures suggest CM 
incidence is on the rise, and a contributing factor could be the consequence of socioeconomic 
pressure on UK dairy producers to maximise profitability from animal performance. Many 
herds demonstrate limited genetic diversity on the basis of promoting favourable production 
traits that may unintentionally be detrimental to animal health. Holstein-Friesians are the 
commercially favoured crossbreed; however, a predominance of Holstein genetics in artificial 
insemination (AI) breeding programmes has led to the overuse of sires from a limited sample 
population, and may be contributing to increased inbreeding and the risks associated with it 
(Kearney, Wall et al. 2004). Comprehensive genome sequencing of a particular Holstein bull 
and leading dairy sire revealed a total of 3.7 million SNP mutations when referenced against 
the Hereford sequence, including >11k NS SNPs and many early stop codons which may 
have phenotypic effects (Stothard, Choi et al. 2011). The introduction and spread of traits 
have resulted in decreased fertility, reproduction, health and longevity, traits not sustainable 
genetically or financially in any dairy breeding strategy. It is therefore important to balance 
herd genetics so that both health and performance may be improved. This could involve the 
expanded use of crossbreeding, although increased heterozygosity can promote genetic 
recombination that, via changes in the genetic effects of dominance and epistasis, could 
impact these health and production traits. Balancing outbreeding with the monitoring of 
disease-associated markers within a herd will be of great benefit to dairy producers, and 
could be a viable option with suitable SNP chip technologies. These represent a fast and cost 
effective approach to genotyping many (>60k) SNP markers, including some of known 
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disease importance, in cattle, providing a robust platform for mapping disease genes and 
QTLs (Matukumalli, Lawley et al. 2009).  
The identification of SNPs linked to dysfunction of proteins vital for the initiation, 
regulation and progression of an immune response may provide suitable genetic risk factors 
for CM, and aid bovine SNP chip development. By selecting animals with favourable 
mutations, herd mastitis rates could be reduced. In addition to the considerable economic 
costs of mastitis, there is an ethical precedence for a reduction in antibiotic usage and the 
improvement of animal welfare. Another concern is the widespread use of waste milk from 
mastitis cows as cost effective feed for calves on UK farms (Brunton, Duncan et al. 2012). 
Waste milk containing antimicrobial products is a biosecurity risk to the calf and may 
promote the development of antibiotic resistance. Lowering the overall use and reliance on 
antibiotics to control mastitis will reduce treatment costs and limit any potential for the 
selection of antibiotic resistance in strains of bacteria important for mastitis. 
By correlating to actual CM data, the research reported in this thesis has identified 
SNPs within key immune genes that associate with reduced CM susceptibility without 
compromising milk yield or quality, and this may improve accuracy of breeding for these 
favourable phenotypes. 
7.1.1 Polymorphisms common to boTLR1 and boCXCR1 could be used for marker-assisted 
selection of cattle less susceptible to mastitis and other diseases 
This is the first report that the boTLR1 tSNP -79T>G, boTLR1 3’UTR SNP +2463C>T, and 
the boCXCR1 SNP -205C>T were each found to associate significantly with CM 
susceptibility. The differences in CM incidence observed between the defined genotypes 
would have a significant impact on both animal welfare and farm profitability. For example, 
boTLR1 -79 TT animals recorded, on average, 40 CM cases/100 cows/year, below the 
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historic national average for England and Wales of 47 cases (Bradley, Leach et al. 2007). 
However, GG and TG animals recorded 75 and 73 cases respectively, substantially more than 
the national average. As a simple demonstration of potential impact, if estimated average 
costs for a clinical case are £175 (Kossaibati 2000), potential losses per 100 cows equate to 
£6,125 and £5,775 for TG and GG animals respectively (when compared to TT animals). 
Likewise animals with the boCXCR1 SNP -205 CC genotype recorded on average 39 CM 
cases/100 cows/year while animals within the CT genotype had 70 cases, equating to 
potential losses per 100 cows of £5,425 for the CT animals (Table 7.1). The estimation of 
average case costs for CM is composed of direct costs, which include antimicrobials, farm-
associated time and discarded milk, and indirect costs, which include those associated with 
reduced yield, increased culling and any fatality due to mastitis (Kossaibati 2000). A more 
recent study reviewing US dairy production calculated average losses per case of CM at 
$179, of which $115 (64%) was due to milk yield losses, $50 (28%) to treatment-associated 
costs and $14 (8%) to increased mortality (Bar, Tauer et al. 2008). Milk losses are therefore a 
major contributory factor to mastitis costs and, as a consequence, estimated CM cost figures 
will depend and vary on the current wholesale price of milk. 
   
Table 7.1 - Comparison of economic losses between genotype populations of CM 
associated SNP markers  
CM Marker Genotype 
CM Incidence 
(CM/100 cows/year) Cost (£) Losses (£) 
BoTLR1 t -79T>G TT* 40 7,000  - 
 
TG 73 12,775 5,775 
 
GG 75 13,125 6,125 
BoTLR1 +2463C>T CC 73 12,775 6,475 
 
CT 74 12,950 6,650 
 
TT* 36 6,300 - 
BoCXCR1 -205C>T CC* 39 6,825  - 
 
CT 70 12,250 5,425 
*Lower CM genotype.  
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The favourable association of reduced CM with increased milk fat and protein, a 
financially rewarded premium, was observed for both boTLR1 SNPs, indicating selection for 
these markers would be beneficial to milk quality. Selection for lowered CM using the 
boCXCR1 SNP -205C>T may also increase milk fat; it remains unclear whether a biological 
link between reduced CM and increased milk fat exists. Reduced milk fat compositions have 
been observed previously in mastitic milk when compared to ‘healthy’ milk (Randolph and 
Erwin 1974). Reduced fat content is therefore more likely a consequence, as opposed to a 
contributory factor, of IMI. Whilst boTLR1 SNPs had no impact on milk yields, analysis of 
the boCXCR1 SNP -205C>T revealed significantly increased milk yields from CT variants 
that associated with CM susceptibility. These findings potentially demonstrate the concerns 
that selecting for optimal milk production can lead to the introduction of mutations in other 
genes detrimental to animal health. Whilst increased milk production from animals with the 
boCXCR1 SNP -205 CT offsets any associated milk losses from increased CM in the 
Mayfield herd, there remains the unfavourable concern of reduced animal welfare and 
increased antibiotic usage. 
All significant CM genotype associations survived adjustments for other milking 
factors (mean logged SCC, milk yield, fat and protein percentages) using a GLM. In a 
separate analysis, the year of CM data recording was shown to not significantly impact yearly 
incidence between variant populations, with genotype CM trends fluctuating with herd 
average trends (Appendixes II and III). 
7.1.2 DNA pools proved successful for initial screening for disease-associated SNPs 
Sequencing of PCR amplicons from a DNA pool comprising Holstein-Friesians with high 
(greater than six lifetime CM cases) or no mastitis case histories revealed 46 SNPs, nine of 
which are novel, within candidate genes boTLR1, boTLR4, boTLR5, boCD14, boCXCR1 and 
boCXCR2. Although this pooling method may miss rare SNPs, and did not identify SNPs 
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within boTLR2 and boTLR6 UTR regions, it proved effective for the rapid detection of three 
CM-associated SNPs common to the Mayfield herd. Extended genotyping of individuals did 
not uncover any additional SNPs indicating a high level of sensitivity in the DNA pooling 
approach. Despite no CM or milk production associations for any of the selected SNP 
markers within boTLR4, boTLR5 boCD14 and boCXCR2, this was a small study and these 
findings would benefit from larger sample populations. Comprehensive analyses of all genes 
in this project may identify other SNPs of interest with regards to disease susceptibility. Due 
to the importance of boTLR4 for the detection of mastitis-causing pathogens, boTLR4 
remains a candidate for additional association studies with CM susceptibility in other 
herds/breeds. Furthermore, the expanded analysis of boTLR1 and boCXCR1 CM-associated 
SNPs from this project into other herds/breeds is highly recommended. These SNPs may, for 
example, exhibit a more deleterious effect within a single herd under the influence of 
inbreeding. Whilst studying one herd can limit variability in CM recordings, reliability and 
accuracy of CM incidence data from the Mayfield herd, and other herds when expanding 
SNP analysis, is crucial for the precise identification and verification of disease-associated 
SNPs in cattle populations.  
 
7.1.3 SNPs found to associate with CM may contribute towards an underlying immunological 
mechanism for disease susceptibility 
This is the first report that the boTLR1 and boCXCR1 SNPs found to associate with CM 
further demonstrate potential consequences at the gene/protein level, and therefore possibly 
underlie an immunological mechanism for disease susceptibility. Both genes display a large 
degree of polymorphism and high pattern of LD that could influence variation in immune 
responses between the genotype populations and subsequently influence the outcome of 
infection. Published research documenting mutations in boCXCR1, a receptor critical to the 
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recruitment of neutrophils, have demonstrated association with disease, impair cell migration 
and impact on immune responses (Youngerman, Saxton et al. 2004a; Rambeaud and Pighetti 
2005; Rambeaud, Clift et al. 2006; Galvao, Pighetti et al. 2011). Evidence presented in this 
thesis (Chapter 6.0) proposes that the boCXCR1 SNP -205C>T may contribute towards 
functional variation by influencing Sp1-regulated transcription. Animals with the CC 
genotype, associated with lowered CM, had significantly lower boCXCR1 expression in milk 
somatic cells when compared with CT animals. In addition this marker may be inherited with 
the introduction of a stop codon determined by the boCXCR1 SNP +621G>A, shown to be in 
linkage with -205C>T in a separate study (Pighetti, Kojima et al. 2012). Cows with the -205 
T allele may express a truncated and dysfunctional boCXCR1 protein with severe 
implications for health, particularly during transient E. coli infections where an efficient 
neutrophil defence is vital to prevent progression of infection and toxic death. A population 
of animals expressing a truncated boCXCR1 protein may therefore demonstrate reduced 
longevity and sustainability, potentially supported by the rare frequency of -205 homozygous 
TT cows in the Mayfield herd, which may have resulted from premature culling due to 
mastitis and other diseases.  
SNPs common to boTLR1 may underpin functional variation in boTLR1, an important 
cell membrane PRR for the detection of bacterial PAMPs, specifically triacylated 
lipoproteins. This is the first report that boTLR1 SNPs that were significantly associated with 
CM demonstrate impaired boTLR1 expression, possibly via interference of Oct-1 binding 
(Chapter 3.0), and subsequent dampening in cytokine responses from bovine whole blood and 
enriched cell populations when exposed to PAM3 or HK bacteria (Chapter 4.0). An 
appropriate immune response, conferred by the favourable boTLR1 tSNP -79 TT variant, 
could reduce clinical manifestations of disease via an efficient and regulated influx of 
inflammatory cells to neutralise pathogens and control infection. These findings further 
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emphasise the importance of boTLR1-related responses in the control of bacterial disease in 
cattle, with particular implications for S. aureus mastitis. Functional data (Chapter 4.0) 
indicate that animals of a -79 GG genotype may be more susceptible to S. aureus infection. 
However, preliminary analysis of Mayfield herd data revealed little difference between the 
variant populations in the percentage of CM cases caused by S. aureus. This may in part be 
due to the lack of comprehensive data on the causative agent of each CM case, as only ~32% 
of Mayfield CM cases resulted in the successful isolation of a pathogen. A separate study 
observed an increase in the frequency of S. aureus isolation from older cows that were into 
their fourth, fifth and sixth parities (De Vliegher, Fox et al. 2012). Analysis of cow data post 
parity three, coupled with comprehensive pathogen data for each CM and subclinical case, 
may strengthen associations between boTLR1 SNP -79 GG variants with susceptibility to 
mastitis caused by S. aureus.  
A bovine population with impaired boTLR1 and boCXCR1 transcript expression and 
protein function may also be more susceptible to other diseases such as bovine TB (Sun, 
Song et al. 2012). This warrants further investigation to determine the suitability of the SNPs 
identified in this thesis as genetic markers of disease. These could then be incorporated into 
bovine SNP chips with the potential to screen currently used and unproven sires that are 
selected for AI programmes, to improve herd fitness and disease resistance in cattle. As a 
multifactoral condition, CM may be influenced by the collective influence of many causal 
SNPs in different genes, which on their own may contribute to a low percentage of cases in 
other herds. In the Mayfield herd, boTLR1 and boCXCR1 SNPs appear to significantly 
influence the immune response and incidence of CM. 
7.1.4 Mean log SCC as a proxy for CM 
Where possible the careful use of accurate CM data, as demonstrated in this thesis, may allow 
the identification of significant disease associations. In most countries selection of a reduced 
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mean lactation SCC (often logged) is used as a surrogate for CM. However, its reliability as a 
marker for disease continues to be questioned. A weak positive correlation of 0.03 was 
initially detected between CM incidence and SCC for Mayfield herd data recorded during the 
years 2001-2010 (Chapter 2.0). Analysis of suitably adjusted datasets (logged SCC and 
adjusted CM incidence) from SNP association analysis did strengthen this to a positive 
correlation of 0.2 (Table 7.2). However, no associations were detected for a raised SCC in 
variants associated with CM at a herd level. The use of individual cow means for log SCC 
may not be the most appropriate disease indicator since it is the measure of all four quarters, 
which will dilute a raised SCC from an infected quarter. Alternative and potentially more 
accurate SCC approaches for determining and monitoring disease status may include the use 
of quarter SCC data or the proportion of high SCC (>200,000 cells/mL milk) events per 
lactation (Bradley and Green 2005). A significant negative correlation (-0.2) was detected 
between CM incidence and milk fat percentage (Table 7.2) following SNP association 
analysis, with all genotypes associating with CM demonstrating significantly reduced  milk 
fat content at the herd level. Additional study re-evaluating the potential use of milk fat 
compositions as an indirect measure of infection status could be considered (Randolph and 
Erwin 1974; Kitchen 1981).   
 
Table 7.2 - Correlation coefficients between CM and production traits for adjusted cow 
data used for SNP association analyses 
 
CM SCC 
Milk 
yield Protein% Fat% 
 CM 
RATE   0.003 0.331 0.126 0.003 
SCC 0.198 
 
0.108 0.168 0.901 
 Milk yield -0.066 -0.109 
 
0 0.004 
 Protein% -0.1 0.094 -0.3 
 
0 
 fat% -0.2 0.008 -0.2 0.6   
 
       P values in bold.  
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7.1.5 Improving heritability and accuracy of CM markers 
Widespread availability of reliable herd CM data is essential for accurate analyses and 
interpretation of SNP data and subsequent associations. Furthermore, knowing the causative 
pathogen for each mastitis case may promote identification of pathogen-specific disease 
markers; boTLR4/boCD14 SNPs are likely to associate with E. coli mastitis for example. The 
current disadvantage of using CM resistance as a breeding trait is its low heritability (Rupp 
and Boichard 1999), in part due to the variability of causative agents and subsequent immune 
responses during disease. Categorising CM QTLs by a predominant causative pathogen may 
improve accuracy for selective breeding for such traits. This could also address an additional 
problem with CM QTLs, in that they cover large regions of chromosome with wide 
confidence intervals, within which many candidate genes are located. Disease-associated 
SNPs from this research are within boTLR1 and boCXCR1, genes already mapped and 
highlighted as strong candidates for underlying QTL regions (Bta 6 and 2 respectively) for 
resistance to diseases such as mastitis (Jann, King et al. 2009; Sodeland, Kent et al. 2011). 
Where boTLR1 markers may underlie a CM QTL by influencing responses to S. aureus for 
example, it is important to understand that weakened CM associations and heritability may be 
demonstrated in other herds where contagious spread is controlled.  
7.1.6 PMNs may contribute to acute cytokine responses during mastitis  
The cytokines produced from PMNs in response to various ligands (Chapter 4.0) not only 
represent stimulation of TLR-induced genes, but also others known to be induced during 
mastitis. The PMN ‘granulocyte’ populations used in this study contained a high proportion 
of neutrophils, short lived phagocytes which undergo apoptosis usually within 6-10 h (Savill, 
Wyllie et al. 1989). However, neutrophil activation, due to CXCR and TLR stimulation for 
example, will prolong their lifespan enabling them to perform antimicrobial effector 
functions important in the early stages of bacterial IMI. PMNs demonstrate greater immune 
197 
 
potential through the synthesis of cytokines that influence their own activity and survival, 
recruit additional immune cells and modulate the immune response (Hayashi, Means et al. 
2003; Paape, Bannerman et al. 2003; Parker, Whyte et al. 2005; Kobayashi 2008). Data in 
this thesis provide further evidence for PMN involvement in directing the mammary immune 
response, although this work would benefit from additional studies with highly purified 
neutrophil populations.  
 
7.2 Conclusions and Future work 
 Marker-assisted selection involving SNPs within boTLR1 and boCXCR1, and other 
genes of immune importance, if well implemented into breeding programmes, may 
play a role in addressing the current trends for increased CM and reduced fertility and 
profitability in UK dairy herds. All SNP associations in the research presented here 
will benefit from expanded analysis in other herds/breeds. 
 Reduced milk fat content may potentially indicate herd problems with IMI. Future 
work to evaluate any breeding and diagnostic potential, for example fat composition 
thresholds of infection and levels of fatty acids in milk during clinical and subclinical 
mastitis, is required. 
 Non-coding SNPs boTLR1-79T>G and boCXCR1 -205C>T may interfere with Oct-1 
and Sp1 DNA binding respectively. To verify these DNA-protein interactions, DNA-
protein binding assays on relevant upstream genomic DNA sequences will be needed. 
Methods for detecting DNA-protein interactions can be performed in vitro via DNA 
electrophoretic mobility shift assays (EMSA), or in vivo via a chromatin 
immunoprecipitation (ChIP) assay, which allows analysis of DNA-protein 
interactions in living cells that can be quantified if coupled with Q-PCR. Assay 
readouts could further reveal differences in binding potential between SNP genotypes. 
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 To validate the cis-acting potential of non-coding SNPs boTLR1-79T>G and 
boCXCR1-205C>T, DNA constructs, involving insertion of a 5’ genomic/reporter 3’ 
DNA template into a suitable expression vector, will be required. The DNA template 
will specifically comprise 1-2 kB of upstream genomic sequence (containing the 
SNP) preceding a reporter gene encoding the enzyme luciferase. Constructs will be 
transfected into a cell-line and the resulting cellular expression and activity of 
luciferase quantified. These measurements could reveal differences between the 
genotypes (SNP variant constructs) indicating that SNP presence, upstream of the 
reporter gene, has an impact on the transcription of luciferase; further demonstrating 
that non-coding SNPs boTLR1-79T>G and boCXCR1-205C>T could interfere with 
Oct-1 / Sp1 regulation of boTLR1 / boCXCR1 transcription in vivo. 
 The presence and inheritance of the boCXCR1 SNP +621G>A (stop codon mutation) 
with the T allele (-205C>T) requires verification. Functional assays to determine 
whether a truncated boCXCR1 protein can effectively signal through its second 
intracellular loop (containing the DRYLAIV motif), or whether the protein is non-
functional, will be required. These may involve investigations into the downstream 
signalling molecules induced by boCXCR1 chemokine interactions, for example 
utilising RNA-Seq, an approach to transcriptome profiling using deep sequencing-
based technologies (Wang, Gerstein et al. 2009). Cell migration assays can also be 
performed and could reveal impaired migration towards a CXCL8 gradient from 
neutrophils expressing truncated CXCR1. 
 Expanding boTLR1 variant assays, by stimulating with live pathogen and measuring 
additional cytokine output, may further demonstrate the importance of boTLR1-
directed immune responses during mastitis and other diseases. The use of microarrays 
or RNA-Seq to evaluate pathway analysis from variants could reveal and detail 
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downstream transcriptome differences that may correlate with genotype differences in 
the cytokine response. Assays to measure NF-κB activity induced by TLR can also be 
performed.  
 Extending the analysis of boTLR1 in T cell activation, a cell response observed 
during S. aureus mastitis (Rivas, Schwager et al. 2007), could be of particular interest 
and further our understanding of disease. Assays to measure TLR1-induced levels of 
immune factors important in T cell recruitment, for example a panel of 
Th1/Th2/Th17-related cytokines, can be performed. 
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Appendix I - Stability of boRPLP2/boGAPDH expression ratios in PMNs exposed to 
TLR ligand 
 
Each column represents the data mean for boRPLP2/boGAPDH gene expression ratios from 
animal samples (n =12) used for Q-PCR assays. Orange columns = 4 h post-stimulation data, 
yellow columns = 8 h post-stimulation data. Error bars = SEM. No significant differences 
between columns detected using one-way ANOVA with Tukey’s post-test. 
PAM3 Ligand treatment
B
o
R
P
L
P
2
/b
o
G
A
P
D
H
 r
a
ti
o
Media 100ng/mL 250ng/mL 500ng/mL 100ng/mL 250ng/mL 500ng/mL LPS
0.0
0.5
1.0
1.5
2.0
212 
 
Appendix II - Genotype trends for yearly CM incidence (2003-2010) between boTLR1 -
79T>G TT, TG and GG cows 
 
Large marker points represent data mean from >30 lactations.*Significance detected (P<0.05 
by ANOVA and Tukey’s multiple comparisons) for that year between GG cows tested 
against both TG and TT cows. 
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Appendix III - Genotype trends for yearly CM incidence (2003-2010) between boCXCR1 
-205C>T CC and CT cows 
 
Large marker points represent data mean from >20 lactations.*Significance detected (P<0.05 
by unpaired t test) for that year between genotypes cows. 
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